Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20190054101A1
Опубликовано: 21-02-2019
Автор(ы): Jagdmann Gunnar E., Van Zandt Michael
Принадлежит:
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Novel arginase inhibitors

Номер патента: WO2020249821A1. Автор: Alexander Domling,Santosh Kurhade. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2020-12-17.

Arginase inhibitors

Номер патента: US11845767B2. Автор: Alexander Domling,Santosh Kurhade. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2023-12-19.

Arginase inhibitors as therapeutics

Номер патента: US09440995B2. Автор: Michael Van Zandt,Gunnar E. Jagdmann. Владелец: Mars Inc. Дата публикации: 2016-09-13.

Arginase Inhibitors as Therapeutic Agents

Номер патента: ES2794006T3. Автор: Zandt Michael Van,Jagdmann, Jr. Владелец: Mars Inc. Дата публикации: 2020-11-17.

Arginase inhibitors as therapeutics

Номер патента: US20150191492A1. Автор: Michael Van Zandt,Gunnar E. Jagdmann. Владелец: Individual. Дата публикации: 2015-07-09.

Arginase Inhibitors as Therapeutics

Номер патента: US20200246362A1. Автор: Van Zandt Michael,Jagdmann Gunnar E.. Владелец: . Дата публикации: 2020-08-06.

Boronates as arginase inhibitors

Номер патента: CA2815536C. Автор: Michael Van Zandt,Gunnar Erik Jagdmann, Jr.. Владелец: Mars Inc. Дата публикации: 2019-10-01.

Arginase inhibitors and methods of use thereof

Номер патента: AU2020218651A1. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Sameer Kawatkar,Scott Nathan Mlynarski,Tyler Grebe. Владелец: AstraZeneca AB. Дата публикации: 2021-09-30.

Arginase inhibitors and methods of use thereof

Номер патента: CA3127755A1. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Sameer Kawatkar,Scott Nathan Mlynarski,Tyler Grebe. Владелец: AstraZeneca AB. Дата публикации: 2020-08-13.

Arginase inhibitors and methods of use thereof

Номер патента: US20220106335A1. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Sameer Kawatkar,Scott Nathan Mlynarski,Tyler Grebe. Владелец: AstraZeneca AB. Дата публикации: 2022-04-07.

Arginase inhibitors and methods of use thereof

Номер патента: NZ767738A. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca AB. Дата публикации: 2023-12-22.

Arginase inhibitors and methods of use thereof

Номер патента: AU2022203938B2. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca AB. Дата публикации: 2024-02-01.

Arginase inhibitors and methods of use thereof

Номер патента: NZ767738B2. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca AB. Дата публикации: 2024-03-26.

Arginase inhibitors and methods of use thereof

Номер патента: US11912727B2. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca AB. Дата публикации: 2024-02-27.

Arginase Inhibitors and Methods of Use Thereof

Номер патента: US20230365599A1. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca Pharmaceuticals LP. Дата публикации: 2023-11-16.

Arginase inhibitors and methods of use thereof

Номер патента: IL285108B2. Автор: . Владелец: AstraZeneca AB. Дата публикации: 2024-10-01.

Arginase inhibitors and methods of use thereof

Номер патента: IL280924B2. Автор: . Владелец: AstraZeneca AB. Дата публикации: 2024-10-01.

Arginase inhibitors and methods of use thereof

Номер патента: IL280924B1. Автор: . Владелец: AstraZeneca AB. Дата публикации: 2024-06-01.

Arginase inhibitors and methods of use thereof

Номер патента: IL276711B2. Автор: . Владелец: AstraZeneca AB. Дата публикации: 2024-06-01.

Boronates as arginase inhibitors

Номер патента: WO2012058065A1. Автор: Michael Van Zandt,Jr. Gunnar Erik Jagdmann. Владелец: Mars Incorporated. Дата публикации: 2012-05-03.

Arginase inhibitors and methods of use thereof.

Номер патента: MX2020008570A. Автор: Maurice Raymond Verschoyle Finlay,Iain Simpson,Steve Cook,Sameer Kawatkar,Dedong Wu,Scott Nathan Mlynarski,Tyler Grebe,Jianyan Wang. Владелец: AstraZeneca AB. Дата публикации: 2020-09-21.

Arginase inhibitors and methods of use thereof

Номер патента: CA3147226A1. Автор: Xiaolan Zheng,Qing Ye,Haixia Wang,Iain Simpson,Sameer Kawatkar,Scott Nathan Mlynarski,Jason Shields,Ray Finlay. Владелец: AstraZeneca AB. Дата публикации: 2021-01-28.

Arginase inhibitors and methods of use thereof

Номер патента: TW201945004A. Автор: 慕里斯 雷蒙 佛斯裘爾 芬萊,史考特 納森 瑪蓮那斯基,泰勒 葛理柏,賽米爾 卡渥卡爾,艾恩 辛浦森,建燕 王,史帝夫 庫克. Владелец: 瑞典商阿斯特捷利康公司. Дата публикации: 2019-12-01.

Novel arginase inhibitors

Номер патента: EP3983068C0. Автор: Alexander Domling,Santosh Kurhade. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2024-03-20.

Borate as arginase inhibitor and composition and application thereof

Номер патента: CN106008569B9. Автор: 迈克尔·范赞特,甘纳尔·艾瑞克·小亚格德曼. Владелец: Mars Inc. Дата публикации: 2020-05-22.

Boronates as arginase inhibitors

Номер патента: PL2632927T3. Автор: Zandt Michael Van,Jr. Gunnar Erik Jagdmann. Владелец: . Дата публикации: 2016-09-30.

Arginase inhibitors and methods of use thereof

Номер патента: CA3109100A1. Автор: Dedong Wu. Владелец: AstraZeneca AB. Дата публикации: 2020-02-27.

BORONATES AS ARGINASE INHIBITORS

Номер патента: BR112013010099B1. Автор: Michael Van Zandt,Gunnar Erik Jagdmann Jr.. Владелец: MARS, INCORPORATED. Дата публикации: 2021-08-10.

ARGINASE INHIBITORS AND THEIR METHODS OF USE

Номер патента: NI202000055A. Автор: Simpson Iain,Cook Steve,KAWATKAR Sameer,WU Dedong,GREBE Tyler,WANG Jianyan,Raymond Verschoyle Finlay Maurice,Nathan Mlynarski Scott. Владелец: AstraZeneca AB. Дата публикации: 2021-06-22.

Arginase inhibitors and methods of use thereof

Номер патента: CN111712302A. Автор: S·库克,王建燕,S·N·姆利纳斯基,I·辛普森,T·格里布,S·卡瓦卡,M·R·V·芬莱,吴德冬. Владелец: AstraZeneca AB. Дата публикации: 2020-09-25.

Boronates as arginase inhibitors

Номер патента: RS54750B1. Автор: Zandt Michael Van,Jr Gunnar Erik Jagdmann. Владелец: Mars Inc. Дата публикации: 2016-10-31.

Boronates as arginase inhibitors

Номер патента: EP2632927B1. Автор: Michael Van Zandt,Jr. Gunnar Erik Jagdmann. Владелец: Mars Inc. Дата публикации: 2016-02-10.

Arginase inhibitors and methods of use thereof

Номер патента: AU2020319132B2. Автор: Xiaolan Zheng,Qing Ye,Haixia Wang,Iain Simpson,Sameer Kawatkar,Scott Nathan Mlynarski,Jason Shields,Ray Finlay. Владелец: AstraZeneca AB. Дата публикации: 2023-09-07.

Novel arginase inhibitors

Номер патента: EP3983068B1. Автор: Alexander Domling,Santosh Kurhade. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2024-03-20.

Arginase inhibitors and methods of use thereof

Номер патента: EP4371614A2. Автор: Dedong Wu. Владелец: AstraZeneca AB. Дата публикации: 2024-05-22.

Arginase inhibitors and methods of use thereof

Номер патента: IL285108B1. Автор: . Владелец: AstraZeneca AB. Дата публикации: 2024-06-01.

Boronates as arginase inhibitors, compositions and applications thereof

Номер патента: CN106008569A. Автор: 迈克尔·范赞特,甘纳尔·艾瑞克·小亚格德曼. Владелец: Mars Inc. Дата публикации: 2016-10-12.

Arginase inhibitors and methods of use thereof

Номер патента: CN114127081A. Автор: H·王,郑晓兰,S·N·姆利纳斯基,J·希尔兹,S·卡瓦特卡,Q·叶,R·芬莱,I·辛普森. Владелец: AstraZeneca AB. Дата публикации: 2022-03-01.

Boronates as arginase inhibitors

Номер патента: EP2632927A1. Автор: Michael Van Zandt,Jr. Gunnar Erik Jagdmann. Владелец: Mars Inc. Дата публикации: 2013-09-04.

boronates as arginase inhibitors

Номер патента: BR112013010099A2. Автор: Michael Van Zandt,Gunnar Erik Jagdmann Jr. Владелец: Mars Inc. Дата публикации: 2016-09-06.

Novel arginase inhibitors

Номер патента: AU2020293645A1. Автор: Alexander Domling,Santosh Kurhade. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2021-12-23.

Boronates as arginase inhibitors

Номер патента: JP5909239B2. Автор: ザント マイケル ヴァン,ザント マイケル ヴァン,ジュニア グンナー エリック ジャグドマン,ジュニア グンナー エリック ジャグドマン. Владелец: Mars Inc. Дата публикации: 2016-04-26.

Boronates as arginase inhibitors

Номер патента: HRP20160305T1. Автор: Michael Van Zandt,Gunnar Erik Jagdmann. Владелец: MARS, INCORPORATED. Дата публикации: 2016-07-01.

Arginase inhibitors and methods of use thereof

Номер патента: EP3840837B1. Автор: Dedong Wu. Владелец: AstraZeneca AB. Дата публикации: 2024-03-20.

Boronates as arginase inhibitors.

Номер патента: MX2013004491A. Автор: Michael Van Zandt,Erik Jagdmann Gunnar Jr. Владелец: Mars Inc. Дата публикации: 2013-11-04.

As the borate of arginase inhibitor

Номер патента: CN103249737B. Автор: 迈克尔·范赞特,甘纳尔·艾瑞克·小亚格德曼. Владелец: Mars Inc. Дата публикации: 2016-06-08.

Arginase inhibitors and methods of use thereof

Номер патента: WO2020038983A1. Автор: Dedong Wu. Владелец: AstraZeneca AB. Дата публикации: 2020-02-27.

Arginase inhibitors and methods of use thereof

Номер патента: US11952392B2. Автор: Dedong Wu. Владелец: AstraZeneca AB. Дата публикации: 2024-04-09.

Arginase inhibitors and methods of use

Номер патента: EP4087583A4. Автор: Christian Fischer,Hongjun Zhang,Anandan Palani,Min Lu,Derun Li,Qinglin Pu,Symon GATHIAKA,Abdelghani Abe Achab,David L Sloman,Matthew L Childers,Rachel L Palte. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2024-01-24.

Use of amine carboxyboranes as therapeutic delivery of carbon monoxide and as general drug delivery system in the presence of reactive oxygen species

Номер патента: US20180194784A1. Автор: Nin N. Dingra,Theppawut Israsena Na Ayudhya. Владелец: Florida Southwestern State College. Дата публикации: 2018-07-12.

USE OF AMINE CARBOXYBORANES AS THERAPEUTIC DELIVERY OF CARBON MONOXIDE AND AS GENERAL DRUG DELIVERY SYSTEM IN THE PRESENCE OF REACTIVE OXYGEN SPECIES

Номер патента: US20200255455A1. Автор: Dingra Nin N.,Ayudhya Theppawut Israsena Na. Владелец: . Дата публикации: 2020-08-13.

Arginase inhibitors and therapeutic use thereof

Номер патента: RU2586219C2. Автор: ЗАНДТ Майкл ВАН,Адам ГОЛЕБИОВСКИ,Минь Коо ЦЗИ,Даррен УАЙТХАУЗ,Тодд РАЙДЕР,Пол БЕККЕТ. Владелец: Марс, Инкорпорейтед. Дата публикации: 2016-06-10.

Arginase inhibitors and methods of use thereof

Номер патента: EP4267590A1. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Jacek CHRZANOWSKI,Jacek OLCZAK,Marcin Mikolaj Grzybowski,Kamil LISIECKI,Damian Kusmirek,Paulina Pomper,Nazan Cemre GÜNER-CHALIMONIUK. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2023-11-01.

Arginase inhibitors and methods of use

Номер патента: WO2010085797A3. Автор: Gary Lee Olson,David W. Christianson,Bruce Edward Tomczuk,Richard Scott Pottorf,Andrew Vargha Colasanti. Владелец: Arginetix, Inc.. Дата публикации: 2010-11-04.

ARGINASE INHIBITORS

Номер патента: US20210002306A1. Автор: KALISIAK Jaroslaw,Guney Tezcan,FOLEY Corinne Nicole,GRANGE Rebecca Louise,NEWCOMB Eric Thomas,TRAN Anh Thu. Владелец: . Дата публикации: 2021-01-07.

Alkylboronic acids as arginase inhibitors

Номер патента: CN113614095A. Автор: 马建斌,王召印,邵延强,李南欣. Владелец: Guangdong Xinqi Biomedical Technology Co ltd. Дата публикации: 2021-11-05.

Arginase Inhibitors and Methods of Use

Номер патента: US20200223871A1. Автор: Tomczuk Bruce Edward,Olson Gary Lee,Pottorf Richard Scott,Christianson David W.,Colasanti Andrew Vargha. Владелец: . Дата публикации: 2020-07-16.

HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS

Номер патента: US20200325161A1. Автор: Wang Zhaoyin,Li Nanxin,Ma Jianbin,Shao Yanqiang. Владелец: Guangdong Newopp Biopharmaceuticals Co., Ltd.. Дата публикации: 2020-10-15.

Arginase inhibitors and methods of use

Номер патента: EP2389352B1. Автор: Gary Lee Olson,David W. Christianson,Bruce Edward Tomczuk,Richard Scott Pottorf,Andrew Vargha Colasanti. Владелец: Astrazeneca Uk Ltd. Дата публикации: 2019-05-08.

Alkylboronic acids as arginase inhibitors

Номер патента: WO2020160707A1. Автор: Nanxin LI,Zhaoyin Wang,Jianbin MA,Yanqiang SHAO. Владелец: Guangdong Newopp Biopharmaceuticals Co., Ltd.. Дата публикации: 2020-08-13.

Arginase Inhibitors and Methods of Use

Номер патента: US20190127395A1. Автор: Tomczuk Bruce Edward,Olson Gary Lee,Pottorf Richard Scott,Christianson David W.,Colasanti Andrew Vargha. Владелец: . Дата публикации: 2019-05-02.

Arginase inhibitors and usage methods.

Номер патента: TR201910726T4. Автор: Lee Olson Gary,W Christianson David,Edward Tomczuk Bruce,Scott Pottorf Richard,Vargha Colasanti Andrew. Владелец: Astrazeneca Uk Ltd. Дата публикации: 2019-08-21.

Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents

Номер патента: US5658897A. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1997-08-19.

Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents

Номер патента: CA2251132C. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2006-05-30.

Arginase inhibitor compounds, compositions comprising same and uses thereof

Номер патента: IL235155B. Автор: . Владелец: Mars Inc. Дата публикации: 2018-06-28.

Ring constrained analogs as arginase inhibitors

Номер патента: CA2870526A1. Автор: Michael Van Zandt,Gunnar Erik Jagdmann, Jr.. Владелец: Mars Inc. Дата публикации: 2013-10-24.

Arginase inhibitors and methods of use

Номер патента: WO2020131598A1. Автор: Hongjun Zhang,Matthew L. CHILDERS,Charles A. Lesburg,Anandan Palani,Min Lu,Jared N. Cumming,Derun Li,Symon GATHIAKA,Matthew J. Mitcheltree,Abdelghani Abe Achab,Rachel L. Palte. Владелец: Merck Sharp & Dohme Corp.. Дата публикации: 2020-06-25.

Arginase inhibitors and methods of use thereof

Номер патента: RU2695650C2. Автор: Брюс Эдвард ТОМЧУК,Гэри Ли ОЛСОН,Ричард Скотт ПОТТОРФ,Джейн ВАН,Бхаскара Рао НАЛЛАГАНЧУ. Владелец: Астразенека Юкей Лимитед. Дата публикации: 2019-07-25.

Arginase inhibitors and methods of use thereof

Номер патента: US09447122B2. Автор: Gary Lee Olson,Lijuan Jane Wang,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Yanqun Zhang. Владелец: AstraZeneca AB. Дата публикации: 2016-09-20.

Process for removing radioactive isotopes from aqueous fluids by fluorine containing reagents, fluorine containing, water-insoluble salts of the radioactive isotopes, and their use as therapeutic agents

Номер патента: WO2017153436A1. Автор: Klaus-Richard Porschke,David Pollak. Владелец: STUDIENGESELLSCHAFT KOHLE MBH. Дата публикации: 2017-09-14.

Arginase inhibitors

Номер патента: US12054500B2. Автор: Jaroslaw Kalisiak,Tezcan Guney,Corinne Nicole FOLEY,Rebecca Louise GRANGE,Eric Thomas NEWCOMB,Anh Thu TRAN. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-08-06.

Arginase inhibitors

Номер патента: AU2019229978B2. Автор: Jaroslaw Kalisiak,Tezcan Guney,Corinne Nicole FOLEY,Rebecca Louise GRANGE,Eric Thomas NEWCOMB,Anh Thu TRAN. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-05-30.

Arginase inhibitors

Номер патента: CA3091805A1. Автор: Jaroslaw Kalisiak,Tezcan Guney,Corinne Nicole FOLEY,Rebecca Louise GRANGE,Eric Thomas NEWCOMB,Anh Thu TRAN. Владелец: Arcus Biosciences Inc. Дата публикации: 2019-09-12.

Arginase inhibitors and methods of use

Номер патента: US11274111B2. Автор: Christian Fischer,Hongjun Zhang,Charles A. Lesburg,Anandan Palani,Min Lu,Jared N. Cumming,Derun Li,David L. Sloman,Symon GATHIAKA,Matthew J. Mitcheltree,Abdelghani Abe Achab,Rachel L. Palte. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2022-03-15.

Arginase inhibitors

Номер патента: WO2019173188A1. Автор: Jaroslaw Kalisiak,Tezcan Guney,Corinne Nicole FOLEY,Rebecca Louise GRANGE,Eric Thomas NEWCOMB,Anh Thu TRAN. Владелец: Arcus Biosciences, Inc.. Дата публикации: 2019-09-12.

Arginase inhibitors and methods of use

Номер патента: EP3810615A1. Автор: Christian Fischer,Hongjun Zhang,Charles A. Lesburg,Anandan Palani,Min Lu,Jared N. Cumming,Derun Li,David L. Sloman,Symon GATHIAKA,Matthew J. Mitcheltree,Abdelghani Abe Achab,Rachel L. Palte. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2021-04-28.

ARGINASE INHIBITORS

Номер патента: EA202092086A1. Автор: Ярослав КАЛИСИАК,Корин Николь Фоли,Ребека Луис Грейндж,Тезджан Гуней,Эрик Томас Ньюкомб,Анх Тху Тран. Владелец: Аркус Байосайенсиз, Инк.. Дата публикации: 2021-02-09.

Arginase inhibitor and its treatment use

Номер патента: CN104876955B. Автор: 迈克尔·范赞特,亚当·戈文比奥夫斯基,邱池民,达伦·怀特豪斯,托德·赖德,保罗·贝克特. Владелец: Mars Inc. Дата публикации: 2018-11-23.

Arginase inhibitors

Номер патента: CO2020012060A2. Автор: Jaroslaw Kalisiak,Tezcan Guney,Corinne Nicole FOLEY,Rebecca Louise GRANGE,Eric Thomas NEWCOMB,Anh Thu TRAN. Владелец: Arcus Biosciences Inc. Дата публикации: 2021-01-18.

EphA4 inhibitors as neuroprotective agents

Номер патента: US09629830B2. Автор: Kit Yu Fu,Wing Yu Fu,Nancy Yuk Yu Ip,Fanny Chui Fun Ip,Shuo Gu,Xuhui HUANG,Kwok Wang HUNG. Владелец: Hong Kong University of Science and Technology HKUST. Дата публикации: 2017-04-25.

Histone deacetylase inhibitors as therapeutics for neurological diseases

Номер патента: EP1951656A1. Автор: Ryan Burnett,Joel M. Gottesfeld,David M. Herman,Kai Jenssen,C. James Chou. Владелец: Scripps Research Institute. Дата публикации: 2008-08-06.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: RU2769827C2. Автор: Султан ЧОВДХУРИ,Жан-Кристоф Андре,Кристен Николь БЕРФОРД,Чарльз Джей КОЭН,Кристоф Мартин ДЕНХАРДТ,Роберт Джозеф ДЕВИТА,Джеймс Рой ЭМПФИЛД,Тило Фоккен,Майкл Эдвард ГРИМВУД,Сайед Абид ХАСАН,Джеймс Филип Мл. ДЖОНСОН,Алла Юрьевна ЗЕНОВА. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2022-04-06.

Spiroheterocyclic compounds and use thereof as therapeutic agents

Номер патента: RU2428424C2. Автор: Сергей СВИРИДОВ,Цзяньминь Фу,Шифэн ЛЮ,Михаил ЧАФЕЕВ,Раджендер КАМБОДЖ,Цзяниу СУНЬ,Султан ЧОВДХУРИ,Роберт ФРЕЙЗЕР,Мехран Сеид БАГХЕРЗАДЕХ. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2011-09-10.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: RU2760303C2. Автор: Султан ЧОВДХУРИ,Ци ЦЗЯ,Жан-Кристоф Андре,Кристен Николь БЕРФОРД,Чарльз Джей КОЭН,Кристоф Мартин ДЕНХАРДТ,Роберт Джозеф ДЕВИТА,Джеймс Рой ЭМПФИЛД,Тило Фоккен,Майкл Эдвард ГРИМВУД,Сайед Абид ХАСАН,Джеймс Филип Мл. ДЖОНСОН,Алла Юрьевна ЗЕНОВА,Дэвид Эрл БОГУЦКИ,Шеннон Мари ДЕКЕР,Майкл Скотт УИЛСОН. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2021-11-23.

Synthesis of resorcylic acid lactones used as therapeutic agents

Номер патента: RU2534527C2. Автор: Николас ВИНССИНГЕР,София БАРЛУЕНГА,Мартин КАРПЛАС. Владелец: Юниверсите Де Страсбур. Дата публикации: 2014-11-27.

Enantiomers of spiro-oxindole compounds and using them as therapeutic agents

Номер патента: RU2535667C2. Автор: Цзяньминь Фу,Михаил ЧАФЕЕВ,Жан-Жак КАДЬЕ. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2014-12-20.

Spirooxyindole derivatives and application thereof as therapeutic agents

Номер патента: RU2415143C2. Автор: Сергей СВИРИДОВ,Цзяньминь Фу,Шифэн ЛЮ,Шаои СУНЬ,Михаил ЧАФЕЕВ,Нагасрее ЧАККА,Раджендер КАМБОДЖ,Цзяниу СУНЬ,Султан ЧОВДХУРИ,Том ХСИЕХ,Роберт ФРЕЙЗЕР,Дуаньцзе ХОУ,Мехран Сеид БАГХЕРЗАДЕХ,Вандна РАИНА. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2011-03-27.

Selective serotonin 2a/2c receptor inverse agonists, used as therapeutics for neurodegeneratives diseases

Номер патента: RU2332401C2. Автор: Дэвид М. УЭЙНЕР,Марк Р. БРЭНН,Роберт Е. ДЭВИС. Владелец: Акадиа Фармасьютикалз Инк.. Дата публикации: 2008-08-27.

Triazine, pyrimidine and pyridine analogues and use thereof as therapeutic agents and diagnostic samples

Номер патента: RU2537945C2. Автор: Владимир ЦМИЛЬЯНОВИЦ,Маттиас ВИМАНН,Натаса ЦМИЛЬЯНОВИЦ,Бернд ГИЗЕ. Владелец: Юниверсити Оф Базель. Дата публикации: 2015-01-10.

Heteroaryl compounds and use thereof as therapeutic drugs

Номер патента: RU2723480C2. Автор: Дзин Кван КИМ,Миеонг-Сеоп КИМ,Сумин КИМ,Хадонг КИМ,Ки Моон РИУ,Сеонг Дзин ПАРК,Таесун ПАРК,Дзоон-Хо ШЕЕН,Таейоунг Йоон,Ми Йеон ДЗАНГ. Владелец: Тон-А Сосио Холдингз Ко., Лтд.. Дата публикации: 2020-06-11.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: CA3125278A1. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2020-07-02.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: PH12021551092A1. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2021-12-06.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: EP3902606A1. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2021-11-03.

Selective inverse serotonin 2a/2c receptor agonists applicables as therapeutic agents for neurodegenerative disorders

Номер патента: RU2465267C2. Автор: Дэвид М. УЭЙНЕР,Марк Р. БРЭНН,Роберт Е. ДЭВИС,Норман НЭШ,Карл-Магнус А. АНДЕРСОН,Алан К. УЛЬДАМ. Владелец: Акадиа Фармасьютикалз Инк.. Дата публикации: 2012-10-27.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: CA3183057A1. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Individual. Дата публикации: 2021-12-23.

Arylcarbonyl derivatives as therapeutic agents

Номер патента: RU2340605C2. Автор: Йеспер ЛАУ,Мустафа Гузель,Пер ВЕДСЁ,Говиндан СУБРАМАНИАН,Роберт Карл ЭНДРЮС,Калпати Чидамбаресваран САНТОШ,Лоне ЙЕППЕСЕН,Дхарма Рао ПОЛИЗЕТТИ,Янос Тибор КОДРА,Пав БЛОК,Мари Кармен ВАЛЬКАРСЕ-ЛОПЕС,Мария Кармен Валькарсе-Лопес,Нильс БЛУМЕ,Аднан М. М. МДЖАЛЛИ,Михаель АНКЕРСЕН,Энтони МЮРРЭЙ. Владелец: Ново Нордиск А/С. Дата публикации: 2008-12-10.

Bicyclosulphonyl acid (bcsa) and use thereof as therapeutic agent

Номер патента: RU2472784C2. Автор: Дэниел РОБИНСОН,Айгарс Йиргенсонс,Гундарс ЛЕЙТИС,Иварс Калвинш,Пол ФИНН,Нагма ХАН. Владелец: Инхайбокс Лтд.. Дата публикации: 2013-01-20.

Spirocyclic compounds and their use as therapeutic agents and diagnostic probes

Номер патента: AU2011228703A1. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: UNIVERSITAET BASEL. Дата публикации: 2012-09-20.

Lsd1 inhibitor, as well as its production method and its application

Номер патента: RU2763898C2. Автор: Ли ЧЖАН,Шухуэй Чэнь,Цзянь ЛИ,Линюнь У,Леле Чжао,Цзяньцзюнь СУНЬ,Чжаого ЧЭНЬ. Владелец: Цспц Чжунци Фармасьютикал Текнолоджи (Шицзячжуан) Ко., Лтд.. Дата публикации: 2022-01-11.

Lsd1 inhibitor, as well as its production method and its application

Номер патента: RU2763898C9. Автор: Ли ЧЖАН,Шухуэй Чэнь,Цзянь ЛИ,Линюнь У,Леле Чжао,Цзяньцзюнь СУНЬ,Чжаого ЧЭНЬ. Владелец: Цспц Чжунци Фармасьютикал Текнолоджи (Шицзячжуан) Ко., Лтд.. Дата публикации: 2022-03-18.

Disubstituted pyrazolobenzodiazepines used as cdk2 and angiogenesis inhibitors, as well as for treating malignant growths in mammary glands, large intestines, lungs and prostate glands

Номер патента: RU2394826C2. Автор: Цзиньцзунь ЛЮ,Чжумин ЧЖАН,Кин-Чун ЛУК,Джякомо ПИЦЦОЛАТО,И Рэнь,Кшитий Ччабилбхай ТХАККАР,Питер Майкл ВОВКУЛИХ. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2010-07-20.

Pharmaceutical composition for preventing or treating cancer, containing mtor-signaling inhibitor as active ingredient

Номер патента: US20230346762A1. Автор: Seyun KIM,Boah LEE,Seung Ju PARK. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2023-11-02.

Gla domains as therapeutic agents

Номер патента: RU2705786C2. Автор: Максин БОЗОН,Терри ХЕРМИСТОН. Владелец: Гладиатор Байосайенсиз, Инк.. Дата публикации: 2019-11-11.

Anti-hcv monoclonal antibody as therapeutic agent for medical treatment and prevention of hcv infections

Номер патента: RU2596409C2. Автор: Роберто БУРИОНИ,Массимо КЛЕМЕНТИ. Владелец: Помона Ричерка С.Р.Л.. Дата публикации: 2016-09-10.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: US20220089547A1. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2022-03-24.

Peptides of il-2 and derivatives thereof and their use as therapeutic agents

Номер патента: EP1097173A1. Автор: Jacques THÈZE,Thierry Rose,Jean-Louis Moreau,Jean-Claude Mazie,Ralph Eckenberg,Pedro Alzari,Michel Goldberg. Владелец: Institut Pasteur de Lille. Дата публикации: 2001-05-09.

Peptides of IL-2 and derivatives thereof and their use as therapeutic agents

Номер патента: US20040202661A1. Автор: Jacques THÈZE,Thierry Rose,Jean-Louis Moreau,Jean-Claude Mazie,Ralph Eckenberg,Pedro Alzari,Michel Golberg. Владелец: Institut Pasteur de Lille. Дата публикации: 2004-10-14.

Peptides of IL-2 and derivatives thereof and their use as therapeutic agents

Номер патента: US6825334B1. Автор: Jacques THÈZE,Thierry Rose,Jean-Louis Moreau,Jean-Claude Mazie,Ralph Eckenberg,Pedro Alzari,Michel Golberg. Владелец: Institut Pasteur de Lille. Дата публикации: 2004-11-30.

The use of peptides of il-2 and derivatives thereof as therapeutic agents

Номер патента: EP1097173B1. Автор: Jacques THÈZE,Thierry Rose,Jean-Louis Moreau,Jean-Claude Mazie,Ralph Eckenberg,Pedro Alzari,Michel Goldberg. Владелец: Institut Pasteur de Lille. Дата публикации: 2008-05-21.

Peptides of IL-2 and derivatives thereof and their use as therapeutic agents

Номер патента: US20060018873A1. Автор: Jacques THÈZE,Thierry Rose,Jean-Louis Moreau,Jean-Claude Mazie,Ralph Eckenberg,Pedro Alzari,Michel Goldberg. Владелец: Institut Pasteur de Lille. Дата публикации: 2006-01-26.

Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents

Номер патента: US20110091383A1. Автор: Ganjam V. Kalpana,Bhaskar C. DAS. Владелец: Individual. Дата публикации: 2011-04-21.

Pseudovirions comprising virus capsids, histones and nucleic acids as therapeutic agents

Номер патента: WO2003018622A1. Автор: Martin Sapp. Владелец: Virofem Diagnostica Gmbh. Дата публикации: 2003-03-06.

N-substituted phenylalkylamines and their use as therapeutic agents

Номер патента: WO2024006226A1. Автор: Paul Daley,Nicholas COZZI. Владелец: Alexander Shulgin Research Institute, Inc.. Дата публикации: 2024-01-04.

Therapeutic agent used for graft-versus-host disease, containing interleukin-6 receptor inhibitor as active ingredient

Номер патента: RU2490025C2. Автор: Масахико МИХАРА,Йоитиро МОРИЯ. Владелец: Чугаи Сейяку Кабусики Кайся. Дата публикации: 2013-08-20.

Pharmaceutical composition for preventing or treating cancer, containing cd300e inhibitor as active ingredient

Номер патента: EP3805258A1. Автор: Joo-Yeon Chung,Areum Jeong,Youn Kyung Houh,Jinyoung Sohn,Yun Yeon Kim,Suro Lee,Kyoung Wan YOON,Bu-Nam JEON. Владелец: Genome and Co. Дата публикации: 2021-04-14.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: EP4427755A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Cncure Biotech Inc. Дата публикации: 2024-09-11.

Composition for preventing or treating diseases caused by overexpression of chemokine cx3cl1, containing death receptor inhibitor as active ingredient

Номер патента: US20230159650A1. Автор: Donghyun Kim,Eugene C. Yi,Min Jueng Kang,Doo Hyun CHUNG,Dongjin Jeong. Владелец: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION. Дата публикации: 2023-05-25.

Composition for preventing or treating diseases caused by overexpression of chemokine CX3CL1, containing death receptor inhibitor as active ingredient

Номер патента: US12091465B2. Автор: Donghyun Kim,Eugene C. Yi,Min Jueng Kang,Doo Hyun CHUNG,Dongjin Jeong. Владелец: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION. Дата публикации: 2024-09-17.

Pharmaceutical composition for preventing or treating cancer comprising LRIT2 inhibitor as active ingredient

Номер патента: US11787870B2. Автор: Joo-Yeon Chung,Areum Jeong,Youn Kyung Houh,Jinyoung Sohn,Yun Yeon Kim,Suro Lee,Kyoung Wan YOON,Bu-Nam JEON. Владелец: Genome and Co. Дата публикации: 2023-10-17.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: AU2022382621A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Cncure Biotech Inc. Дата публикации: 2024-05-30.

Use of composition for enhancing anticancer effect, comprising err.gamma. inhibitor as active ingredient

Номер патента: CA3159428C. Автор: Mi Jin Kim,Sung Jin Cho,Dong Su Kim,In Kyu Lee,Yong Hyun Jeon,Hoe Yune Jung,Jin A Kim,Yeon Kyung Choi,Keun Gyu Park,Jung Wook Chin. Владелец: Novmetapharma Co Ltd. Дата публикации: 2024-05-28.

Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer

Номер патента: CA3236831A1. Автор: Jung-Joon Min,Yeongjin Hong,Sung-Hwan YOU,Nguyen Dinh Huy. Владелец: Individual. Дата публикации: 2023-05-11.

Highly selective c-Met inhibitors as anticancer agents

Номер патента: US09695175B2. Автор: FENG Zhou,Chuan Shih,Boyu Zhong,Hongbin Yuan. Владелец: CB Therapeutics Inc Cayman Island. Дата публикации: 2017-07-04.

Sulfonyloxazolamines as therapeutically active compounds

Номер патента: RU2232757C2. Автор: Хеннинг БЁТТХЕР,Герд БАРТОШИК,Хартмут ГРАЙНЕР,Герхард БАРНИКЕЛЬ,Бертрам СЕЗАННЕ. Владелец: Мерк Патент Гмбх. Дата публикации: 2004-07-20.

Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents

Номер патента: WO2000037465A3. Автор: Cheng Guo,Rajan N Shah,Francois D Tropper. Владелец: Francois D Tropper. Дата публикации: 2000-09-08.

Cyclic indole-3-carboxamide, production and use thereof as therapeutic preparations

Номер патента: RU2485102C2. Автор: Ханс Ульрих ШТИЛЬЦ,Ханс МАТТЕР,Гари Маккорт,Хеннинг ШТАЙНХАГЕН,Бодо ШАЙПЕР. Владелец: Санофи-Авентис. Дата публикации: 2013-06-20.

Novel compounds that can be used as therapeutic agents

Номер патента: WO2024161041A1. Автор: Roman Marty,Johann Zimmermann,Viktoria REINMÜLLER,Olivier Wagnieres,Jean-Baptiste GUALTIEROTTI,Madeleine FELLNER,Matthias OSTERMAIER. Владелец: Xeniom Gmbh. Дата публикации: 2024-08-08.

Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents

Номер патента: US5457131A. Автор: Steven W. Andrews. Владелец: Allergan Inc. Дата публикации: 1995-10-10.

Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents

Номер патента: US5650413A. Автор: Jeremy Carver,Rajan Shah. Владелец: Glycodesign Inc. Дата публикации: 1997-07-22.

Substituted gamma-lactames as therapeutic agents

Номер патента: RU2543379C2. Автор: Данни Т. ДИНХ,Дэвид В. ОЛД. Владелец: Аллерган, Инк.. Дата публикации: 2015-02-27.

Substituted gamma lactams as therapeutic agents

Номер патента: MY150518A. Автор: David W Old,Danny T Dinh. Владелец: Allergan Inc. Дата публикации: 2014-01-30.

Arginase inhibitors and their therapeutic applications

Номер патента: US12053451B2. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Marek DZIEGIELEWSKI,Karol JEDRZEJCZAK,Julita NOWICKA,Joanna Brzezinska,Jacek OLCZAK,Krzysztof MATYSZEWSKI. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2024-08-06.

Arginase inhibitors and their therapeutic applications

Номер патента: AU2017259887B2. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Marek DZIEGIELEWSKI,Karol JEDRZEJCZAK,Julita NOWICKA,Joanna Brzezinska,Jacek OLCZAK,Krzysztof MATYSZEWSKI. Владелец: Molecure Sa. Дата публикации: 2022-03-17.

Arginase inhibitors and their therapeutic applications

Номер патента: CA3022482C. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Marek DZIEGIELEWSKI,Karol JEDRZEJCZAK,Julita NOWICKA,Joanna Brzezinska,Jacek OLCZAK,Krzysztof MATYSZEWSKI. Владелец: Molecure Sa. Дата публикации: 2024-06-11.

Arginase inhibitors and methods of use thereof

Номер патента: CA2824599C. Автор: Gary Lee Olson,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Jane Wang. Владелец: Astrazeneca Uk Ltd. Дата публикации: 2020-03-10.

Arginase Inhibitors and Their Therapeutic Applications

Номер патента: US20170319536A1. Автор: BLASZCZYK Roman,BRZEZINSKA Joanna,OLCZAK Jacek,GOLEBIOWSKI Adam,Borek Bartlomiej,Gzik Anna,Dziegielewski Marek,Jedrzejczak Karol,Nowicka Julita,Matyszewski Krzysztof. Владелец: . Дата публикации: 2017-11-09.

Arginase inhibitors and therapeutic uses thereof

Номер патента: KR102374788B1. Автор: 로만 브와슈치크,줄리타 노윅카,바르틀로미어 보레크,조안나 브줴진스카,안나 그직,마레크 드지글루스키,아담 골비아우스키,카롤 예제이차크,크지슈토프 마트세브스키,야체크 오자크. Владелец: 온코아렌디 테라퓨틱스 에스.에이.. Дата публикации: 2022-03-15.

Arginase inhibitors and methods of use thereof

Номер патента: CN103402549A. Автор: J·王,B·E·汤米克祖克,G·L·奥逊,R·S·波特夫,B·R·那拉干储. Владелец: Corridor Pharmaceuticals Inc. Дата публикации: 2013-11-20.

Arginase inhibitors and their therapeutic applications

Номер патента: CA3022482A1. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Marek DZIEGIELEWSKI,Karol JEDRZEJCZAK,Julita NOWICKA,Joanna Brzezinska,Jacek OLCZAK,Krzysztof MATYSZEWSKI. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2017-11-09.

Arginase inhibitors and their therapeutic applications

Номер патента: US10391077B2. Автор: Adam Golebiowski,Roman Blaszczyk,Anna GZIK,Bartlomiej BOREK,Marek DZIEGIELEWSKI,Karol JEDRZEJCZAK,Julita NOWICKA,Joanna Brzezinska,Jacek OLCZAK,Krzysztof MATYSZEWSKI. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2019-08-27.

Arginase Inhibitors and Methods of Use Thereof

Номер патента: US20120171116A1. Автор: Gary Lee Olson,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Jane Wang. Владелец: Corridor Pharmaceuticals Inc. Дата публикации: 2012-07-05.

ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS

Номер патента: US20180009830A1. Автор: BLASZCZYK Roman,BRZEZINSKA Joanna,GOLEBIOWSKI Adam A.,OLCZAK Jacek. Владелец: . Дата публикации: 2018-01-11.

Arginase Inhibitors and Methods of Use Thereof

Номер патента: US20160039847A1. Автор: Gary Lee Olson,Lijuan Jane Wang,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Yanqun Zhang. Владелец: AstraZeneca AB. Дата публикации: 2016-02-11.

Arginase Inhibitors and Their Therapeutic Applications

Номер патента: US20190365701A1. Автор: BLASZCZYK Roman,BRZEZINSKA Joanna,GOLEBIOWSKI Adam A.,Borek Bartlomiej,Gzik Anna,Dziegielewski Marek,Jedrzejczak Karol,Nowicka Julita. Владелец: . Дата публикации: 2019-12-05.

Arginase Inhibitors and Their Therapeutic Applications

Номер патента: US20210260019A1. Автор: BLASZCZYK Roman,BRZEZINSKA Joanna,OLCZAK Jacek,GOLEBIOWSKI Adam,Borek Bartlomiej,Gzik Anna,Dziegielewski Marek,Jedrzejczak Karol,Nowicka Julita,Matyszewski Krzysztof. Владелец: . Дата публикации: 2021-08-26.

Arginase inhibitor and its treatment use

Номер патента: CN109415387A. Автор: J·欧莱扎克,R·布拉什奇克,J·诺维卡,B·博雷克,J·布则因斯卡,A·格兹克,M·蒂兹杰勒斯基,A·戈列波斯基,K·杰德尔泽扎克,K·马蒂什埃乌斯基. Владелец: Alan Treatment Co Of Aung Ke. Дата публикации: 2019-03-01.

Arginase inhibitors and methods of use thereof

Номер патента: WO2012091757A1. Автор: Gary Lee Olson,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Jane Wang. Владелец: Corridor Pharmaceuticals, Inc.. Дата публикации: 2012-07-05.

Arginase inhibitors and methods of use thereof

Номер патента: CA2824599A1. Автор: Gary Lee Olson,Bhaskara Rao Nallaganchu,Bruce Edward Tomczuk,Richard Scott Pottorf,Jane Wang. Владелец: Corridor Pharmaceuticals Inc. Дата публикации: 2012-07-05.

Arginase inhibitors and their therapeutic applications.

Номер патента: MX2018013387A. Автор: BLASZCZYK Roman,BRZEZINSKA Joanna,OLCZAK Jacek,GOLEBIOWSKI Adam,Borek Bartlomiej,Gzik Anna,Dziegielewski Marek,Jedrzejczak Karol,Nowicka Julita,Matyszewski Krzysztof. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2019-02-28.

Human helicase ddx3 inhibitors as therapeutic agents

Номер патента: US20200140398A1. Автор: Javier Martinez,Maurizio Botta,Andreas Meyerhans,Annalaura BRAI,Cristina TINTORI,Roberta Fazi,José-Esté Araque,Miguel-Angel MARTINEZ DE LA SIERRA. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE. Дата публикации: 2020-05-07.

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

Номер патента: US20180016243A1. Автор: Botta Maurizio,Martinez Javier,MEYERHANS Andreas,MARTINEZ DE LA SIERRA Miguel-Angel,BRAI Annalaura,FAZI Roberta,TINTORI Cristina,ARAQUE Jose-Este. Владелец: . Дата публикации: 2018-01-18.

HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS

Номер патента: US20200140398A1. Автор: Botta Maurizio,Martinez Javier,MEYERHANS Andreas,MARTINEZ DE LA SIERRA Miguel-Angel,BRAI Annalaura,FAZI Roberta,TINTORI Cristina,ARAQUE Jose-Este. Владелец: AZIENDA OSPEDALIERA UNIVERSITARIA SENESE. Дата публикации: 2020-05-07.

Quaternary n-(halomethyl) ammonium salts as therapeutic agents

Номер патента: US20140194640A1. Автор: Luz Amalia Rios Vasquez,Rogelio Ocampo Cardona,Sandra Milena Duque,Sara Maria Robledo Restrepo,Ivan Dario Velez Bernal,David Leonardo Cedeño Medina,Marjorie Ann Jones. Владелец: Individual. Дата публикации: 2014-07-10.

Quaternary n-(halomethyl) ammonium salts as therapeutic agents

Номер патента: US20140194640A1. Автор: Luz Amalia Rios Vasquez,Rogelio Ocampo Cardona,Sandra Milena Duque,Sara Maria Robledo Restrepo,Ivan Dario Velez Bernal,David Leonardo Cedeño Medina,Marjorie Ann Jones. Владелец: Individual. Дата публикации: 2014-07-10.

Novel inhibitors of pyruvate kinase as therapeutic agents for cancer

Номер патента: CA2610647C. Автор: Brian Smith,Brian Leyland-Jones,Tak-Hang Chan. Владелец: Individual. Дата публикации: 2015-02-03.

3,4-methylenedioxy-substituted chalcones as therapeutic agents

Номер патента: CA2462276A1. Автор: Gerard Andrew Potter,Paul Crispin Butler. Владелец: Paul Crispin Butler. Дата публикации: 2003-04-10.

Substituted chalcones as therapeutic compounds

Номер патента: AU3945001A. Автор: Gerard Andrew Potter,Paul Crispin Butler,Elugba Wanogho. Владелец: Spear Therapeutics Ltd. Дата публикации: 2001-10-08.

PROCESS FOR REMOVING RADIOACTIVE ISOTOPES FROM AQUEOUS FLUIDS BY FLUORINE CONTAINING REAGENTS, FLUORINE CONTAINING, WATER-INSOLUBLE SALTS OF THE RADIOACTIVE ISOTOPES, AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20190092793A1. Автор: PÖRSCHKE Klaus-Richard,POLLAK David. Владелец: STUDIENGESELLSCHAFT KOHLE MBH. Дата публикации: 2019-03-28.

Process for removing radioactive isotopes from aqueous fluids by fluorine containing reagents, fluorine containing water-insoluble salts of the radioactive isotopes, and their use as therapeutic agents

Номер патента: CA3015721A1. Автор: Klaus-Richard Porschke,David Pollak. Владелец: STUDIENGESELLSCHAFT KOHLE MBH. Дата публикации: 2017-09-14.

Arginase inhibitor and its therapeutical uses

Номер патента: CN107406464A8. Автор: R·布瓦什奇克,J·布热津斯卡,A·A·戈文比奥夫斯基,J·欧莱扎克. Владелец: Oncoarendi Therapeutics SpZOO. Дата публикации: 2018-01-12.

Arginase inhibitor and its therapeutical uses

Номер патента: CN107406464A. Автор: R·布瓦什奇克,J·布热津斯卡,A·A·戈文比奥夫斯基,J·欧莱扎克. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2017-11-28.

Arginase inhibitors and their therapeutic applications

Номер патента: PL3240777T3. Автор: Roman Blaszczyk,Joanna Brzezinska,Jacek OLCZAK,Adam A Gołębiowski. Владелец: Oncoarendi Therapeutics SA. Дата публикации: 2019-10-31.

Novel drp-1 inhibitors as therapeutic agents

Номер патента: US20240294481A1. Автор: Adel Nefzi,Stephen Black,Kim TIEU. Владелец: Florida International University FIU. Дата публикации: 2024-09-05.

Kinase inhibitors as therapeutic agents

Номер патента: EP1268481A2. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Stephen St.Gallay,Helen L. Twigger. Владелец: BASF SE. Дата публикации: 2003-01-02.

Kinase inhibitors as therapeutic agents

Номер патента: CA2385769A1. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Helen L. Twigger,Stephen St. Gallay. Владелец: Individual. Дата публикации: 2001-03-22.

Kinase inhibitors as therapeutic agents

Номер патента: CN1390220A. Автор: G·C·希尔斯特,K·里特,H·L·特维格,P·拉菲蒂,S·圣加莱,D·卡尔德伍德. Владелец: Abert & Co KG GmbH. Дата публикации: 2003-01-08.

Kinase inhibitors as therapeutic agents

Номер патента: AU7491400A. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,David Calderwood,Helen L. Twigger,Stephen St. Gallay. Владелец: BASF SE. Дата публикации: 2001-04-17.

Use of stat-6 inhibitors as therapeutic agents

Номер патента: AU2001294515A1. Автор: Dennis A. Carson,Lorenzo M. Leoni,Howard B Cottam,Sylvie Barchechath. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2002-02-25.

Kinase inhibitors as therapeutic agents.

Номер патента: ZA200202122B. Автор: Kurt Ritter,Paul Rafferty,David Calderwood,Gavin C Hirst,Helen L Twigger,Stephen St Gallay. Владелец: Abbott Gmbh & Co Kg. Дата публикации: 2003-08-27.

Imide derivatives as therapeutic agents for senile dementia

Номер патента: CA2531980C. Автор: Takeo Ishiyama,Yukihiro Ohno. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2013-09-17.

Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Номер патента: US7211667B2. Автор: Ibert Clifton Wells. Владелец: Magnesium Diagnostics Inc. Дата публикации: 2007-05-01.

Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Номер патента: US20090030080A1. Автор: Ibert Clifton Wells. Владелец: Magnesium Diagnostics Inc. Дата публикации: 2009-01-29.

SPYROCYCLIC COMPOUNDS AND THEIR APPLICATION AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES

Номер патента: RU2012143689A. Автор: ЦМИЛЯНОВИЦ Владимир,ЦМИЛЯНОВИЦ Натаса,ГИЗЕ Бернд,ВИМАНН Маттиас. Владелец: Юниверсити Оф Базель. Дата публикации: 2014-04-20.

Pyridazine derivatives and their use as therapeutic agents for the treatment of skin disorders

Номер патента: RU2010139285A. Автор: Андреас БИЛЛИХ,Майкл Д. УИНТЕР,Йигал Пол ГОЛДБЕРГ,Гезине ВИНЦЕНБУРГ,Карин РАПП,Андреас ФРИТЦЕ,Майкл Д. УИНТЕР (CA),Андреас БИЛЛИХ (AT),Йигал Пол ГОЛДБЕРГ (CA),Гезине ВИНЦЕНБУРГ (CH),Карин РАПП (CH),Андреас ФРИТЦЕ (CH). Владелец: Зинон Фармасьютиклз Инк. (Ca). Дата публикации: 2012-04-10.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: AU2019414950A1. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2021-06-03.

Phenoxy acids for use as therapeutically active substances

Номер патента: SE8903364D0. Автор: P H Ylitalo. Владелец: Huhtamaeki Oy. Дата публикации: 1989-10-13.

New substd. phenoxy acids - useful as therapeutically active substances to inhibit thromboxane prodn. and human thrombocyte aggregation

Номер патента: SE8903364L. Автор: P H Ylitalo. Владелец: Huhtamaeki Oy. Дата публикации: 1991-04-14.

Phenoxy acids for use as therapeutically active substances

Номер патента: SE9001823D0. Автор: P H Ylitalo. Владелец: Huhtamaeki Oy. Дата публикации: 1990-05-21.

Compounds having n-arylpyrimidin-2-amine derivatives as therapeutic agents

Номер патента: EP4401735A1. Автор: Alexandre Vasilievich IVACHTCHENKO,Alexei Pushechnikov,Volodymyr KYSIL,Nikolay Savchuk,Vladislav Zenonovich Parchinsky. Владелец: Lomond Therapeutics Inc. Дата публикации: 2024-07-24.

Compounds for use as therapeutically active substances in the treatment of retinal diseases

Номер патента: US20200207719A1. Автор: Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2020-07-02.

Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases

Номер патента: SG11202104958UA. Автор: Mauro Marigo,Matthias Steger,Bernhard FASCHING,Alex Mueller,Daphna Mokady. Владелец: Endogena Therapeutics Inc. Дата публикации: 2021-07-29.

Succinate and crystal form thereof as therapeutics

Номер патента: EP4244222A4. Автор: HUI Wang,Jun Liu,Shudong Wang,Jinchen LV. Владелец: Aucentra Therapeutics Pty Ltd. Дата публикации: 2024-04-10.

Succinate and crystal form thereof as therapeutics

Номер патента: WO2022099357A1. Автор: HUI Wang,Jun Liu,Shudong Wang,Jinchen LV. Владелец: Changzhou Qianhong Bio-Pharma Co., Ltd.. Дата публикации: 2022-05-19.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: US20220110921A1. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Endogena Therapeutics Inc. Дата публикации: 2022-04-14.

New compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium

Номер патента: US20230124312A1. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Endogena Therapeutics Inc. Дата публикации: 2023-04-20.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: IL301613A. Автор: . Владелец: Endogena Therapeutics Inc. Дата публикации: 2023-05-01.

Prion protein ligands as therapeutic agents for neurodegenerative disorders

Номер патента: US20150196508A1. Автор: David A. Harris,Emiliano BIASINI,Maria Letizia BARRECA,Nunzio Iraci,Aaron Beeler,Brian R. Fluharty,Oscar Ingham. Владелец: Universita degli Studi di Perugia. Дата публикации: 2015-07-16.

Compounds having n-arylpyrimidin-2-amine derivatives as therapeutic agents

Номер патента: US20240270699A1. Автор: Alexandre Vasilievich IVACHTCHENKO,Alexei Pushechnikov,Volodymyr KYSIL,Nikolay Savchuk,Vladislav Zenonovich Parchinsky. Владелец: Lomond Therapeutics Inc. Дата публикации: 2024-08-15.

Cyclopentane derivatives as therapeutic agents

Номер патента: WO2002024639A1. Автор: Mark Holoboski,Robert M. Burk,Mari F. Posner. Владелец: ALLERGAN, INC.. Дата публикации: 2002-03-28.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: ZA202303863B. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Endogena Therapeutics Inc. Дата публикации: 2024-09-25.

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

Номер патента: US09814700B2. Автор: Xicheng Sun,Sarah Strong,Jian Qiu,Gary J. Rosenthal,Jan Wasley. Владелец: Nivalis Therapeutics Inc. Дата публикации: 2017-11-14.

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

Номер патента: US09675620B2. Автор: Thomas C. Chen,Florence M. Hofman,Jean C. SHIH. Владелец: University of Southern California USC. Дата публикации: 2017-06-13.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US09630929B2. Автор: QI Jia,Zaihui Zhang,Mikhail Chafeev,Shaoyi Sun,Alla Yurevna Zenova,Renata Marcella Oballa. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2017-04-25.

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

Номер патента: US09550785B2. Автор: Diane Mary Coe,Stephen Allan Smith. Владелец: GlaxoSmithKline LLC. Дата публикации: 2017-01-24.

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

Номер патента: US09498466B2. Автор: Xicheng Sun,Sarah Strong,Jian Qiu,Gary J. Rosenthal,Jan Wasley. Владелец: Nivalis Therapeutics Inc. Дата публикации: 2016-11-22.

Biaryl ether sulfonamides and their use as therapeutic agents

Номер патента: US09481677B2. Автор: Zaihui Zhang,Shifeng Liu,Navjot Chahal,Thilo FOCKEN,Julia Fonarev,Renata Marcella Oballa. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-11-01.

Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

Номер патента: US09434720B2. Автор: Jianxin Chen,Jun Yan,Zaihui Zhang,Xinyao Du,Serguei V. Sviridov,Shisen Wang,Timothy S. Daynard,Gregory B. Chopiuk. Владелец: Dirmira (canada) Inc. Дата публикации: 2016-09-06.

Succinate and crystal form thereof as therapeutics

Номер патента: US20230399325A1. Автор: HUI Wang,Jun Liu,Shudong Wang,Jinchen LV. Владелец: Aucentra Therapeutics Pty Ltd. Дата публикации: 2023-12-14.

Succinate and crystal form thereof as therapeutics

Номер патента: EP4244222A1. Автор: HUI Wang,Jun Liu,Shudong Wang,Jinchen LV. Владелец: Aucentra Therapeutics Pty Ltd. Дата публикации: 2023-09-20.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: AU2021358736A1. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Endogena Therapeutics Inc. Дата публикации: 2023-04-13.

New compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium

Номер патента: EP4225441A1. Автор: Mauro Marigo,Matthias Steger,Alex Mueller. Владелец: Endogena Therapeutics Inc. Дата публикации: 2023-08-16.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: IL278949B2. Автор: . Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2024-08-01.

Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases.

Номер патента: ZA200103605B. Автор: Gerd Zimmermann,Hans-Willi Krell,Frank Grams,Herbert Leinert. Владелец: Roche Diagnostics GmbH. Дата публикации: 2001-12-11.

Cyclopentane derivatives as therapeutic agents

Номер патента: EP1318979A1. Автор: Mark Holoboski,Robert M. Burk,Mari F. Posner. Владелец: Allergan Sales LLC. Дата публикации: 2003-06-18.

Urea derivatives as therapeutic agents

Номер патента: US3510557A. Автор: Albert Rene Joseph Castaigne. Владелец: CENTRE ETD IND PHARMA. Дата публикации: 1970-05-05.

Prion protein ligands as therapeutic agents for neurodegenerative disorders

Номер патента: WO2014025785A3. Автор: David A. Harris,Emiliano BIASINI,Maria Letizia BARRECA,Nunzio Iraci,Aaron Beeler,Brian R. Fluharty,Oscar Ingham. Владелец: Universita Di Perugia. Дата публикации: 2014-05-08.

Compounds for use as therapeutic agents affecting p53 expression and/or activity

Номер патента: US09890112B2. Автор: Didier Scherrer,Florence Mahuteau,Jamal Tazi,Romain Najman,Pierre Roux. Владелец: Abivax SA. Дата публикации: 2018-02-13.

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Номер патента: IL279810B1. Автор: . Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2024-11-01.

PYRIDAZIN-3(2H)-ONE DERIVATIVES AS MONOAMINE OXIDASE SELECTIVE ISOFORM B INHIBITORS (As Amended)

Номер патента: US20180215718A1. Автор: Pedro Besada Pereira,Dolores Viña Castelao,Mª del Carmen TERÁN MOLDES,Tamara COSTAS CAAMAÑO,Mª del Carmen COSTAS LAGO,Noemí Vila Molares. Владелец: Universidade de Vigo. Дата публикации: 2018-08-02.

Development and optimization of thiochromenothiazole-based msut2 inhibitors as candidates for the treatment of tauopathy

Номер патента: US20240342139A1. Автор: Brian Kraemer. Владелец: US Department of Veterans Affairs VA. Дата публикации: 2024-10-17.

Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States

Номер патента: US20120142781A1. Автор: Ibert Clifton Wells. Владелец: Magnesium Diagnostics Inc. Дата публикации: 2012-06-07.

ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20130072537A1. Автор: Fu Jianmin,Chafeev Mikhail,Cadieux Jean-Jacques. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2013-03-21.

Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US20130137727A1. Автор: Robert E. Davis,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. ULDAN. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2013-05-30.

Novel hydroxamates as therapeutic agents

Номер патента: US20130142758A1. Автор: James Robinson,Martin Sendzik,Erik J. Verner,Joseph J. Buggy,Chitra Baskaran. Владелец: Pharmacyclics LLC. Дата публикации: 2013-06-06.

Adamantyl Derivatives as Therapeutic Agents

Номер патента: US20130143962A1. Автор: SINGH Rakesh K.,Moore Richard G.. Владелец: Women & Infants' Hospital of Rhode Island. Дата публикации: 2013-06-06.

ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20150025121A1. Автор: Fu Jianmin,Chafeev Mikhail,Cadieux Jean-Jacques Alexandre. Владелец: . Дата публикации: 2015-01-22.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20190030015A1. Автор: WEINER David M.,DAVIS Robert E.,BRANN Mark R.,ANDERSSON Carl-Magnus A.,Uldam Allan K.. Владелец: . Дата публикации: 2019-01-31.

NOVEL INHIBITORS OF GUANOSINE MONOPHOSPHATE SYNTHETASE AS THERAPEUTIC AGENTS

Номер патента: US20220048866A1. Автор: Zhang Chao,Ni Feng,Ekanayake Arunika,Espinosa Biancha. Владелец: . Дата публикации: 2022-02-17.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20140140982A1. Автор: WEINER David M.,DAVIS Robert E.,BRANN Mark R.,ANDERSSON Carl-Magnus A.,Uldam Allan K.. Владелец: ACADIA Pharmaceuticals Inc.. Дата публикации: 2014-05-22.

SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS

Номер патента: US20160075677A1. Автор: WINSSINGER Nicolas,BARLUENGA Sofia,KARPLUS Martin. Владелец: Universite De Strasbourg. Дата публикации: 2016-03-17.

COMPOUNDS FOR USE AS THERAPEUTIC AGENTS AFFECTING P53 EXPRESSION AND/OR ACTIVITY

Номер патента: US20180127353A1. Автор: Roux Pierre,Tazi Jamal,Mahuteau Florence,Najman Romain,Scherrer Didier. Владелец: . Дата публикации: 2018-05-10.

ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS

Номер патента: US20180134654A1. Автор: Li Wei,HONDA Tadashi,Zheng Suqing,Dinkova-Kostova Albena. Владелец: . Дата публикации: 2018-05-17.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US20210171537A1. Автор: QI Jia,Christoph Martin Dehnhardt,Sultan Chowdhury,Michael Edward Grimwood,Alla Yurevna Zenova,Thilo FOCKEN,Jean-Christophe ANDREZ,Kristen Nicole Burford,Michael Scott Wilson,Charles Jay Cohen,Robert Joseph Devita,James Roy Empfield,Syed Abid Hasan,James Philip Johnson, JR.,David Earl Bogucki,Shannon Marie Decker. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2021-06-10.

COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS

Номер патента: US20200138787A1. Автор: Paik David Choohyun,Trokel Stephen Lewis. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2020-05-07.

HYDROXYEICOSATRIENOIC ACID COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20190161456A1. Автор: Holman Theodore R.,Holinstat Michael,WHITE Andrew. Владелец: . Дата публикации: 2019-05-30.

Novel ep4 agonists as therapeutic compounds

Номер патента: US20170183293A1. Автор: David W. Old,Christopher D. HEIN. Владелец: Allergan Inc. Дата публикации: 2017-06-29.

MAO Inhibitors and Their Conjugates as Therapeutics For The Treatment of Brain Cancer

Номер патента: US20150209361A1. Автор: Chen Thomas C.,SHIH Jean C.,HOFMAN Florence M.. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2015-07-30.

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

Номер патента: US20140301976A1. Автор: ROBINSON JAMES,Verner Erik J.,Buggy Joseph J.,Sendzik Martin,Baskaran Chitra. Владелец: . Дата публикации: 2014-10-09.

TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS

Номер патента: US20140309257A1. Автор: Labarbera Daniel V.. Владелец: . Дата публикации: 2014-10-16.

Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US20160250200A1. Автор: Robert E. Davis,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. Uldam. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2016-09-01.

4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

Номер патента: US20170253560A1. Автор: DALLAVALLE Sabrina,DAIDONE Maria Grazia,APPIERTO Valentina,TIBERIO Paola,MUSSO Loana,NICCOLINI Elisa. Владелец: . Дата публикации: 2017-09-07.

Suppressors of Premature Termination Codons as Therapeutics and Methods for Their Use

Номер патента: US20180258123A1. Автор: Michel Roberge,Stephen G. Withers,Alireza BARADARAN-HERAVI,Carla D. Zimmerman,Aruna Dinesh Balgi,Kunho Choi. Владелец: University of British Columbia. Дата публикации: 2018-09-13.

PKC Delta Inhibitors for use as Therapeutics

Номер патента: US20150283114A1. Автор: Faller Douglas V.,Williams Robert M.. Владелец: . Дата публикации: 2015-10-08.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US20150291623A1. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic,Alla Yurevna Zenova,Jean-Jacques Alexandre CADIEUX. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2015-10-15.

MAO Inhibitors and Their Conjugates as Therapeutics For The Treatment of Brain Cancer

Номер патента: US20160339034A9. Автор: Chen Thomas C.,SHIH Jean C.,HOFMAN Florence M.. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2016-11-24.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20200323836A1. Автор: WEINER David M.,DAVIS Robert E.,BRANN Mark R.,ANDERSSON Carl-Magnus A.,Uldam Allan K.. Владелец: ACADIA Pharmaceuticals Inc.. Дата публикации: 2020-10-15.

MAO INHIBITORS AND THEIR CONJUGATES AS THERAPEUTICS FOR THE TREATMENT OF BRAIN CANCER

Номер патента: US20180360843A1. Автор: Chen Thomas C.,SHIH Jean C.,Hoffman Florence M.. Владелец: . Дата публикации: 2018-12-20.

SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS

Номер патента: US20190359585A1. Автор: WINSSINGER Nicolas,BARLUENGA Sofia,KARPLUS Martin. Владелец: . Дата публикации: 2019-11-28.

Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use

Номер патента: WO2003106462A1. Автор: William Henry Romines, Iii,Robert Steven Kania,Jihong Lou,Michael Raymond Collins,Stephan James Cripps,Mingying He,Ru Zhou,Cynthia Louise Palmer,Judith Gail Deal. Владелец: PFIZER INC.. Дата публикации: 2003-12-24.

Cyclopropyl-substituted azolyl methyl carbinoles, process for their preparation and their use as therapeutic agents

Номер патента: EP0370300A2. Автор: Karl Heinz Prof. Dr. Büchel,Manfred Dr. Plempel,Burkhard Dr. Fugmann,Klaus Dr. Stroech. Владелец: Bayer AG. Дата публикации: 1990-05-30.

Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use

Номер патента: CN1671714A. Автор: W·H·罗明斯三世,R·S·卡尼亚,娄霁竑,M·R·柯林斯,S·J·克里普斯,何明英,周茹,C·L·帕尔默,J·G·迪尔. Владелец: SmithKline Beecham Ltd. Дата публикации: 2005-09-21.

Aryl carbonyl derivatives as therapeutic agents

Номер патента: CN1678311A. Автор: R·C·安德鲁斯,J·T·克德拉,J·劳,D·R·泊利赛缇,P·布洛赫,M·C·瓦尔卡斯-洛佩兹,N·布鲁姆,M·戈泽尔,K·C·圣瑟施,A·M·M·玛雅利,G·萨布拉玛尼安,M·安克森,P·维德索,A·穆雷,L·耶普森. Владелец: Novo Nordisk AS. Дата публикации: 2005-10-05.

NEW EP4 AGONISTS AS THERAPEUTIC COMPOUNDS

Номер патента: RU2016150902A. Автор: Дейвид У. ОЛД,Кристофер Д. ХЕЙН. Владелец: Аллерган, Инк.. Дата публикации: 2018-07-17.

Peptide Conjugates of Microtubule Targeting Agents as Therapeutic Agents

Номер патента: JP2022541747A. Автор: リチャード マーシャル，ダニエル,マリー チェンゲリー，ヨハンナ,ジョン マグワイア，ロバート,エイ ボークマン，ロバート. Владелец: Cybrexa 3 Inc. Дата публикации: 2022-09-27.

Substituted gamma lactams as therapeutic agents

Номер патента: CN101137622A. Автор: D·W·奥尔德,D·T·迪安. Владелец: Allergan Inc. Дата публикации: 2008-03-05.

Pyridazine derivatives and their use as therapeutic agents

Номер патента: RU2006105716A. Автор: Хайнц У. ГШВЕНД,Вишнумурти КОДУМУРУ,Шифэн ЛЮ,Райэндер КАМБОЙ,Хайнц У. ГШВЕНД (US),Вишнумурти КОДУМУРУ (CA),Шифэн ЛЮ (CA),Райэндер КАМБОЙ (CA). Владелец: Зинон Фармасьютиклз Инк. (Ca). Дата публикации: 2007-09-10.

Benzopyran derivatives and their use as therapeutic agents for heart disease

Номер патента: KR970064604A. Автор: 다카가키 히데스구,아베 마사요시,아오키 야수오,나카니시 시게노리,키무라 노부유키,미스미 오사무. Владелец: 디케미쯔 다카하시. Дата публикации: 1997-10-13.

Spiroheterocyclic compounds and their uses as therapeutic agents

Номер патента: WO2008046084A2. Автор: Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Shifeng Liu,Mikhail Chafeev,Duanjie Hou. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2008-04-17.

Spiroheterocyclic compounds and their uses as therapeutic agents

Номер патента: US7799798B2. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Mehran Seid Bagherzadeh. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2010-09-21.

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: WO2011002708A1. Автор: Jean-Jacques Cadieux,Jianmin Fu,Mikhail Chafeev. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2011-01-06.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US7935721B2. Автор: Jianyu Sun,Jianmin Fu,Shifeng Liu. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2011-05-03.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US8263606B2. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Jean-Jacques Cadieux,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Alla Zenova,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-09-11.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: EP3241834A1. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Jian-Min Fu,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2017-11-08.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US8106087B2. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-01-31.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: EP2752417A1. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Jian-Min Fu,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2014-07-09.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: EP2428515A1. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina,Jinamin Fu. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-03-14.

Spiroheterocyclic compounds and their uses as therapeutic agents

Номер патента: WO2008046084A3. Автор: Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Shifeng Liu,Mikhail Chafeev,Duanjie Hou. Владелец: Duanjie Hou. Дата публикации: 2009-06-25.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US8916580B2. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic,Alla Yurevna Zenova,Jean-Jacques Alexandre CADIEUX. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2014-12-23.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US8415370B2. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Jean-Jacques Cadieux,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic,Alla Yurevna Zenova. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2013-04-09.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: EP2942350A1. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Jean-Jacques Cadieux,Sultan Chowdhury,Tom Hsieh,Shifeng Liu,Jian-Min Fu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Alla Zenova,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2015-11-11.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US9458178B2. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic,Alla Yurevna Zenova,Jean-Jacques Alexandre CADIEUX. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-10-04.

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US8450358B2. Автор: Jean-Jacques Cadieux,Jianmin Fu,Mikhail Chafeev. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2013-05-28.

Enantiomers of spiro-oxindole and their uses as therapeutic agents

Номер патента: EP3156407A1. Автор: Jean-Jacques Cadieux,Jian-Min Fu,Mikhail Chafeev. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2017-04-19.

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US8883840B2. Автор: Jean-Jacques Cadieux,Jianmin Fu,Mikhail Chafeev. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2014-11-11.

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: US9480677B2. Автор: Jianmin Fu,Mikhail Chafeev,Jean-Jacques Alexandre CADIEUX. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-11-01.

Design of oligonucleotide analogs as therapeutic agents

Номер патента: CN103298475A. Автор: R·P·伊耶,J·E·库格林. Владелец: Spring Bank Pharmaceuticals Inc. Дата публикации: 2013-09-11.

Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents

Номер патента: KR100671632B1. Автор: 로민스윌리엄헨리3세,카니아로버트스티븐,로지홍,콜린스마이클레이몬드,크립스스테판제임스,히밍잉,조루,팔머신티아루이스,딜주디트가일. Владелец: 화이자 인코포레이티드. Дата публикации: 2007-02-28.

Substituted morpholine derivatives and their use as therapeutic agents

Номер патента: CN1067683C. Автор: R·贝克,T·哈里逊,A·M·麦考劳德,A·P·奥文斯,E·M·西沃德,C·J·施维恩,M·R·蒂奥尔. Владелец: Merck and Co Inc. Дата публикации: 2001-06-27.

PIPERASIN DERIVATIVES AND THEIR APPLICATION AS THERAPEUTIC AGENTS

Номер патента: RU2006105717A. Автор: Сергей СВИРИДОВ,Хайнц У. ГШВЕНД,Вишнумурти КОДУМУРУ,Шифэн ЛЮ,Райэндер КАМБОЙ,Мелвин АБРЕО,Майкл Д. УИНТЕР,Шаоиль СУНЬ,Марк У. ХОЛЛАДЕЙ,Веньбао ЛИ,Чи ТУ,Хайнц У. ГШВЕНД (US),Вишнумурти КОДУМУРУ (CA),Шифэн ЛЮ (CA),Райэндер КАМБОЙ (CA),Сергей СВИРИДОВ (CA),Мелвин АБРЕО (US),Майкл Д. УИНТЕР (CA),Шаоиль СУНЬ (CA),Марк У. ХОЛЛАДЕЙ (US),Веньбао ЛИ (US),Чи ТУ (US). Владелец: Зинон Фармасьютиклз Инк. (Ca). Дата публикации: 2007-09-20.

Pharmaceutical compositions including benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, and methods for their use

Номер патента: KR100714545B1. Автор: 윌리엄 헨리 3세 로민스,로버트 스티븐 카니아,지홍 로,마이클 레이몬드 콜린스,스테판 제임스 크립스,밍잉 히,루 조,신티아 루이스 팔머,주디트 가일 딜. Владелец: 화이자 인코포레이티드. Дата публикации: 2007-05-07.

Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes

Номер патента: WO2008044762A1. Автор: Tsutomu Sato. Владелец: Chugai Seiyaku Kabushiki Kaisha. Дата публикации: 2008-04-17.

Self-stabilized oligonucleotides as therapeutic agents

Номер патента: CA2139319A1. Автор: Sudhir Agrawal,Jin-Yan Tang. Владелец: Individual. Дата публикации: 1994-01-20.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: KR101432460B1. Автор: 미카일 챠피브,술탄 초우두리,로버트 프레이저,지안민 푸,라젠더 캄보즈,두안지 호우,쉬펭 리우,메란 세이드 바게르자데,세르게이 스비리도브,사오이 쑨,?위 쑨,나가스리 차카,톰 시에,반드나 라이나. Владелец: 제논 파마슈티칼스 인크.. Дата публикации: 2014-08-21.

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US5352708A. Автор: Steven W. Andrews,Michael E. Garst,David F. Woodward,Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1994-10-04.

Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US5545665A. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1996-08-13.

Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US5688819A. Автор: Steven W. Andrews,Michael E. Garst,David F. Woodward,Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1997-11-18.

Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US6403649B1. Автор: Steven W. Andrews,Michael E. Garst,David F. Woodward,Robert M. Burk. Владелец: Allergan Sales LLC. Дата публикации: 2002-06-11.

Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Номер патента: US6602900B2. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2003-08-05.

Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension

Номер патента: CA2221110C. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2009-08-04.

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US5607978A. Автор: Steven W. Andrews,Michael E. Garst,David F. Woodward,Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1997-03-04.

Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US5798378A. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1998-08-25.

Cyclopentane (ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US5990138A. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1999-11-23.

Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US6716876B2. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2004-04-06.

Cyclopentane(ENE) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US5906989A. Автор: Robert M. Burk. Владелец: Allergan Sales LLC. Дата публикации: 1999-05-25.

Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US5587391A. Автор: Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 1996-12-24.

Cyclopentane heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents

Номер патента: US6303658B1. Автор: Robert M. Burk. Владелец: Allergan Sales LLC. Дата публикации: 2001-10-16.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US10662184B2. Автор: Christoph Martin Dehnhardt,Sultan Chowdhury,Michael Edward Grimwood,Alla Yurevna Zenova,Thilo FOCKEN,Jean-Christophe ANDREZ,Kristen Nicole Burford,Charles Jay Cohen,Robert Joseph Devita,James Roy Empfield,Syed Abid Hasan,James Philip Johnson, JR.. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2020-05-26.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US10745392B2. Автор: Alla Yurevna Zenova,Thilo FOCKEN,Kristen Nicole Burford,Verner Alexander LOFSTRAND,Michael Scott Wilson. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2020-08-18.

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Номер патента: US10981905B2. Автор: QI Jia,Christoph Martin Dehnhardt,Shaoyi Sun,Michael Edward Grimwood,Alla Yurevna Zenova,Thilo FOCKEN,Jean-Christophe ANDREZ,Kristen Nicole Burford,Verner Alexander LOFSTRAND,Steven Sigmund WESOLOWSKI,Michael Scott Wilson. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2021-04-20.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US10815229B1. Автор: Christoph Martin Dehnhardt,Sultan Chowdhury,Michael Edward Grimwood,Thilo FOCKEN,Kristen Nicole Burford,Syed Abid Hasan. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2020-10-27.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: US11299490B2. Автор: Christoph Martin Dehnhardt,Sultan Chowdhury,Michael Edward Grimwood,Alla Yurevna Zenova,Thilo FOCKEN,Jean-Christophe ANDREZ,Kristen Nicole Burford,Charles Jay Cohen,Robert Joseph Devita,James Roy Empfield,Syed Abid Hasan,James Philip Johnson, JR.. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2022-04-12.

Bicyclic nucleosides and nucleotides as therapeutic agents

Номер патента: US8802840B2. Автор: Alistair George Draffan,Paula Francom,Silas Bond,Roland Henry Nearn,John Nicholas Lambert. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2014-08-12.

Organometallic complexes as therapeutic agents

Номер патента: WO2008070557A2. Автор: Laurent Brard,Satyan Kalkunte,Rakesh Singh,Robert Strongin,Onur Alpturk. Владелец: Louisiana State University. Дата публикации: 2008-06-12.

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Номер патента: KR20210054510A. Автор: 사오이 쑨,틸로 포켄,진-크리스토프 안드레즈,크리스틴 니콜 버포드,크리스토프 마틴 덴하르트,마이클 에드워드 그림우드,치 자,버너 알렉산더 로프스트랜드,마이클 스콧 윌슨,알라 유레브나 제노바,스티븐 시그먼드 웨솔로우스키. Владелец: 제논 파마슈티칼스 인크.. Дата публикации: 2021-05-13.

4-oxo-n-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer

Номер патента: KR20170076649A. Автор: 마리아 그라치아 다이도네,발렌티나 아피에르토,파올라 티베리오,사브리나 달라발레,로아나 무소,엘리사 니콜리니. Владелец: 유니버시타' 데글리 스튜디 디 밀라노. Дата публикации: 2017-07-04.

Use of hederagenin 3-O-?-L-rhamnopyranosyl1?2-[?-D-glucopyranosyl1?4]-?-L-arabinopyranoside or extracts from Pulsatillae radix containing the same as therapeutic agents for solid tumors

Номер патента: KR100568607B1. Автор: 김용,안병준,김송배. Владелец: 김송배. Дата публикации: 2006-04-07.

Benzene sulfonamide compounds and their use as therapeutic agents

Номер патента: JP6938545B2. Автор: ジーン−クリストフ アンドレス，,クリステン ニコル バーフォード，,クリステン ニコル バーフォード，,スルタン チョウドリー，,チャールズ ジェイ コーエン，,チャールズ ジェイ コーエン，,クリストフ マーティン デーンハルト，,クリストフ マーティン デーンハルト，,ロバート ジョセフ デヴィータ，,ロバート ジョセフ デヴィータ，,ジェイムズ ロイ エンプフィールド，,ジェイムズ ロイ エンプフィールド，,ティーロ フォッケン，,マイケル エドワード グリムウッド，,マイケル エドワード グリムウッド，,サイド アビド ハサン，,サイド アビド ハサン，,ジェイムズ フィリップ ジュニア ジョンソン，,ジェイムズ フィリップ ジュニア ジョンソン，,アラ ユレブナ ゼノバ，,アラ ユレブナ ゼノバ，. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2021-09-22.

Spiral shell oxindole compounds and the purposes as therapeutical agent thereof

Номер патента: CN105218565A. Автор: 刘世峰,孙建宇,贾琦,傅建民,琼-杰克库·卡迪厄,麦克海里·乔威夫,苏鲁旦·乔德亨瑞,乔纳森·朗吉乐,劳伦·弗雷泽,孙绍毅,歇吉瑞·史瑞威多,马克·伍德,埃拉·泽诺瓦,西蒙·J·高蒂尔,艾米·弗郎西丝·道格拉斯,谢瀚霄,娜贾司瑞·恰卡,卓兰·西科杰韦克. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-01-06.

Isoxazol-3(2h)-one analogs as therapeutic agents

Номер патента: KR101675607B1. Автор: 요나스 보슈트롬,라이펭 쳉,토마스 펙스,미첼 카를레,다니엘 페터센,페터 쉘. Владелец: 에머리티 파마 아베. Дата публикации: 2016-11-11.

Spiro-piperidine derivatives and their use as therapeutic agents.

Номер патента: EA001574B1. Автор: Тимоти Харрисон,Брайан Джон ВИЛЛЬЯМС,Рэймонд Бейкер,Нил Рой Кертис,Джейсон Мэттью Эллиотт,Грегори Джон Холлингворт,Филип Стефен Джексон,Януш Йозеф Кулаговский,Эйлин Мэри Сьюард,Кристофер Джон Свейн. Владелец: Мерк Шарп Энд Домэ Лимитед. Дата публикации: 2001-06-25.

Heterocyclic carboxamide derivatives and their use as therapeutic agents

Номер патента: JPH11508599A. Автор: ケリガン フランク,マーティン バーチ アラン,ジョン ヒール デイヴィッド,フランク マーティン キース,レスリー ニーダム パトリシア,ジェレミー サージェント ブルース. Владелец: クノル アクチエンゲゼルシャフト. Дата публикации: 1999-07-27.

Aryl carbonyl derivatives as therapeutic agents

Номер патента: US20060183783A1. Автор: Kalpathy Santhosh,Mustafa Guzel,Paw Bloch,Jesper Lau,Govindan Subramanian,Anthony Murray,Adnan Mjalli,Lone Jeppesen,Per VEDSØ,Robert Andrews,Michael Ankersen,Janos Kodra,Dharma Polisetti,Maria Lopez,Niels Blume. Владелец: Individual. Дата публикации: 2006-08-17.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: CA2956647A1. Автор: Jianyu Sun,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina,Rajender K. Kamboj,Serguei V. Sviridov. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2006-10-19.

Pirazolopyrimidines as therapeutic agents

Номер патента: TR200201505T2. Автор: Ritter Kurt,Rafferty Paul,WISHART Neil,C. Hirst Gavin,Calderwood David,D. Arnold Lee,M. Friedman Michael. Владелец: Abbott Gmbh & Co.Kg. Дата публикации: 2003-01-21.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US20100137299A1. Автор: QI Jia,Jianyu Sun,Serguei Sviridov,Jean-Jacques Cadieux,Sultan Chowdhury,Jianmin Fu,Tom Hsieh,Shifeng Liu,Mikhail Chafeev,Amy Frances Douglas,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Alla Zenova,Simon J. Gauthier,Nagasree Chakka,Zoran Cikojevic. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2010-06-03.

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US8017655B2. Автор: Steven W. Andrews,Michael E. Garst,David F. Woodward,Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2011-09-13.

Pyridyl derivatives and their use as therapeutic agents

Номер патента: WO2005011656A3. Автор: Bagherzadeh Mehran Seid,Zaihui Zhang,Serguei Sviridov,Rajender Kamboj,Shifeng Liu,Shaoyi Sun,Vandna Raina,Melwyn Abreo,Daniel F Harvey,Heinz W Gschwend,Wenbao Li,Chi Tu,Michael D Winther,Vishnumurthy Kodumuru,Cindy J Hudson,Mikhail A Kondratenko. Владелец: Mikhail A Kondratenko. Дата публикации: 2005-05-06.

Benzenesulfonamide compounds and their use as therapeutic agents

Номер патента: AU2017268006A1. Автор: Christoph Martin Dehnhardt,Sultan Chowdhury,Michael Edward Grimwood,Alla Yurevna Zenova,Thilo FOCKEN,Jean-Christophe ANDREZ,Kristen Nicole Burford,Charles Jay Cohen,Robert Joseph Devita,James Roy Empfield,Syed Abid Hasan,James Philip Johnson Jr.. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2018-11-22.

4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents

Номер патента: CA2508275A1. Автор: Geoffrey Wells,Malcolm Francis Graham Stevens,Andrew David Westwell,Tracey Dawn Poole,Jane Marie Berry. Владелец: Individual. Дата публикации: 2004-07-08.

Substituted morpholine derivatives and their use as therapeutic agents

Номер патента: US5612337A. Автор: Raymond Baker,Timothy Harrison,Eileen M. SEWARD,Andrew P. Owens,Angus M. MaCleod,Christopher J. Swain,Martin R. Teall. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 1997-03-18.

Pyrazolopyrimidines as therapeutic agents

Номер патента: HK1050355B. Автор: Ritter Kurt,Rafferty Paul,WISHART Neil,Calderwood David,C Hirst Gavin,D Arnold Lee,M Friedman Michael. Владелец: Abbott Gmbh & Co Kg. Дата публикации: 2004-10-15.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: RS52295B. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2012-12-31.

Pyridazine derivatives and their use as therapeutic agents

Номер патента: AU2004261252C1. Автор: Mark W. Holladay,Zaihui Zhang,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Shifeng Liu,Jian-Min Fu,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Nagasree Chakka,Vandna Raina,Heinz W. Gschwend,Melwyn Abreo,Wenbao Li,Chi Tu,Vishnumurthy Kodumuru,Sengen Sun,Michael D. Winther. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2009-09-17.

Heterocyclic derivatives and their use as therapeutic agents

Номер патента: TW200626155A. Автор: Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Jian-Min Fu,Vishnumurthy Kodumuru,zai-hui Zhang. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2006-08-01.

Spiro-piperidine derivatives and their use as therapeutic agents

Номер патента: WO1997049710A1. Автор: Gregory John Hollingworth,Raymond Baker,Neil Roy Curtis,Jason Matthew Elliott,Timothy Harrison,Philip Stephen Jackson,Janusz Jozef Kulagowski,Christopher John Swain,Brian John Williams,Eileen Mary Seward. Владелец: Merck Sharp & Dohme Limited. Дата публикации: 1997-12-31.

Organometallic complexes as therapeutic agents

Номер патента: US20100273763A1. Автор: Laurent Brard,Satyan Kalkunte,Rakesh Singh,Robert Strongin,Onur Alpturk. Владелец: Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2010-10-28.

Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

Номер патента: CA2492964C. Автор: Jianxin Chen,Jun Yan,Zaihui Zhang,Xinyao Du,Serguei V. Sviridov,Shisen Wang,Timothy S. Daynard,Gregory B. Chopiuk. Владелец: Dermira Canada Inc. Дата публикации: 2012-07-17.

Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes

Номер патента: AU2007307544A1. Автор: Tsutomu Sato. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2008-04-17.

Pyridyl derivatives and their use as therapeutic agents

Номер патента: CA2533898A1. Автор: Serguei Sviridov,Rajender Kamboj,Shifeng Liu,Shaoyi Sun,Nagasree Chakka,Heinz W. Gschwend,Melwyn Abreo,Wenbao Li,Vishnumurthy Kodumuru,Michael D. Winther,Daniel F. Harvey,Mikhail A. Kondratenko. Владелец: Discovery Partners International, Inc.. Дата публикации: 2005-02-10.

Substituted morpholine derivatives and their use as therapeutic agents

Номер патента: BG100644A. Автор: Angus Macleod,Raymond Baker,Timothy Harrison,Martin Teall,Andrew Owens,Christopher Swain,Eileen SEWARD. Владелец: Merck Sharp & Dohme Limited. Дата публикации: 1997-03-31.

4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching

Номер патента: CA2524498C. Автор: Takuya Kishimoto,Yukiko Muraki,Tomokazu Fujimoto. Владелец: Nisshin Seifun Group Inc. Дата публикации: 2012-01-24.

SUBSTITUTED MORPHOLINE DERIVATIVES AND ITS USE AS THERAPEUTIC AGENTS.

Номер патента: ES2164758T3. Автор: Raymond Baker,Timothy Harrison,Christopher John Swain,Angus Murray Macleod,Eileen Mary Seward,Andrew Pate Owens. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2002-03-01.

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US20040213816A1. Автор: Robert Davis,David Weiner,Mark Brann. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2004-10-28.

Pyrazolopyrimidines as therapeutic agents

Номер патента: CA2385747A1. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,Neil Wishart,Lee D. Arnold,David Calderwood,Michael M. Friedman. Владелец: Individual. Дата публикации: 2001-03-22.

Ep4 agonists as therapeutic compounds

Номер патента: CA2953218A1. Автор: David W. Old,Christopher D. HEIN. Владелец: Allergan Inc. Дата публикации: 2015-12-10.

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Номер патента: US20030114528A1. Автор: David Woodward,Michael Garst,Steven Andrews,Robert Burk. Владелец: Allergan Inc. Дата публикации: 2003-06-19.

Substituted gamma lactams as therapeutic agents

Номер патента: CA2676291C. Автор: David W. Old,Wha Bin Im. Владелец: Allergan Inc. Дата публикации: 2017-11-28.

Spiro-oxindole compounds and their uses as therapeutic agents

Номер патента: HK1168104A1. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina,Jinamin Fu. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-12-21.

Morpholine derivatives and their use as therapeutic agents

Номер патента: DK0777659T3. Автор: Timothy Harrison,Christopher John Swain,Andrew Pate Owens. Владелец: Merck Sharp & Dohme. Дата публикации: 2001-09-03.

Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds

Номер патента: CA2584651C. Автор: Adrian Liam Gill,Richard David Taylor,Dan Niculescu-Duvaz,Delphine Menard,Caroline Joy Springer,Richard Malcolm Marais,Harmen Dijkstra,Catherine Gaulon,Esteban Roman Vela. Владелец: Institute of Cancer Research. Дата публикации: 2013-05-28.

Piperazine derivatives and their use as therapeutic agents

Номер патента: EP1651620A2. Автор: Mark W. Holladay,Serguei Sviridov,Rajender Kamboj,Shifeng Liu,Shaoyi Sun,Heinz W. Gschwend,Melwyn Abreo,Wenbao Li,Chi Tu,Vishnumurthy Kodumuru,Michael D. Winther. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2006-05-03.

CHOLECALCIFEROLD DERIVATIVES, THESE DERIVATIVES FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES, PROCEDURES FOR THE PRODUCTION OF THESE, PHARMACEUTICAL PREPARATIONS BASED ON THESE APPLICATIONS USED BY THIS

Номер патента: DK159656B. Автор: Enrico Baggiolini,Giacomo Pizzolato,Milan Uskokovic,Gary Truitt. Владелец: Hoffmann La Roche. Дата публикации: 1990-11-12.

Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders

Номер патента: CA2716336A1. Автор: Andreas Billich,Yigal Paul Goldberg,Karin Rapp,Michael D. Winther,Gesine Winzenburg,Andreas Fritze. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2009-09-03.

Benzopyran derivatives and their use as therapeutic agents for heart disease

Номер патента: KR100574907B1. Автор: 다카가키 히데스구,아베 마사요시,아오키 야수오,나카니시 시게노리,키무라 노부유키,미스미 오사무. Владелец: 다이닛뽄 잉크 앤드 케미칼즈, 인코포레이티드. Дата публикации: 2006-07-06.

Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes

Номер патента: WO2010052569A2. Автор: Vladimir Cmiljanovic,Matthias Wymann,Natasa Cmiljanovic,Bernd Giese. Владелец: UNIVERSITY OF BASEL. Дата публикации: 2010-05-14.

Pyrazolopyrimidines as therapeutic agents

Номер патента: CA2440724A1. Автор: Kurt Ritter,Gavin C. Hirst,Paul Rafferty,Neil Wishart,Lee D. Arnold,David Calderwood,Michael M. Friedman. Владелец: Abbott GmbH and Co KG. Дата публикации: 2002-10-17.

Morpholine derivatives and their use as therapeutic agents

Номер патента: GR3036006T3. Автор: Timothy Harrison,Christopher John Swain,Andrew Owens. Владелец: Merck Sharp & Dohme. Дата публикации: 2001-09-28.

Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications

Номер патента: US20240309408A1. Автор: Matthew Joseph AMICUCCI,Cory Glen VIERRA,Riley Anne DREXLER,Yiyun LIU,Megan Lee,Angela Maria Marcobal-Barranco,Steven Michael WATKINS,Maria Ximena Maldonado Gomez,Nithya KRISHNAKUMAR,Alexandria Marie Salazar CONNER,Jennifer Elizabeth NILL,Bruce Robert MCCONNELL,James Patrick CERNEY. Владелец: Bcd Bioscience Inc. Дата публикации: 2024-09-19.

Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof

Номер патента: WO2024011332A1. Автор: Jean-Simon Diallo,Rozanne ARULANANDAM,Boaz WONG,Anabel BERGERON,Glib Viktorovich MAZNYI. Владелец: Ottawa Hospital Research Institute. Дата публикации: 2024-01-18.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: AU2020337054B2. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2024-10-17.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: AU2020337054B9. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2024-11-07.

Composition comprising pip4k2c inhibitor as active ingredient for treatment of cancer

Номер патента: US20240316066A1. Автор: Darren Williams,Da-Woon Jung,Hyunju Lee,Eun-mi Jang,Jihee SOH. Владелец: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY. Дата публикации: 2024-09-26.

Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredients

Номер патента: US20220288143A1. Автор: Tae-Ho Hwang,Jae-Joon Kim,Mong Cho. Владелец: Bionoxx Inc. Дата публикации: 2022-09-15.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: EP4433095A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-09-25.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: IL312884A. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-07-01.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: US20230416331A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2023-12-28.

Peptide conjugates of peptidic tubulin inhibitors as therapeutics

Номер патента: AU2022390891A1. Автор: Robert John Maguire,Johanna Marie Csengery. Владелец: Cybrexa 4 Inc. Дата публикации: 2024-06-06.

Type 2 cytokines as predictors of disease severity and/or as therapeutic targets for covid-19

Номер патента: US20230227546A1. Автор: Mayuresh M. Abhyankar,William A. Petri, Jr.,Barbara J. Mann,Alexandra N. DONLAN,Mary Katherine Young. Владелец: UNIVERSITY OF VIRGINIA PATENT FOUNDATION. Дата публикации: 2023-07-20.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: WO2005038005A3. Автор: Pamela A Davol,Raymond A Frackelton Jr. Владелец: Roger Williams Hospital. Дата публикации: 2006-01-19.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: WO2005038005A9. Автор: Pamela A Davol,Raymond A Frackelton Jr. Владелец: Roger Williams Hospital. Дата публикации: 2005-09-29.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: EP1670811A2. Автор: Pamela A. Davol,Raymond A. Frackelton Jr.. Владелец: Roger Williams General Hospital. Дата публикации: 2006-06-21.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: EP1670811A4. Автор: Pamela A Davol,Raymond A Frackelton Jr. Владелец: Roger Williams General Hospital. Дата публикации: 2006-12-06.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: WO2005038005A2. Автор: Pamela A. Davol,Raymond A. Frackelton Jr.. Владелец: Roger Williams Hospital. Дата публикации: 2005-04-28.

Chimeric antigen receptor (car) t cells as therapeutic interventions for auto- and allo-immunity

Номер патента: EP3355937A1. Автор: Bruce R. Blazar,Ryan P. FLYNN,Christopher A. PENNELL. Владелец: University of Minnesota. Дата публикации: 2018-08-08.

Use of Deuterated Empathogens as Therapeutic Agents

Номер патента: US20240351993A1. Автор: Paul F. Daley,Nicholas V. Cozzi. Владелец: Alexander Shulgin Research Institute Inc. Дата публикации: 2024-10-24.

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US09566271B2. Автор: Robert E. Davis,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. Uldam. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2017-02-14.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: EP3682892A2. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2020-07-22.

ANTI-DESPR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20130177500A1. Автор: Ruiz-Opaz Nelson,Herrera Victoria L.M.. Владелец: Trustee of Boston University. Дата публикации: 2013-07-11.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20190092865A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2019-03-28.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20160108124A1. Автор: Herrera Victoria L.M.,Ruiz-Opazo Nelson. Владелец: . Дата публикации: 2016-04-21.

ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: US20210155700A1. Автор: Herrera Victoria L.M.,Ruiz-Opazo Nelson. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2021-05-27.

Anti-Despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: AU2011280969A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2013-02-07.

ANTI-DEsupR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY

Номер патента: WO2012012750A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2012-01-26.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: EP3696195A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2020-08-19.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: CA2806921A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2012-01-26.

Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders

Номер патента: EP1399471A2. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Ulrich Heiser,Konrad Glund,Stephan Von Horsten. Владелец: PROBIODRUG AG. Дата публикации: 2004-03-24.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: CA3075471C. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2024-02-20.

Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Номер патента: EP3696195B1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2024-02-14.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: US20230234985A1. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2023-07-27.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: AU2018332486A1. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2020-03-26.

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US8618130B2. Автор: Robert E. Davis,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. ULDAN. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2013-12-31.

Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: CA2512639A1. Автор: Robert E. Davis,Norman Nash,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. Uldam. Владелец: Individual. Дата публикации: 2004-08-05.

Hepatocyte Growth Factor Mimics as Therapeutic Agents

Номер патента: US20140088004A1. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University WSU. Дата публикации: 2014-03-27.

Hepatocyte growth factor mimics as therapeutic agents

Номер патента: NZ616210A. Автор: Joseph W Harding,John W Wright,Leen H Kawas,Caroline C Benoist,Gary A Wayman. Владелец: Univ Washington State Res Fdn. Дата публикации: 2015-07-31.

Hepatocyte growth factor mimics as therapeutic agents

Номер патента: US8598118B2. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University WSU. Дата публикации: 2013-12-03.

Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Номер патента: US20210371479A1. Автор: Pinchas Cohen,Kelvin YEN. Владелец: University of Southern California USC. Дата публикации: 2021-12-02.

Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Номер патента: US20190194275A1. Автор: Pinchas Cohen,Kelvin YEN. Владелец: University of Southern California USC. Дата публикации: 2019-06-27.

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Номер патента: US11760783B2. Автор: Pinchas Cohen,Kelvin YEN. Владелец: University of Southern California USC. Дата публикации: 2023-09-19.

Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Номер патента: US20240018199A1. Автор: Pinchas Cohen,Kelvin YEN. Владелец: University of Southern California USC. Дата публикации: 2024-01-18.

Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: US20240091212A1. Автор: Robert E. Davis,Carl-Magnus A. Andersson,David M. Weiner,Mark R. Brann,Allan K. Uldam. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2024-03-21.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: US20240009264A1. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2024-01-11.

Hepatocyte growth factor mimics as therapeutic agents

Номер патента: EP2709650A2. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University Research Foundation. Дата публикации: 2014-03-26.

Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Номер патента: EP3474877A1. Автор: Pinchas Cohen,Kelvin YEN. Владелец: University of Southern California USC. Дата публикации: 2019-05-01.

10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Номер патента: EP1181046A2. Автор: Alberto Bartorelli. Владелец: PHARMAPRODUCTS UK Ltd. Дата публикации: 2002-02-27.

10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Номер патента: WO2000074711A3. Автор: Alberto Bartorelli. Владелец: PHARMAPRODUCTS UK Ltd. Дата публикации: 2001-07-26.

10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Номер патента: WO2000074711A2. Автор: Alberto Bartorelli. Владелец: Pharmaproducts Uk Limited. Дата публикации: 2000-12-14.

Splice choice antagonists as therapeutic agents

Номер патента: US20020068321A1. Автор: Stuart NEWMAN,Natalie Bronstein. Владелец: New York Medical College. Дата публикации: 2002-06-06.

10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Номер патента: EP1181046B1. Автор: Alberto Bartorelli. Владелец: PHARMAPRODUCTS UK Ltd. Дата публикации: 2003-08-27.

PKC Delta Inhibitors for use as Therapeutics

Номер патента: US20160250183A1. Автор: Robert M. Williams,Douglas V. Faller. Владелец: Individual. Дата публикации: 2016-09-01.

PKC delta inhibitors for use as therapeutics

Номер патента: US9844534B2. Автор: Robert M. Williams,Douglas V. Faller. Владелец: Faller & Williams Technology LLC. Дата публикации: 2017-12-19.

PKC delta inhibitors for use as therapeutics

Номер патента: US9572793B2. Автор: Robert M. Williams,Douglas V. Faller. Владелец: Faller & Williams Technology LLC. Дата публикации: 2017-02-21.

Pkc delta inhibitors for use as therapeutics

Номер патента: EP2897610A2. Автор: Robert M. Williams,Douglas V. Faller. Владелец: Individual. Дата публикации: 2015-07-29.

Modified carbazoles as therapeutic agents

Номер патента: AU2019287498A1. Автор: Nephi Stella,Philippe Diaz. Владелец: UNIVERSITY OF MONTANA. Дата публикации: 2021-01-07.

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Номер патента: IL312577A. Автор: . Владелец: Beigene Switzerland Gmbh. Дата публикации: 2024-07-01.

Substituted gamma lactams as therapeutic agents

Номер патента: EP2240473A1. Автор: David W. Old. Владелец: Allergan Inc. Дата публикации: 2010-10-20.

Cyclic structured oligonucleotides as therapeutic agents

Номер патента: EP4405482A2. Автор: Sudhir Agrawal. Владелец: Arnay Sciences LLC. Дата публикации: 2024-07-31.

Cyclic structured oligonucleotides as therapeutic agents

Номер патента: CA3174342A1. Автор: Sudhir Agrawal. Владелец: Arnay Sciences LLC. Дата публикации: 2023-03-23.

Substituted gamma lactams as therapeutic agents

Номер патента: AU2009209330A1. Автор: David W. Old. Владелец: Allergan Inc. Дата публикации: 2009-08-06.

Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics

Номер патента: ZA981434B. Автор: Mitchell E Reff,Takehiko Nakamura,Williams S Kloetzer. Владелец: Seikagaku Kogyo Co Ltd. Дата публикации: 1998-08-24.

Prosaposin and cytokine-derived peptides as therapeutic agents

Номер патента: AU2758102A. Автор: Yasuo Kishimoto,John S. O'brien. Владелец: Myelos Corp. Дата публикации: 2002-05-16.

Prosaposin and cytokine-derived peptides as therapeutic agents

Номер патента: AU781182B2. Автор: Yasuo Kishimoto,John S. O'brien. Владелец: Myelos Corp. Дата публикации: 2005-05-12.

Prosaposin and cytokine-derived peptides as therapeutic agents

Номер патента: AU2010200055A1. Автор: Yasuo Kishimoto,John S. O'brien. Владелец: Myelos Corp. Дата публикации: 2010-01-28.

Prosaposin and cytokine-derived peptides as therapeutic agents

Номер патента: AU3921199A. Автор: Yasuo Kishimoto,John S. O'brien. Владелец: Myelos Corp. Дата публикации: 1999-09-16.

Prosaposin and Cytokine-Derived Peptides as Therapeutic Agents

Номер патента: AU2005203513A1. Автор: Yasuo Kishimoto,John S O'brien. Владелец: Myelos Corp. Дата публикации: 2005-09-01.

Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis

Номер патента: US09951111B2. Автор: Howard M. Johnson,Chulbul M. AHMED. Владелец: University of Florida Research Foundation Inc. Дата публикации: 2018-04-24.

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

Номер патента: US09907847B2. Автор: Diane Mary Coe,Stephen Allan Smith. Владелец: GlaxoSmithKline LLC. Дата публикации: 2018-03-06.

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Номер патента: US09834606B2. Автор: Hao Peng,Kang Li,QI Liu,Jing Song,Tong Zhang,Lanlan Xu. Владелец: Beigene Ltd. Дата публикации: 2017-12-05.

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Номер патента: IL296026B2. Автор: . Владелец: Beigene Switzerland Gmbh. Дата публикации: 2024-10-01.

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

Номер патента: US09540383B2. Автор: Diane Mary Coe,Stephen Allan Smith. Владелец: GlaxoSmithKline LLC. Дата публикации: 2017-01-10.

Block of ccl18 signaling through ccr6 as therapeutic method of treating fibrotic diseases and cancer

Номер патента: RU2609649C2. Автор: Гернот ЦИССЕЛЬ,Йоахим МЮЛЛЕР-КЁРНХАЙМ,Анти ПРАССЕ. Владелец: Универзитетсклиникум Фрайбург. Дата публикации: 2017-02-02.

Chimeric antigen receptor (car) t cells as therapeutic interventions for gvhd

Номер патента: EP3858388B1. Автор: Bruce R. Blazar,Ryan P. FLYNN,Christopher A. PENNELL. Владелец: University of Minnesota. Дата публикации: 2024-07-03.

Pkc delta inhibitors for use as therapeutics

Номер патента: WO2014047328A3. Автор: Robert M. Williams,Douglas V. Faller. Владелец: Faller Douglas V. Дата публикации: 2015-07-16.

Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases

Номер патента: US20140194343A1. Автор: Yoichiro Iwakura,Shigeru Kakuta,Masanori Murayama,Harumichi Ishigame. Владелец: University of Tokyo NUC. Дата публикации: 2014-07-10.

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Номер патента: US20230303689A1. Автор: Hao Peng,Kang Li,QI Liu,Jing Song,Tong Zhang,Lanlan Xu. Владелец: Beigene Switzerland Gmbh. Дата публикации: 2023-09-28.

Shc proteins as therapeutic targets in proliferative diseases

Номер патента: AU2004282598A1. Автор: Pamela A. Davol,Raymond A. Frackelton Jr.. Владелец: Roger Williams General Hospital. Дата публикации: 2005-04-28.

Type 2 cytokines as predictors of disease severity and/or as therapeutic targets for covid-19

Номер патента: EP4157320A4. Автор: Barbara J Mann,Mary Katherine Young,William A Petri Jr,Alexandra N Donlan,Mayuresh M Abhyankar. Владелец: University of Manchester. Дата публикации: 2024-08-21.

Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis

Номер патента: EP1210114A1. Автор: James T. Kurnick,Judith Hellman,H. Shaw Warren. Владелец: General Hospital Corp. Дата публикации: 2002-06-05.

Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases

Номер патента: AU2155800A. Автор: Warren Strober,Rolf O. Ehrhardt,Bjorn R. Ludviksson. Владелец: US Department of Health and Human Services. Дата публикации: 2000-06-13.

Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases

Номер патента: EP1133315A1. Автор: Warren Strober,Rolf O. Ehrhardt,Bjorn R. Ludviksson. Владелец: US Department of Health and Human Services. Дата публикации: 2001-09-19.

Oncolytic viruses as therapeutic agents for treating cancer

Номер патента: WO2024164051A1. Автор: Darren Shafren. Владелец: Immvirx Pty Ltd. Дата публикации: 2024-08-15.

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Номер патента: US09988450B2. Автор: Hao Peng,Kang Li,QI Liu,Jing Song,Tong Zhang,Lanlan Xu. Владелец: Beigene Switzerland Gmbh. Дата публикации: 2018-06-05.

10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Номер патента: AU5969500A. Автор: Alberto Bartorelli. Владелец: PHARMAPRODUCTS UK Ltd. Дата публикации: 2000-12-28.

Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases

Номер патента: US20120156214A1. Автор: Fabienne MacKay,Paul D. Rennert,Jeffrey L. Browning,Paula S. Hochman. Владелец: BIOGEN IDEC MA INC. Дата публикации: 2012-06-21.

DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS

Номер патента: US20130022551A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: Boston University. Дата публикации: 2013-01-24.

Hepatocyte growth factor mimics as therapeutic agents

Номер патента: US20130165392A1. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University WSU. Дата публикации: 2013-06-27.

Crosslinked Polymers with the Crosslinker as Therapeutic for Sustained Release

Номер патента: US20130225857A1. Автор: Rachit Ohri,Phillip Blaskovich,Steven L. Bennett,Arthur Driscoll,Joshua Kennedy. Владелец: Confluent Surgical Inc. Дата публикации: 2013-08-29.

Hepatocyte Growth Factor Mimics as Therapeutic Agents

Номер патента: US20140088004A1. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University WSU. Дата публикации: 2014-03-27.

PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS

Номер патента: US20210009536A1. Автор: MARSHALL Daniel Richard,Csengery Johanna Marie,Maguire Robert John,Volkmann Robert A.. Владелец: . Дата публикации: 2021-01-14.

PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS

Номер патента: US20210009719A1. Автор: MARSHALL Daniel Richard,Csengery Johanna Marie,Maguire Robert John,Volkmann Robert A.. Владелец: . Дата публикации: 2021-01-14.

GLA DOMAINS AS THERAPEUTIC AGENTS

Номер патента: US20210015900A1. Автор: HERMISTON Terry,Bauzon Maxine. Владелец: GLADIATOR BIOSCIENCES, INC.. Дата публикации: 2021-01-21.

ANTI-BAG3 ANTIBODIES AS THERAPEUTIC REAGENT IN CARDIOVASCULAR DISEASE

Номер патента: US20210024623A1. Автор: TURCO Maria Caterina,BASILE Anna,ROSATI Alessandra,MARZULLO Liberato,DE MARCO Margot. Владелец: . Дата публикации: 2021-01-28.

Hepatocyte Growth Factor Mimics as Therapeutic Agents

Номер патента: US20170049843A1. Автор: Joseph W. Harding,John W. Wright,Caroline C. BENOIST,Leen H. KAWAS,Gary A. Wayman. Владелец: Washington State University WSU. Дата публикации: 2017-02-23.

TYPE I INTERFERON MIMETICS AS THERAPEUTICS FOR CANCER, VIRAL INFECTIONS, AND MULTIPLE SCLEROSIS

Номер патента: US20140134237A1. Автор: JOHNSON HOWARD M.,AHMED CHULBUL M.. Владелец: . Дата публикации: 2014-05-15.

COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF NEURORETINAL DISEASES

Номер патента: US20220089547A1. Автор: Marigo Mauro,Fasching Bernhard,STEGER Matthias,MUELLER Alex,MOKADY Daphna. Владелец: ENDOGENA THERAPEUTICS, INC.. Дата публикации: 2022-03-24.

MODIFIED CARBAZOLES AS THERAPEUTIC AGENTS

Номер патента: US20210094949A1. Автор: Diaz Philippe,Stella Nephi. Владелец: . Дата публикации: 2021-04-01.

Gla domains as therapeutic agents

Номер патента: US20190105370A1. Автор: Maxine Bauzon,Terry Hermiston. Владелец: Gladiator Biosciences Inc. Дата публикации: 2019-04-11.

Soluble proteins for use as therapeutics

Номер патента: US20140193408A1. Автор: Thomas Huber,Frank Kolbinger,Karl Welzenbach. Владелец: NOVARTIS AG. Дата публикации: 2014-07-10.

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20180111995A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: . Дата публикации: 2018-04-26.

MENTSH ANALOGS AS THERAPEUTICS FOR DIABETES, OBESITY, AND THEIR ASSOCIATED DISEASES AND COMPLICATIONS

Номер патента: US20190194275A1. Автор: Cohen Pinchas,Yen Kelvin. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2019-06-27.

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20210230274A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: . Дата публикации: 2021-07-29.

MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS

Номер патента: US20160222115A1. Автор: Yansura Daniel G.,Schwall Ralph H.,Huang Arthur Jyh-Yen. Владелец: Genentech, Inc.. Дата публикации: 2016-08-04.

Anti-pd-l1 antibodies and their use as therapeutics and diagnostics

Номер патента: US20180215825A1. Автор: Kang Li,Jing Song,Yucheng Li,Tong Zhang,Zhiying REN,Yanshen KANG. Владелец: Beigene Ltd. Дата публикации: 2018-08-02.

COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT OF RETINAL DISEASES

Номер патента: US20200207719A1. Автор: Fasching Bernhard,STEGER Matthias,MUELLER Alex,MOKADY Daphna. Владелец: ENDOGENA THERAPEUTICS, INC.. Дата публикации: 2020-07-02.

COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT OF RETINAL DISEASES

Номер патента: US20200207749A1. Автор: Fasching Bernhard,STEGER Matthias,MUELLER Alex,MOKADY Daphna. Владелец: ENDOGENA THERAPEUTICS, INC.. Дата публикации: 2020-07-02.

QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE

Номер патента: US20140315886A1. Автор: Miyamura Shin,Takahashi Haruka,Suzuki Masaki,KONDO Kazumi,Newcom Jason S.,Kurimura Muneaki,Valluru Krishna Reddy,Kuroda Takeshi,Fukushima Tae,Ghosh Indranath,Dogra Abhishek,Harriman Geraldine,Elder Amy,Hodgetts Kevin J.,Takahahi Akira,Shimiza Satoshi. Владелец: OTSUKA PHARMACEUTICAL CO., LTD.. Дата публикации: 2014-10-23.

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20200216535A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: . Дата публикации: 2020-07-09.

PKC Delta Inhibitors for use as Therapeutics

Номер патента: US20170252322A1. Автор: Faller Douglas V.,Williams Robert M.. Владелец: Faller & Williams Technology, LLC. Дата публикации: 2017-09-07.

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20180251551A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: . Дата публикации: 2018-09-06.

ANTI-HLA CLASS-IB ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) USEFUL AS THERAPEUTIC IVIG MIMETICS AND METHODS OF THEIR USE

Номер патента: US20140348846A1. Автор: Ravindranath Mepur H.,Terasaki Paul I.. Владелец: . Дата публикации: 2014-11-27.

CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AS THERAPEUTIC INTERVENTIONS FOR AUTO- AND ALLO-IMMUNITY

Номер патента: US20180264038A1. Автор: Blazar Bruce R.,Flynn Ryan P.,Pennell Christopher A.. Владелец: . Дата публикации: 2018-09-20.

TYPE I INTERFERON MIMETICS AS THERAPEUTICS FOR CANCER, VIRAL INFECTIONS, AND OTHER DISEASES

Номер патента: US20160289288A1. Автор: JOHNSON HOWARD M.,AHMED CHULBUL M.. Владелец: . Дата публикации: 2016-10-06.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

Номер патента: US20200276260A1. Автор: Sun Young PARK,Kyung Eun Kim,Dae Ho Cho,Myun Soo Kim,Hee Young Jung. Владелец: Kine Sciences Co Ltd. Дата публикации: 2020-09-03.

USE OF PEPTIDES AS THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES

Номер патента: US20200283477A1. Автор: Park Sun Young,Jung Hee Young,KIM Myun SOO,Cho Dae Ho,KIM Kyung Eun. Владелец: . Дата публикации: 2020-09-10.

ANTI-PD-L1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20200283527A1. Автор: Song Jing,Li Kang,Zhang Tong,Li Yucheng,REN Zhiying,KANG Yanshen. Владелец: . Дата публикации: 2020-09-10.

UBIQUITIN INTERACTING MOTIF PEPTIDES AS THERAPEUTICS

Номер патента: US20180305423A1. Автор: Chen Hong,DONG Yunzhou. Владелец: Oklahoma Medical Research Foundation. Дата публикации: 2018-10-25.

COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT

Номер патента: US20170320939A1. Автор: Henrotin Yves,LAMBERT Cécile,BORDERIE Didier,RANNOU François. Владелец: . Дата публикации: 2017-11-09.

Semaphorin 3d and plexin d1 as therapeutic targets for pancreatic cancer treatment

Номер патента: US20190316124A1. Автор: Lei Zheng. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2019-10-17.

ANTI-TIGIT ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Номер патента: US20200331999A1. Автор: Li Kang,Liu Qi,Zhang Tong,Wei Min,Xue Liu. Владелец: . Дата публикации: 2020-10-22.

COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT

Номер патента: US20200347121A1. Автор: Henrotin Yves,LAMBERT Cécile,BORDERIE Didier,RANNOU François. Владелец: . Дата публикации: 2020-11-05.

Monovalent antibody fragments useful as therapeutics

Номер патента: CA2548757A1. Автор: Arthur Jyh-Yen Huang,Ralph H. Schwall,Daniel G. Yansura. Владелец: Daniel G. Yansura. Дата публикации: 2005-07-14.

Monovalent antibody fragments useful as therapeutics

Номер патента: US20050227324A1. Автор: Ralph Schwall,Arthur Huang,Daniel Yansura. Владелец: Genentech Inc. Дата публикации: 2005-10-13.

Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis

Номер патента: CN101080239A. Автор: M·帕格,M·弗里德,A·E·施密德特,D·施托伯尔. Владелец: LOLUNTISS CO Ltd. Дата публикации: 2007-11-28.

Cd147 binding molecules as therapeutics

Номер патента: KR20010034554A. Автор: 데이비스씨지오프리,블래쳐러셀더블유,코르발란호세알,컬웰알란알,그린래리엘,헤일즈조안나,해브릴라낸시,이바노프블라디미르이,리파니존에이,리우퀴앙,웨버리차드에프,양쟈오-동. Владелец: 레이몬드, 엠. 위티. Дата публикации: 2001-04-25.

Anti-HLA class-IB antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (IVIG) useful as therapeutic IVIG mimetics and methods of their use

Номер патента: US10800847B2. Автор: Mepur H. Ravindranath,Paul I. Terasaki. Владелец: Ravindranath Mepur Dr. Дата публикации: 2020-10-13.

Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases

Номер патента: WO2019020734A1. Автор: Maria Caterina Turco,Liberato Marzullo,Alessandra Rosati,Margot DE MARCO,Anna BASILE. Владелец: BIOUNIVERSA S.R.L.. Дата публикации: 2019-01-31.

Modified peptides as therapeutic agents

Номер патента: US6660843B1. Автор: Chuan-Fa Liu,Ulrich Feige. Владелец: AMGEN INC. Дата публикации: 2003-12-09.

SOLUBLE PROTEINS FOR USE AS THERAPEUTIC TOOLS

Номер патента: EA201490020A1. Автор: Франк КОЛЬБИНГЕР,Томас Хубер,Карл Вельценбах. Владелец: НОВАРТИС АГ. Дата публикации: 2014-04-30.

γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

Номер патента: US7033589B1. Автор: Mitchell E. Reff,William S. Kloetzer,Takehiko Nakamura. Владелец: BIOGEN IDEC MA INC. Дата публикации: 2006-04-25.

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

Номер патента: CN1816524A. Автор: 大卫·M·韦纳,罗伯特·E·戴维斯,马克·R·布伦. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2006-08-09.

Monovalent antibody fragments useful as therapeutics

Номер патента: EP2275448A2. Автор: Arthur Jyh-Yen Huang,Ralph H. Schwall,Daniel G. Yansura. Владелец: Genentech Inc. Дата публикации: 2011-01-19.

Modified peptides as therapeutic agents

Номер патента: US20040077022A1. Автор: Thomas Boone,Jean Gudas,Ulrich Feige,Janet Cheetham,Chun-Fa Liu. Владелец: Chun-Fa Liu. Дата публикации: 2004-04-22.

Soluble proteins for use as therapeutics

Номер патента: CN103635490A. Автор: T·胡贝尔,F·科尔宾格,K·韦尔岑巴赫. Владелец: NOVARTIS AG. Дата публикации: 2014-03-12.

Soluble proteins for use as therapeutics

Номер патента: WO2012172521A1. Автор: Thomas Huber,Frank Kolbinger,Karl Welzenbach. Владелец: NOVARTIS AG. Дата публикации: 2012-12-20.

F11 receptor (F11R) antagonists as therapeutic agents

Номер патента: US7829663B2. Автор: Elizabeth Kornecki,Anna Babinska,Yigal H. Ehrlich. Владелец: Research Foundation of State University of New York. Дата публикации: 2010-11-09.

Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease

Номер патента: US5925351A. Автор: Jeffrey L. Browning,Paula S. Hochman,Christopher D. Benjamin. Владелец: Biogen Inc. Дата публикации: 1999-07-20.

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

Номер патента: US6893636B2. Автор: Mitchell E. Reff,William S. Kloetzer,Takehiko Nakamura. Владелец: BIOGEN IDEC MA INC. Дата публикации: 2005-05-17.

Modified peptides as therapeutic agents

Номер патента: US7488590B2. Автор: Chuan-Fa Liu,Ulrich Feige,Thomas Charles Boone,Jean Marie Gudas,Janet C. Cheetham. Владелец: AMGEN INC. Дата публикации: 2009-02-10.

DKK1 oncogene as therapeutic target for cancer and a diagnosing marker

Номер патента: US8709731B2. Автор: Yusuke Nakamura,Yataro Daigo,Shuichi Nakatsuru. Владелец: ONCOTHERAPY SCIENCE INC. Дата публикации: 2014-04-29.

F11 receptor (F11R) antagonists as therapeutic agents

Номер патента: US9556235B2. Автор: Elizabeth Kornecki,Anna Babinska,Yigal H. Ehrlich,Moro Salifu. Владелец: Research Foundation of State University of New York. Дата публикации: 2017-01-31.

GLA domains as therapeutic agents

Номер патента: US10925926B2. Автор: Maxine Bauzon,Terry Hermiston. Владелец: Gladiator Biosciences Inc. Дата публикации: 2021-02-23.

Modified peptides, comprising an fc domain, as therapeutic agents

Номер патента: WO2001083525A2. Автор: Chuan-Fa Liu,Ulrich Feige,Thomas Charles Boone,Jean Marie Gudas,Janet C. Cheetham. Владелец: Amgen Inc.. Дата публикации: 2001-11-08.

Modified peptides, comprising an FC domain, as therapeutic agents

Номер патента: AU2001259432B2. Автор: Chuan-Fa Liu,Ulrich Feige,Thomas Charles Boone,Jean Marie Gudas,Janet C. Cheetham. Владелец: AMGEN INC. Дата публикации: 2005-04-21.

Modified peptides as therapeutic agents

Номер патента: US20050123548A1. Автор: Thomas Boone,Chuan-Fa Liu,Ulrich Feige,Janet Cheetham. Владелец: AMGEN INC. Дата публикации: 2005-06-09.

Modified peptides as therapeutic agents

Номер патента: CA2347131C. Автор: Chuan-Fa Liu,Ulrich Feige,Janet Cheetham,Thomas Charles Boone. Владелец: AMGEN INC. Дата публикации: 2012-11-27.

Monovalent antibody fragments useful as therapeutics

Номер патента: EP1718677A2. Автор: Arthur Jyh-Yen Huang,Ralph H. Schwall,Daniel G. Yansura. Владелец: Genentech Inc. Дата публикации: 2006-11-08.

DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS

Номер патента: WO2013112467A1. Автор: Victoria L.M. Herrera,Nelson Ruiz-Opazo. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2013-08-01.

Modified peptides as therapeutic agents

Номер патента: CN1781946A. Автор: U·菲格,C·-F·刘,J·彻塔姆,T·C·波尼. Владелец: AMGEN INC. Дата публикации: 2006-06-07.

Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease

Номер патента: CN1146441C. Автор: ,Jl,J·L·布朗宁格,C·D·本扎明,P·S·霍克曼. Владелец: Biogen Inc. Дата публикации: 2004-04-21.

F11 receptor (F11R) antagonists as therapeutic agents

Номер патента: US20050265992A1. Автор: Elizabeth Kornecki,Anna Babinska,Yigal Ehrlich. Владелец: Research Foundation of State University of New York. Дата публикации: 2005-12-01.

anti-PD 1 antibodies and their use as therapeutic and diagnostic agents

Номер патента: CN112552401A. Автор: 刘琦,李康,张彤,徐兰兰,宋兢,彭浩. Владелец: Guangzhou Baiji Shenzhou Biopharmaceutical Co ltd. Дата публикации: 2021-03-26.

Anti- PD-L1 antibody and its purposes as therapeutic agent and diagnosticum

Номер патента: CN106604742B. Автор: 李玉成,李康,张彤,宋兢,任志英,康延申. Владелец: Beigene Ltd. Дата публикации: 2019-01-11.

Modified peptides, comprising an fc domain, as therapeutic agents

Номер патента: WO2000024782A2. Автор: Chuan-Fa Liu,Ulrich Feige,Janet Cheetham,Thomas Charles Boone. Владелец: Amgen Inc.. Дата публикации: 2000-05-04.

Modified peptides as therapeutic agents

Номер патента: US20040053845A1. Автор: Thomas Boone,Chuan-Fa Liu,Ulrich Feige,Janet Cheetham. Владелец: AMGEN INC. Дата публикации: 2004-03-18.

Immunological reagents for the detection of viral hepatitis NANB, processes for preparing them and their applications in processes for the detection of viral hepatitis NANB and as therapeutic agents

Номер патента: FR2609807A2. Автор: Jacques Pillot. Владелец: Institut Pasteur de Lille. Дата публикации: 1988-07-22.

Gla domains as therapeutic agents

Номер патента: CA2905986A1. Автор: Maxine Bauzon,Terry Hermiston. Владелец: Bayer HealthCare LLC. Дата публикации: 2014-09-25.

Boronic peptides derivatives; process for preparing the same and their use as therapeutic agents

Номер патента: CA2146833A1. Автор: Gilbert Lassalle,Jean-Claude Muller,Sergio Mallart,Thomas Andrew Purcell. Владелец: Thomas Andrew Purcell. Дата публикации: 1995-10-13.

A family of porphinic core substances, their process for obtaining cyanophyceae, and their applications as cosmetics and as therapeutic products.

Номер патента: FR2693904A1. Автор: Daniel Jean,Denise Pepin. Владелец: VICHY CIE FERMIERE ETABL THERM. Дата публикации: 1994-01-28.

COMPLEX HYBRID PROTEINS, PROCESS FOR THEIR PREPARATION, AND THEIR APPLICATIONS AS A DIAGNOSTIC AGENT, AS THERAPEUTICALLY ACTIVE AGENT OR AS A REAGENT FOR USE IN MEDICAL IMAGING.

Номер патента: FR2687157A1. Автор: Boulain Jean-Claude,Ducancel Frédéric,Gillet Daniel,Menez Andre. Владелец: Commissariat a lEnergie Atomique CEA. Дата публикации: 1993-08-13.

Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptors and ligand antibodies as therapeutic agents for the treatment of immunological diseases

Номер патента: KR100493980B1. Автор: 엘. 브라우닝 제프리,디. 벤자민 크리스토퍼,에스. 호크만 폴라. Владелец: 바이오겐 아이덱 엠에이 인코포레이티드. Дата публикации: 2005-11-11.

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Номер патента: RS63571B9. Автор: Hao Peng,Kang Li,QI Liu,Jing Song,Tong Zhang,Lanlan Xu. Владелец: Beigene Switzerland Gmbh. Дата публикации: 2023-02-28.

Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases

Номер патента: CA2269614A1. Автор: Jeffrey Browning,Fabienne MacKay,Paul D. Rennert,Paula Susan Hochman. Владелец: Individual. Дата публикации: 1998-04-30.

Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

Номер патента: US10544225B2. Автор: Kang Li,Jing Song,Yucheng Li,Tong Zhang,Zhiying REN,Yanshen KANG. Владелец: Beigene Ltd. Дата публикации: 2020-01-28.

Antibodies against t-cells as therapeutics

Номер патента: WO1995035321A1. Автор: Stefan Thierfelder. Владелец: GSF - Forschungszentrum für Umwelt und Gesundheit GmbH. Дата публикации: 1995-12-28.

PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS

Номер патента: CU20200068A7. Автор: Rene Roy,Tze Chieh SHIAO. Владелец: Koranex Capital. Дата публикации: 2021-04-07.

Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia

Номер патента: CA2089088A1. Автор: Lyle J. Arnold, Jr.,Mark A. Reynolds,Morteza M. Vaghefi. Владелец: Individual. Дата публикации: 1992-02-10.

Soluble proteins for use as therapeutics

Номер патента: CA2838478A1. Автор: Thomas Huber,Frank Kolbinger,Karl Welzenbach. Владелец: NOVARTIS AG. Дата публикации: 2012-12-20.

Modified peptides as therapeutic agents

Номер патента: US20040071712A1. Автор: Thomas Boone,Chuan-Fa Liu,Ulrich Feige,Janet Cheetham. Владелец: AMGEN INC. Дата публикации: 2004-04-15.

Anti-TIGIT antibodies and their use as therapeutics and diagnostics

Номер патента: US11214616B2. Автор: LIU XUE,Kang Li,MIN Wei,QI Liu,Tong Zhang. Владелец: Beigene Ltd. Дата публикации: 2022-01-04.

New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents

Номер патента: CA2139100A1. Автор: Lieven Stuyver,Geert Maertens. Владелец: Individual. Дата публикации: 1994-11-10.

Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders

Номер патента: WO2008145749A1. Автор: Ezio Ghigo,Aart Jan Van Der Lely,Riccarda Granata. Владелец: ALIZÉ PHARMA SAS. Дата публикации: 2008-12-04.

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

Номер патента: US7438906B2. Автор: Mitchell E. Reff,William S. Kloetzer,Takehiko Nakamura. Владелец: BIOGEN IDEC MA INC. Дата публикации: 2008-10-21.

Carotene analog of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents

Номер патента: CA2331763A1. Автор: Thomas J. Dougherty,Ravindra K. Pandey,William R. Potter. Владелец: Individual. Дата публикации: 1999-12-29.

Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient

Номер патента: US09752151B2. Автор: Jin Sun Kim,Jai Hee Moon,Bong Cheol Kim,Eun kyung Choi,Tae Won Kim,Seung Woo Hong,Ky Youb Nam,Dong Hoon Jin,Jae Sik Shin,Yong Sang HONG,Kyung Ah Jung,Jung Shin Lee,Jae Lyun Lee,Kyu Pyo Kim. Владелец: Asan Foundation. Дата публикации: 2017-09-05.

Composition for preventing or treating cancer comprising msh2 or msh6 inhibitor as active ingredient

Номер патента: EP4385524A1. Автор: Suk-Woo Nam,Min Jeong NA. Владелец: Neornat. Дата публикации: 2024-06-19.

Production of organoid derived from ctc of small cell lung cancer patient, and igf1r inhibitor as a molecular target drug for small cell lung cancer

Номер патента: EP4403186A1. Автор: Hiroyuki Yasuda,Toshiro Sato,Takahiro Fukushima,Koichi Fukunaga,Toshiki EBISUDANI,Junko HAMAMOTO. Владелец: KEIO UNIVERSITY. Дата публикации: 2024-07-24.

Pharmaceutical composition for preventing or treating fabry disease, containing TSP1 protein inhibitor as active ingredient

Номер патента: AU2019352379A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2021-05-06.

Pharmaceutical composition for preventing and treating metabolic disease comprising MKRN1 expression or activity inhibitor as an active ingredient

Номер патента: US10696970B2. Автор: Jae Whan SONG,Min Sik LEE. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2020-06-30.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: EP3848039A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2021-07-14.

Pharmaceutical composition for preventing or treating fabry disease, containing tsp1 protein inhibitor as active ingredient

Номер патента: CA3114875A1. Автор: Yong Mahn Han,Hyo Sang Do. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2020-04-09.

Composition for treating retinal or choroidal diseases, containing acta2 inhibitor as active ingredient

Номер патента: US20230392150A1. Автор: Soo Jin Kim,Junyeop LEE. Владелец: Asan Foundation. Дата публикации: 2023-12-07.

2',4'-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds and their use as therapeutic agents

Номер патента: US20080221220A1. Автор: Stuart Hamilton Ralston,Iain Robert Greig,Robert Jurgen Van 't Hof. Владелец: Individual. Дата публикации: 2008-09-11.

Quinolynylmethylimidizoles as therapeutic agents

Номер патента: US20100076020A1. Автор: Ken Chow,Michael E. Garst,Todd M. Heidelbaugh,Phong X. Nguyen. Владелец: Allergan Inc. Дата публикации: 2010-03-25.

Naphthylmethylimidizoles as therapeutic agents

Номер патента: US20100004305A1. Автор: Ken Chow,Michael E. Garst,Todd M. Heidelbaugh,Phong X. Nguyen. Владелец: Allergan Inc. Дата публикации: 2010-01-07.

Quinolynylmethylimidizoles as therapeutic agents

Номер патента: US20100113516A1. Автор: Ken Chow,Michael E. Garst,Todd M. Heidelbaugh,Phong X. Nguyen. Владелец: Allergan Inc. Дата публикации: 2010-05-06.

Sulfonamido- and sulfonabidocabonyl-pyridine-2-carboxylic acid amides and their pyridine-n-oxides, method of obtaining them and their application as therapeutic agents as well therapeutic agents containing them and method of obtaining such therapeutic

Номер патента: PL298195A1. Автор: Martin Bickel,Klaus Weidmann,Volkmar Guenzler-Pukall. Владелец: Hoechst AG. Дата публикации: 1994-01-10.

Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents

Номер патента: CA2681320C. Автор: Stuart Hamilton Ralston,Iain Robert Greig,Robert Jurgen Van 't Hof. Владелец: University of Aberdeen. Дата публикации: 2015-05-19.

Heterotricyclic substituted derivatives of phenylocyclohexane carboxylic acid, method of obtaining them as well as therapeutic agents containing such derivatives and method of obtaining such therapeutic agents

Номер патента: PL175560B1. Автор: Andreas Knorr,Johannes-Peter Stasch,Thomas Kramer,Peter Fey,Martin Beuck,Stanislav Kazda,Stefan Wohlfeil,Walter Hübsch,Jurgen Dressel,Ulrich E. Muller,Matthias Muller-Gliemann,Siegfried Zaiss,Rudolf H. Hanko. Владелец: Bayer AG. Дата публикации: 1999-01-29.

PYRAZOLE DERIVATIVES AS THERAPEUTIC AGENTS

Номер патента: RU2008108179A. Автор: Лейфенг ЧЕНГ,Хенрик Серенсен,Матти АЛЬКВИСТ,Роберт ЛУНДКВИСТ,Лейфенг ЧЕНГ (SE),Матти АЛЬКВИСТ (SE),Роберт ЛУНДКВИСТ (SE),Хенрик СЕРЕНСЕН (SE). Владелец: Астразенека Аб (Se). Дата публикации: 2009-09-20.

Transcription factor brn2 inhibitory compounds for use as therapeutics

Номер патента: AU2022333667A1. Автор: Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER. Владелец: University of British Columbia. Дата публикации: 2024-03-07.

Transcription factor brn2 inhibitory compounds for use as therapeutics

Номер патента: EP4392410A1. Автор: Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER. Владелец: University of British Columbia. Дата публикации: 2024-07-03.

Substituted gamma lactams as therapeutic agents

Номер патента: AU2007257768A1. Автор: David W. Old. Владелец: Allergan Inc. Дата публикации: 2007-12-21.

Substituted gamma lactams as therapeutic agents

Номер патента: EP2041128A2. Автор: David W. Old. Владелец: Allergan Inc. Дата публикации: 2009-04-01.

Substituted gamma lactams as therapeutic agents

Номер патента: US20070293551A1. Автор: David Old. Владелец: Allergan Inc. Дата публикации: 2007-12-20.

Substituted gamma lactams as therapeutic agents

Номер патента: WO2007146856A2. Автор: David W. Old. Владелец: ALLERGAN, INC.. Дата публикации: 2007-12-21.

Novel laulimalide analogues as therapeutic agents

Номер патента: US20090099252A1. Автор: Paul A. Wender. Владелец: Individual. Дата публикации: 2009-04-16.

Transcription factor brn2 inhibitory compounds as therapeutics and methods for their use

Номер патента: EP3860994B1. Автор: Jennifer L. Bishop,Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER,Sepideh VAHID. Владелец: University of British Columbia. Дата публикации: 2024-08-14.

Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents

Номер патента: US20100048663A1. Автор: Moshe Laudon,Tal Peleg-Shulman,Dorah Daily. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2010-02-25.

Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

Номер патента: WO2008041140A8. Автор: Moshe Laudon,Tal Peleg-Shulman,Dvorah Daily. Владелец: Dvorah Daily. Дата публикации: 2009-07-09.

Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents

Номер патента: US20080132559A1. Автор: Moshe Laudon,Tal Peleg-Shulman,Dorah Daily. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2008-06-05.

Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

Номер патента: TW200824684A. Автор: Moshe Laudon,Tal Peleg-Shulman,Dvorah Daily. Владелец: Neurim Pharma 1991. Дата публикации: 2008-06-16.

Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

Номер патента: EP2086932B1. Автор: Moshe Laudon,Tal Peleg-Shulman,Dvorah Daily. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2014-08-27.

Substituted aryl-indole compounds and their kynurenine kynuramine-like metabolites as therapeutic agents

Номер патента: HK1133886A1. Автор: Moshe Laudon,Tal Peleg-Shulman,Dvorah Daily. Владелец: Neurim Pharma 1991. Дата публикации: 2010-04-09.

Muscarinic agents as therapeutic compounds

Номер патента: WO2005054242A1. Автор: Eric James Thomas,Robin Havard Davies,Maxime Buffat. Владелец: Muscagen Limited. Дата публикации: 2005-06-16.

Muscarinic agents as therapeutic compounds

Номер патента: US7691857B2. Автор: Maxime Buffat,James Eric Thomas,Harvard Robin Davies. Владелец: Muscagen Ltd. Дата публикации: 2010-04-06.

Transcription factor brn2 inhibitory compounds as therapeutics and methods for their use

Номер патента: EP3860994A1. Автор: Jennifer L. Bishop,Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER,Sepideh VAHID. Владелец: University of British Columbia. Дата публикации: 2021-08-11.

Transcription Factor BRN2 Inhibitory Compounds as Therapeutics and Methods for Their Use

Номер патента: US20220106304A1. Автор: Jennifer L. Bishop,Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER,Sepideh VAHID. Владелец: University of British Columbia. Дата публикации: 2022-04-07.

Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning

Номер патента: US20100286125A1. Автор: Alan T. Johnson,Seongjin Kim. Владелец: PanThera Biopharma LLC. Дата публикации: 2010-11-11.

Mglur1 anatgonists as therapeutic agents

Номер патента: EP1966220A2. Автор: Li Qiang,Duane A. Burnett,Deen Tulshian,Peter Korakas,Lisa S. Silverman,Julius J. Matasi,Wen-Lian Wu,Martin S. Domalski,Sasikumar K. Thavalakulamgara. Владелец: Schering Corp. Дата публикации: 2008-09-10.

Azole compounds as therapeutic agents for fungal infections.

Номер патента: ZA200207208B. Автор: Ashwani Kumar Verma,Ashok Rattan,Jasbir Singh Arora,Sudershan K Arora. Владелец: Ranbaxy Lab Ltd. Дата публикации: 2003-07-04.

Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

Номер патента: US09487535B2. Автор: Tarek Suhayl Mansour,Sultan Chowdhury,Jianmin Fu,Shaoyi Sun,Michael Edward Grimwood,Ivan William Hemeon. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-11-08.

4-aryl quinols and analogs thereof as therapeutic agents

Номер патента: EP1404659A1. Автор: M. F. G. School Pharmaceutical Sciences STEVENS,G. Dept. Pharma. & Biological Chemistry WELLS,A. D. School Pharmaceutical Sciences WESTWELL,T. D. School Pharmaceutical Sciences POOLE. Владелец: Cancer Research Technology LTD. Дата публикации: 2004-04-07.

4-aryl quinols and analogs thereof as therapeutic agents

Номер патента: NZ530787A. Автор: Geoffrey Wells,Malcolm Francis Graham Stevens,Andrew David Westwell,Tracey Dawn Poole. Владелец: Cancer Rec Tech Ltd. Дата публикации: 2005-07-29.

DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS

Номер патента: WO2018141002A3. Автор: Shudong Wang,Yi Long,Sarah AL HAJ DIAB. Владелец: University of South Australia. Дата публикации: 2018-11-22.

Transcription factor brn2 inhibitory compounds for use as therapeutics

Номер патента: CA3229820A1. Автор: Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER. Владелец: Individual. Дата публикации: 2023-03-02.

Substituted fused and bridged bicyclic compounds as therapeutic agents

Номер патента: AU1998995A. Автор: HONG Hu,Jose Serafin Mendoza,G. Erik Jagdmann Jr.. Владелец: Eli Lilly and Co. Дата публикации: 1995-11-29.

Benzopyrans and their use as therapeutic agents

Номер патента: WO1995034546A1. Автор: Mervyn Thompson,John Morris Evans,Wai Ngor Chan. Владелец: Smithkline Beecham P.L.C.. Дата публикации: 1995-12-21.

Substituted fused and bridged bicyclic compounds as therapeutic agents

Номер патента: GR3032950T3. Автор: HONG Hu,Jose Serafin Mendoza,G Erik Jagdmann Jr. Владелец: Lilly Co Eli. Дата публикации: 2000-07-31.

Human ets-related gene (erg) compounds as therapeutics and methods for their use

Номер патента: WO2018145217A1. Автор: Michael Hsing,Artem Tcherkassov,Paul. S. RENNIE,Miriam S. BUTLER,Mani ROSHAN-MONIRI,Michael E. Cox. Владелец: The University of British Columbia. Дата публикации: 2018-08-16.

DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO[1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS

Номер патента: US20200231586A1. Автор: Shudong Wang,Yi Long,Sarah AL HAJ DIAB. Владелец: Aucentra Therapeutics Pty Ltd. Дата публикации: 2020-07-23.

Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents

Номер патента: US20110319494A1. Автор: Moshe Laudon,Tal Peleg-Shulman,Dorah Daily. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2011-12-29.

Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

Номер патента: EP2086932A2. Автор: Moshe Laudon,Tal Peleg-Shulman,Dvorah Daily. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2009-08-12.

Novel laulimalide analogues as therapeutic agents

Номер патента: WO2009023123A1. Автор: Paul A. Wender. Владелец: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. Дата публикации: 2009-02-19.

Muscarinic agonists as therapeutic compounds

Номер патента: EP1697359A1. Автор: Maxime Muscagen Limited BUFFAT,Eric James Muscagen Limited THOMAS,Robin Havard Muscagen Limited DAVIES. Владелец: Muscagen Ltd. Дата публикации: 2006-09-06.

Transcription factor brn2 inhibitory compounds for use as therapeutics

Номер патента: WO2023023853A1. Автор: Amina Zoubeidi,Daksh THAPER,Ravi Munuganti. Владелец: The University of British Columbia. Дата публикации: 2023-03-02.

Transcription factor brn2 inhibitory compounds as therapeutics and methods for their use

Номер патента: WO2020069625A1. Автор: Jennifer L. Bishop,Amina Zoubeidi,Ravi Shashi Nayana MUNUGANTI,Daksh THAPER,Sepideh VAHID. Владелец: The University of British Columbia. Дата публикации: 2020-04-09.

Process for the preparation of 1,4 - dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents

Номер патента: US20030230478A1. Автор: Vijay Kapoor,Kasturi Bedi,Kanaya Dhar,Ravi Khajuria,Neeraj Mahendroo. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2003-12-18.

Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals

Номер патента: US09422233B2. Автор: Ned D. Heindel,Jeffrey D. Laskin,Diane E. Heck,Marion Gordon,Carl Jeffrey Lacey,Abhilash N. Pillai. Владелец: Rutgers State University of New Jersey. Дата публикации: 2016-08-23.

Azole derivatives and fused bicyclic azole derivatives as therapeutic agents

Номер патента: US20120088778A1. Автор: Xin Chen,Xiao-Chuan Guo,Adnan M.M. Mjalli,Robert C. Andrews,Suparna Gupta,David R. Jones,Ramesh Gopalaswamy,Ghassan Qabaja,Anitha Hari,Kwasi S. Avor. Владелец: vTvx Holdings I LLC. Дата публикации: 2012-04-12.

ROR1 as Therapeutic and Diagnostic Target

Номер патента: US20120282177A1. Автор: Jonathan Alexander Terrett,Christian Rohlff,Alasdair Stamps. Владелец: OXFORD BIOTHERAPEUTICS LTD. Дата публикации: 2012-11-08.

ANTI-HLA CLASS-Ib ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIg) USEFUL AS THERAPEUTIC IVIg MIMETICS AND METHODS OF THEIR USE

Номер патента: US20130177574A1. Автор: Mepur H. Ravindranath,Paul I. Terasaki. Владелец: PAUL I TERASAKI FOUNDATION LABS. Дата публикации: 2013-07-11.

INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS

Номер патента: US20220073470A1. Автор: Maloney David,Lowery Robert G.,Kumar Meera,Boxer Matthew,Boyd Susan. Владелец: . Дата публикации: 2022-03-10.

Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

Номер патента: US20170066777A1. Автор: Tarek Suhayl Mansour,Sultan Chowdhury,Jianmin Fu,Shaoyi Sun,Michael Edward Grimwood,Ivan William Hemeon. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2017-03-09.

N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS

Номер патента: US20220267315A1. Автор: Wang Shudong,YU Mingfeng,ZELEKE Solomon Tadesse. Владелец: . Дата публикации: 2022-08-25.

FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20200181067A1. Автор: Slassi Abdelmalik. Владелец: TRILLIUM THERAPEUTICS INC.. Дата публикации: 2020-06-11.

N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS

Номер патента: US20180222900A1. Автор: Wang Shudong,YU Mingfeng,ZELEKE Solomon Tadesse. Владелец: . Дата публикации: 2018-08-09.

DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO[1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS

Номер патента: US20200231586A1. Автор: Long Yi,Wang Shudong,AL HAJ DIAB Sarah. Владелец: . Дата публикации: 2020-07-23.

AZOLYLACRYLOYL DERIVATIVES AS THERAPEUTIC AGENTS FOR SICKLE CELL DISEASE

Номер патента: US20180282287A1. Автор: Zhang Yan,SAFO Martin K.,GHATGE Mohini,ABDULMALIK Osheiza,Omar Abdelsattar Mansour Ebid,El-Araby Moustafa El-Sayed. Владелец: . Дата публикации: 2018-10-04.

N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS

Номер патента: US20200283431A1. Автор: Wang Shudong,YU Mingfeng,ZELEKE Solomon Tadesse. Владелец: . Дата публикации: 2020-09-10.

FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20180334425A1. Автор: Slassi Abdelmalik. Владелец: TRILLIUM THERAPEUTICS INC.. Дата публикации: 2018-11-22.

1,2,3',5'-TETRAHYDRO-2'H-SPIRO[INDOLE-3,1'-PYRROLO[3,4-C]PYRROLE]-2,3'-DIONE COMPOUNDS AS THERAPEUTIC AGENTS ACTIVATING TP53

Номер патента: US20200354372A1. Автор: FEDER Marcin,MAZUR Maria,KALINOWSKA Iwona,JASZCZEWSKA-ADAMCZAK Joanna,LEWANDOWSKI Wojciech,WITKOWSKI Jakub,JELEN Sabina,WOS-LATOSI Katarzyna. Владелец: . Дата публикации: 2020-11-12.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20200361927A1. Автор: FOCKEN Thilo,WILSON Michael Scott,ZENOVA Alla Yurevna,Burford Kristen Nicole,Lofstrand Verner Alexander. Владелец: . Дата публикации: 2020-11-19.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20190382398A1. Автор: FOCKEN Thilo,WILSON Michael Scott,ZENOVA Alla Yurevna,Burford Kristen Nicole,Lofstrand Verner Alexander. Владелец: . Дата публикации: 2019-12-19.

Ror1 as therapeutic and diagnostic target

Номер патента: WO2011054007A1. Автор: Jonathan Alexander Terrett,Christian Rohlff,Alasdair Stamps. Владелец: Oxford Biotherapeutics Ltd.. Дата публикации: 2011-05-05.

Novel Pyrazolopyrimidinethione Derivatives, Preparation Methods Thereof and Their Use as Therapeutics for Erectile Dysfunction

Номер патента: KR100393160B1. Автор: 김동현,김중협,김유승,최경일,서재홍,남길수. Владелец: 한국과학기술연구원. Дата публикации: 2003-07-31.

Fused tetracyclic mGluR1 antagonists as therapeutic agents

Номер патента: US7482360B2. Автор: Duane A. Burnett,Wen-Lian Wu. Владелец: Schering Corp. Дата публикации: 2009-01-27.

ASOLES DERIVATIVES AS THERAPEUTIC AGENTS AGAINST FUNGAL INFECTIONS

Номер патента: RU2002126272A. Автор: Ашвани Кумар ВЕРМА,Судершан К. АРОРА,Джасбир Сингх АРОРА,Ашок РАТТАН,Ашвани Кумар ВЕРМА (IN),Судершан К. АРОРА (IN),Джасбир Сингх АРОРА (IN),Ашок РАТТАН (IN). Владелец: Рэнбакси Лабораториз Лимитед (In). Дата публикации: 2004-08-10.

Spiro-oxindole compounds and their use as therapeutic agents

Номер патента: US8101647B2. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Shifeng Liu,Mikhail Chafeev,Jonathan Langille,Shaoyi Sun,Mark Wood,Lauren Fraser,Alla Zenova. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-01-24.

Novel tricyclic nucleosides or nucleotides as therapeutic agents

Номер патента: NZ546055A. Автор: YI Jin,Phillip Dan Cook,Marija Prhavc,John Lambert,Gregory Ewing,Vasanthakumar Rajappan,Vivek K Rajwanshi,Kandasamy Sakthivel. Владелец: Biota Scient Management. Дата публикации: 2010-05-28.

Morpholine derivatives and their use as therapeutics

Номер патента: JP2000500154A. Автор: スウエイン，クリストフアー・ジヨン,テイール，マーテイン・リチヤード,ウイリアムズ，ブライアン・ジヨン. Владелец: メルク シヤープ エンド ドーム リミテツド. Дата публикации: 2000-01-11.

Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Номер патента: US7183310B2. Автор: Yariv Donde,Michael E. Garst,Robert M. Burk. Владелец: Allergan Inc. Дата публикации: 2007-02-27.

Tricyclic nucleosides or nucleotides as therapeutic agents

Номер патента: US7268119B2. Автор: YI Jin,Phillip Dan Cook,Marija Prhavc,John Lambert,Kandasamy Sakthivel,Vasanthankumar Rajappan,Vivek K. Rajwanshi,Gregory Ewing, deceased. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2007-09-11.

Bicyclic nucleosides and nucleotides as therapeutic agents

Номер патента: US8501699B2. Автор: Alistair George Draffan,George Kukolj,Michael Harding,Richard Hufton,Barbara Frey,Paula Francom,Silas Bond,Saba Hangiri,Michael John Lilly,Edward Tyndall,Jianmin Duan,Richard Bethell. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2013-08-06.

Tricyclic nucleosides or nucleotides as therapeutic agents

Номер патента: US7713941B2. Автор: YI Jin,Phillip Dan Cook,Marija Prhavc,John Lambert,Gregory Ewing,Kandasamy Sakthivel,Vasanthankumar Rajappan,Vivek K. Rajwanshi. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2010-05-11.

Novel tricyclic nucleosides or nucleotides as therapeutic agents

Номер патента: NO20060979L. Автор: YI Jin,Phillip Dan Cook,John Lambert,Vasanthakumar Rajappan,Vivek K Rajwanshi,Kandasamy Sakthivel,Gergory Ewing. Владелец: Biota Inc. Дата публикации: 2006-05-02.

Piperazine derivatives as therapeutic agents

Номер патента: JP4108747B2. Автор: ケリガン フランク,クローフォード チーサム シャロン,ポール ウォッツ ジョン. Владелец: Abbott GmbH and Co KG. Дата публикации: 2008-06-25.

Small-molecules as therapeutics

Номер патента: US9023848B2. Автор: Jonathan Bayldon Baell,Andrew John Harvey,Bernard Luke Flynn,Dharam Paul,Damian Wojciech Grobelny,Brad Sleebs,Sue O'Connor,Ian Phillip Street. Владелец: Bionomics Ltd. Дата публикации: 2015-05-05.

N-（Pyridine -2- bases）-4-（Thiazole -5- bases）Pyrimidine -2- aminated compounds is as therapeutic compound

Номер патента: CN108349964A. Автор: 王淑东,泽莱克·所罗门·塔德塞,俞鸣烽. Владелец: CHANGZHOU QIANHONG BIOPHARMA Co Ltd. Дата публикации: 2018-07-31.

Azole compounds as therapeutics for fungal infections

Номер патента: JP2004501867A. Автор: ベルマ，アシュワニ，クマール,アロラ，サデルシャン，ケイ．,アロラ，ジャスビル，シング,ラタン，アソク. Владелец: ランバクシー　ラボラトリーズ　リミテッド. Дата публикации: 2004-01-22.

3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents

Номер патента: US20040259926A1. Автор: Michael Connolly,Michael Wilson,Helen Lee,Aurash Shahripour,Michelle Bruendl,Annise Goodman,Rocco Gogliotti,Mark Plummer,Karen Sexton,Greg Reichard,Melean Visnick. Владелец: Shahripour Aurash B.. Дата публикации: 2004-12-23.

5-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents

Номер патента: US20040266760A1. Автор: Chris Rundfeldt,Thomas Pfeifer,Nobert Hofgen,Hildegard Kuss,Karin Steinike,Ute Egerland. Владелец: Elbion GmbH. Дата публикации: 2004-12-30.

ANTAGONISTS A1-ADRENOCEPTORS, THEIR EMPLOYMENTS AS THERAPEUTICAL AGENTS AND THE METHODS OF THEIR PREPARATION

Номер патента: PE46497A1. Автор: Arturo Perez-Medrano,Saul Jaime-Figueroa,Jurg R Pfister,Francisco X Talamas,Gary W Bantle,Angel Guzman,Eric B Sjogren,Jr David J Morgans,Todd R Elworthy,Francisco J Lopez-Tapia. Владелец: Hoffmann La Roche. Дата публикации: 1997-12-04.

Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension

Номер патента: CA2450220A1. Автор: David W. Old,Robert M. Burk. Владелец: Individual. Дата публикации: 2002-12-19.

Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents

Номер патента: CA2578332A1. Автор: Jörg Holenz,Rosa Cuberes Altisen,Mario Colombo Pinol,Mercedes Port De Pol. Владелец: Laboratorios Del Dr.Esteve, S.A.. Дата публикации: 2006-02-02.

Imidazolylalkyl derivatives of imidazol(5,1-c)(1,4)benzoxazin-1-one and their use as therapeutic agents

Номер патента: CA2166617A1. Автор: Carla Caccia,Patricia Salvati,Mario Varasi,Franco Heidempergher. Владелец: Individual. Дата публикации: 1995-11-30.

Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents

Номер патента: CA2223696A1. Автор: Rajan N. Shah,Jeremy Carver. Владелец: Individual. Дата публикации: 1996-12-19.

Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents

Номер патента: CA2536930A1. Автор: Gregory Adam Reichard,Clarence Ray Hurt,Melean Visnick,Michael Kevin Connolly,Rocco Dean Cogliotti. Владелец: Rocco Dean Cogliotti. Дата публикации: 2005-03-17.

Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Номер патента: US20060035961A1. Автор: Yariv Donde,Michael Garst,Robert Burk. Владелец: Allergan Inc. Дата публикации: 2006-02-16.

3-Arylcarbonyl-1H-indoles useful as therapeutic agents

Номер патента: EP0444451A2. Автор: Philip Michael Carabateas,Edward Richard Bacon,Malcolm Rice Bell,Michael Allen Eissenstat,Virendra Kumar,John Peter Mallamo,Susan Jean Ward,Thomas Edward D'ambra. Владелец: Sterling Winthrop Inc. Дата публикации: 1991-09-04.

2,3,4-substituted cyclopentanones as therapeutic agents

Номер патента: CA2588056C. Автор: Yariv Donde,Michael E. Garst,Robert M. Burk,Jeremiah H. Nguyen. Владелец: Allergan Inc. Дата публикации: 2014-06-03.

Derivatives of fusarochromanone as therapeutic agents

Номер патента: WO2004103985A3. Автор: Brian A Salvatore,Ferdinand C Solis. Владелец: Ferdinand C Solis. Дата публикации: 2005-03-24.

Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents

Номер патента: AU736668B2. Автор: James Dennis,Jeremy Carver,Jose Marino-Albernas,Rajan Shah,Francois Tropper,Igor Tvaroska. Владелец: Glycodesign Inc. Дата публикации: 2001-08-02.

ANTIBODIES AGAINST IMMUNOGLOBULIN AND DOMAIN 3 CONTAINING MUCINE OF T-CELLS (ANTI-TIM3), USEFUL AS THERAPEUTIC AGENTS

Номер патента: AR103867A1. Автор: Zhou Heyue,Krapf Irina,Dixon Gray John. Владелец: Sorrento Therapeutics Inc. Дата публикации: 2017-06-07.

Heterocyclic derivatives and their use as therapeutic agents

Номер патента: JP5043668B2. Автор: ラジェンダー カンボジ，,ザイホイ チャン，,チーアン−ミン フ，,バゲールザデー メヘラーン セイド，,サーグェイ スビリドフ，,サルタン チョーダリー，,シーフェン リュー，,ビシュヌマーシー コドゥムル，. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2012-10-10.

SPIRO-KETAL DERIVATIVES AND THEIR USE AS THERAPEUTIC ACTIVE SUBSTANCES

Номер патента: DE69707104T2. Автор: Matthew Elliott,Fintan Kelleher,John Swain. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2002-06-20.

CEPHALOSPORINS, THEIR PREPARATION METHODS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: FR2399432A1. Автор: . Владелец: Takeda Chemical Industries Ltd. Дата публикации: 1979-03-02.

Substituted gamma lactams as therapeutic agents

Номер патента: US20090270392A1. Автор: David W. Old,Danny T. Dinh. Владелец: Allergan Inc. Дата публикации: 2009-10-29.

Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents

Номер патента: AU711148B2. Автор: Jeremy Carver,Rajan Shah. Владелец: Glycodesign Inc. Дата публикации: 1999-10-07.

MGLUR1 ANTAGONIST TRICICLIC COMPOUNDS AS THERAPEUTIC AGENTS

Номер патента: AR049300A1. Автор: . Владелец: Schering Corp. Дата публикации: 2006-07-12.

Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereof

Номер патента: WO2006127977A1. Автор: Mark B. Jones,Kevin J. Yarema,Srinivasa-Gopalan Sampathkumar,Christopher Thomas Campbell. Владелец: THE JOHNS HOPKINS UNIVERSITY. Дата публикации: 2006-11-30.

Compounds of macrocyclic prodrugs useful as therapeutic

Номер патента: ES2610156T3. Автор: John C. Chabala,Jin-Chen Yu,Ruihong Chen,Nicolas Winssinger,Sofia Barluenga,James Heck,Allan Rubenstein. Владелец: Oncosynergy Inc. Дата публикации: 2017-04-26.

Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents

Номер патента: NZ310385A. Автор: Jeremy Carver,Rajan Shah. Владелец: Glycodesign Inc. Дата публикации: 2000-01-28.

Cyclohexane derivatives and their use as therapeutic agents

Номер патента: CA2408849A1. Автор: Jose Luis Castro Pineiro,Gregory John Hollingworth,Jason Matthew Elliott,Christopher John Swain,Kevin Dinnell,Duncan Edward Shaw. Владелец: Individual. Дата публикации: 2001-11-22.

DERIVATIVES OF 1- (ARILALQUIL-AMINOALQUIL) IMIDAZOLE, PREPARATION AND USE PROCEDURES AS THERAPEUTIC AGENTS.

Номер патента: ES2131574T3. Автор: Colin Gerhart Pryce Jones,Lawrence Stephen The Boo Clegg,Ian Michael The Boo Hunneyball,Paul The Boots Compan Rafferty,Leslie The Boots Compan Steele. Владелец: British Technology Group Inter Corporate Licensing Ltd. Дата публикации: 1999-08-01.

Heterocyclic derivatives and their use as therapeutic agents

Номер патента: TW200626138A. Автор: Zaihui Zhang,Serguei Sviridov,Sultan Chowdhury,Rajender Kamboj,Shifeng Liu,Jian-Min Fu,Mehran Seid Bagherzadeh,Vishnumurthy Kodumuru. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2006-08-01.

Novel 2-naphtamide derivatives and their use as therapeutic agents

Номер патента: KR100447033B1. Автор: 까미유-죠르지 웨르무스,앙드레 맨,파브리히쎄 가리히도,쟝느-메리히 르꽁떼,쟝-챨리 스키와르쯔,피에르 쏘콜로쁘. Владелец: 쏘시에트 씨빌르 바이오프로젯. Дата публикации: 2004-11-03.

Arginase Inhibitors and Methods of Use Thereof

Номер патента: US20210002305A1. Автор: Simpson Iain,FINLAY Maurice Raymond Verschoyle,Cook Steve,MLYNARSKI Scott Nathan,KAWATKAR Sameer,WU Dedong,GREBE Tyler,WANG Jianyan. Владелец: . Дата публикации: 2021-01-07.

ARGINASE INHIBITORS AND METHODS OF USE

Номер патента: US20220056051A1. Автор: Lu Min,Palani Anandan,Zhang Hongjun,Cumming Jared N.,Li Derun,Childers Matthew L.,Lesburg Charles A.,Achab Abdelghani Abe,Gathiaka Symon,Mitcheltree Matthew J.,Palte Rachel L.. Владелец: Merck Sharp & Dohme Corp.. Дата публикации: 2022-02-24.

ARGINASE INHIBITORS AND METHODS OF USE

Номер патента: US20210163505A1. Автор: Lu Min,Fischer Christian,Palani Anandan,Zhang Hongjun,Cumming Jared N.,Sloman David L.,Li Derun,Lesburg Charles A.,Achab Abdelghani Abe,Gathiaka Symon,Mitcheltree Matthew J.,Palte Rachel L.. Владелец: Merck Sharp & Dohme Corp.. Дата публикации: 2021-06-03.

RING CONSTRAINED ANALOGS AS ARGINASE INHIBITORS

Номер патента: US20150080341A1. Автор: Van Zandt Michael,Jagdmann,JR. Gunnar Erik. Владелец: . Дата публикации: 2015-03-19.

ARGINASE INHIBITORS AND METHODS OF USE

Номер патента: US20160194340A1. Автор: Tomczuk Bruce Edward,Olson Gary Lee,Pottorf Richard Scott,Christianson David W.,Colasanti Andrew Vargha. Владелец: . Дата публикации: 2016-07-07.

Arginase Inhibitors and Methods of Use thereof

Номер патента: US20210332068A1. Автор: WU Dedong. Владелец: . Дата публикации: 2021-10-28.

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

Номер патента: US20220267356A1. Автор: Ye Qing,Wang Haixia,Simpson Iain,MLYNARSKI Scott Nathan,SHIELDS Jason,KAWATKAR Sameer,ZHENG Xiaolan,FINLAY Ray. Владелец: . Дата публикации: 2022-08-25.

Novel compounds useful as therapeutic agents and assay reagents

Номер патента: AU7846998A. Автор: Tariq Hussain Khan,Helen Mary Isted Osborn,Andrew Photiou,Patrick Anthony Riley. Владелец: Individual. Дата публикации: 1998-07-03.

Thiophene-2-sulphonamide derivatives and their use as therapeutic agents sheet orienting apparatus

Номер патента: GB1459571A. Автор: . Владелец: Pfizer Ltd. Дата публикации: 1976-12-22.

Mannosidase inhibitors, process for their preparation and their use as therapeutic agents

Номер патента: US5773239A. Автор: Jeremy Carver,Rajan Shah,James Wilson Dennis. Владелец: Glycodesign Inc. Дата публикации: 1998-06-30.

Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes

Номер патента: CA1339935C. Автор: Joseph A. Walder,Roxanne Y. Walder,Paul S. Eder,John M. Dagle. Владелец: University of Iowa Research Foundation UIRF. Дата публикации: 1998-06-30.

Arginase inhibitors for treating depression

Номер патента: RU2488390C2. Автор: Валло ВОЛКЕ,Мааря КРАСС,Анника ВОЛКЕ,Ээро ВАЗАР. Владелец: Тартуский Университет. Дата публикации: 2013-07-27.

Pharmaceutical compositions of spiro-oxindole compound for local administration and use thereof as therapeutic agents

Номер патента: RU2596488C2. Автор: Конрад Стюарт ВИНТЕРС,Мэйдун ЯН,Хайган ЧЭНЬ. Владелец: Ксенон Фармасьютикалз Инк.. Дата публикации: 2016-09-10.

Preparation of mixture of flavonoids with free b-ring and flavans as therapeutic agent

Номер патента: RU2379031C2. Автор: Ци ДЗЯ. Владелец: Юниджен Фармасьютиклз, Инк.. Дата публикации: 2010-01-20.

The use of aryl-, heteroaryl- and alkyltartronic acids as therapeutical agents

Номер патента: WO1994009770A1. Автор: Gaetano Clavenna,Carmelo A. Gandolfi,Gianfranco Caselli,Marco Mantovanini,Claudio Omini,Lorella Cotini. Владелец: Dompe' Farmaceutici S.P.A.. Дата публикации: 1994-05-11.

Combination of kynurenin and antigen-presenting cells (apc) as therapeutic agents and a method for use thereof in immunomodulation

Номер патента: RU2727573C2. Автор: Азиз ГАХАРИ,Реза Б. ДЖАЛИЛИ,Рухангиз Т. КИЛАНИ,Юньюань ЛИ. Владелец: Ти Юниверсити Оф Бритиш Коламбиа. Дата публикации: 2020-07-22.

Methods of use of oligosaccharide compositions for modulating microbiota and their metabolic products, and as therapeutics for health applications

Номер патента: CA3214678A1. Автор: Matthew Joseph AMICUCCI,Cory Glen VIERRA,Riley Anne DREXLER,Yiyun LIU,Megan Lee,Angela Maria Marcobal-Barranco,Steven Michael WATKINS,Maria Ximena Maldonado Gomez,Nithya KRISHNAKUMAR,Alexandria Marie Salazar CONNER,Jennifer Elizabeth NILL,Bruce Robert MCCONNELL,James Patrick CERNEY. Владелец: Bcd Bioscience Inc. Дата публикации: 2022-11-17.

Methods of use of oligosaccharide compositions for modulating microbiota and their metabolic products, and as therapeutics for health applications

Номер патента: EP4337031A1. Автор: Matthew Joseph AMICUCCI,Cory Glen VIERRA,Riley Anne DREXLER,Yiyun LIU,Megan Lee,Angela Maria Marcobal-Barranco,Steven Michael WATKINS,Maria Ximena Maldonado Gomez,Nithya KRISHNAKUMAR,Alexandria Marie Salazar CONNER,Jennifer Elizabeth NILL,Bruce Robert MCCONNELL,James Patrick CERNEY. Владелец: Bcd Bioscience Inc. Дата публикации: 2024-03-20.

Trpv4 inhibitor as therapeutic drug for eye disease

Номер патента: EP4183415A4. Автор: Eiji Sugaru,Hideaki Hara,Shuzo Watanabe,Masamitsu Shimazawa,Kentaro Ohara. Владелец: Raqualia Pharma Inc. Дата публикации: 2024-07-17.

Pharmaceutical composition for treating thyroid cancer comprising tyrosine kinase activity inhibitor as active ingredient

Номер патента: US12011447B2. Автор: Byeong Cheol Ahn,Ji Min Oh. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2024-06-18.

Thromboxane synthase inhibitors as antiobesity agents

Номер патента: US4591594A. Автор: Joseph Triscari,Ann C. Sullivan,James G. Hamilton,Lawrence D. Tobias. Владелец: Hoffmann La Roche Inc. Дата публикации: 1986-05-27.

Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients

Номер патента: CA2350992A1. Автор: Akira Matsumori,Yoichi Nunokawa. Владелец: Individual. Дата публикации: 2001-03-29.

Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancer

Номер патента: AU2022402987A1. Автор: Sergei Gryaznov,Nikhil C. Munshi,Eugenio MORELLI. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2024-05-30.

Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancer

Номер патента: CA3238432A1. Автор: Sergei Gryaznov,Nikhil C. Munshi,Eugenio MORELLI. Владелец: Dana Farber Cancer Institute Inc. Дата публикации: 2023-06-08.

Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancer

Номер патента: WO2023102377A2. Автор: Sergei Gryaznov,Nikhil C. Munshi,Eugenio MORELLI. Владелец: Dana-Farber Cancer Institute, Inc.. Дата публикации: 2023-06-08.

Inhibitors of microRNAs that regulate production of atrial natriuretic peptide (ANP) as therapeutics and uses thereof

Номер патента: US09388412B2. Автор: Kenneth D. Bloch,Pankaj Arora,Christopher Newton-Cheh,Thomas J. Wang. Владелец: General Hospital Corp. Дата публикации: 2016-07-12.

miRNAS AS THERAPEUTIC TARGETS IN CANCER

Номер патента: US20120087992A1. Автор: Bo Song,Jingfang Ju,Yuan Wang. Владелец: Research Foundation of State University of New York. Дата публикации: 2012-04-12.

MONOCARBOXYLATE TRANSPORTER 4 (MCT4) ANTISENSE OLIGONUCLEOTIDE (ASO) INHIBITORS FOR USE AS THERAPEUTICS IN THE TREATMENT OF CANCER

Номер патента: US20190010492A1. Автор: Wang Yuzhuo,Choi Stephen Yiu Chuen. Владелец: . Дата публикации: 2019-01-10.

INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF

Номер патента: US20150133521A1. Автор: ARORA PANKAJ,Bloch Kenneth D.,Newton-Cheh Christopher,Wang Thomas J.. Владелец: . Дата публикации: 2015-05-14.

LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER

Номер патента: US20190224228A1. Автор: Lieberman Judy,SONG Erwei,YU Fengyan,HU Xiaoqu. Владелец: THE CHILDREN'S HOSPITAL CORPORATION. Дата публикации: 2019-07-25.

Polymer melbine and its purposes as therapeutic agent and as delivery vector

Номер патента: CN107531900A. Автор: L.黄,Y.赵,S.郭,K.施. Владелец: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL. Дата публикации: 2018-01-02.

Methods of using gap junctions as therapeutic targets for the treatment of degenerative disorders of the retina

Номер патента: CA2951721A1. Автор: Stewart BLOOMFIELD. Владелец: Research Foundation of State University of New York. Дата публикации: 2015-12-17.

Let-7 microrna and mimetics thereof as therapeutics for cancer

Номер патента: WO2008095096A9. Автор: Judy Lieberman,Erwei Song,Fengyan Yu,Xiaoqu Hu. Владелец: Immune Disease Inst. Дата публикации: 2008-10-09.

Let-7 microrna and mimetics thereof as therapeutics for cancer

Номер патента: US20100310583A1. Автор: Judy Lieberman,Erwei Song,Fengyan Yu,Xiaoqu Hu. Владелец: Immune Disease Institute Inc. Дата публикации: 2010-12-09.

Use of syk as therapeutic target of hepatic fibrosis/hepatic cirrhosis

Номер патента: WO2017050052A1. Автор: 洪健. Владелец: 洪健. Дата публикации: 2017-03-30.

Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof

Номер патента: MY107088A. Автор: Annegrete Hoffmann. Владелец: Lts Lohmann Therapie Systeme Gmbh & Co Kg. Дата публикации: 1995-09-30.

Polymerizable quantum dot nanoparticles and their use as therapeutic, ablation and tattooing agents

Номер патента: EP3522926A1. Автор: Imad Naasani,Mark Saunders. Владелец: Nanoco Technologies Ltd. Дата публикации: 2019-08-14.

Compositions and particles containing cellulosic fibers and stabilized-and/or activated-urease inhibitors, as well as methods of making and using the same

Номер патента: US09370764B2. Автор: Gopal C. Goyal,Zheng Tan,Linnea J. Shaver. Владелец: International Paper Co. Дата публикации: 2016-06-21.

Compositions and particles containing cellulosic fibers and stabilized- and/or activated-urease inhibitors, as well as methods of making and using the same

Номер патента: CA2687995C. Автор: Gopal C. Goyal,Zheng Tan,Linnea J. Shaver. Владелец: International Paper Co. Дата публикации: 2015-04-21.

Anticancer agent containing rhoa peptide inhibitor as an active ingredient

Номер патента: US20230086119A1. Автор: Jae Gyu Kim,Jae Bong PARK. Владелец: El Med. Дата публикации: 2023-03-23.

Arginase Inhibitor Combination Therapies

Номер патента: KR20190104521A. Автор: 아마니 마크코우크,매튜 아이. 그로스,프란체스코 파라티. Владелец: 프란체스코 파라티. Дата публикации: 2019-09-10.

Arginase inhibitor combination therapies.

Номер патента: MX2019005402A. Автор: PARLATI Francesco,MAKKOUK Amani,I Gross Matthew. Владелец: Calithera Biosciences Inc. Дата публикации: 2019-12-05.

Mir-17~92 as therapeutic or diagnostic target of motor neuron (mn) degeneration diseases

Номер патента: EP3773606A1. Автор: Jun-An Chen,Kuan-Chih PENG,Ying-Tsen TUNG. Владелец: Academia Sinica. Дата публикации: 2021-02-17.

Mir-17˜92 as therapeutic or diagnostic target of motor neuron (MN) degeneration diseases

Номер патента: US12144822B2. Автор: Jun-An Chen,Kuan-Chih PENG,Ying-Tsen TUNG. Владелец: Academia Sinica. Дата публикации: 2024-11-19.

RECEPTOR ANTAGONIST AS THERAPEUTIC AGENTS FOR iNOS GENERATING ILLNESS

Номер патента: WO2007058970A3. Автор: Douglas S Webber,Robert J Webber. Владелец: Robert J Webber. Дата публикации: 2009-05-22.

Novel use of mpk38/melk as therapeutic agent for obesity or metabolic diseases specific to middle-aged men

Номер патента: US20240100131A1. Автор: Hyunjung HA,Hyun-A SEONG. Владелец: Industry Academic Cooperation Foundation of CBNU. Дата публикации: 2024-03-28.

RECEPTOR ANTAGONIST AS THERAPEUTIC AGENTS FOR iNOS GENERATING ILLNESS

Номер патента: WO2007058970A2. Автор: Robert J. Webber,Douglas S. Webber. Владелец: Webber Douglas S. Дата публикации: 2007-05-24.

Partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases

Номер патента: EP3597213B1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2022-02-09.

Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease

Номер патента: US09885049B2. Автор: Gordon J. Lutz,Melanie K. Tallent,Nicole Michele Lykens. Владелец: DREXEL UNIVERSITY. Дата публикации: 2018-02-06.

Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases

Номер патента: WO2014125110A1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG. Дата публикации: 2014-08-21.

Abhd5 and partial hdac4 fragments and variants as therapeutic approach for the treatment of cardiovascular diseases

Номер патента: EP2956162A1. Автор: Hugo Katus,Oliver Müller,Lorenz Lehmann,Johannes Backs,Zegeye JEBESSA. Владелец: UNIVERSITAET HEIDELBERG. Дата публикации: 2015-12-23.

Composition comprising compounds for use as therapeutical agent

Номер патента: AU1082195A. Автор: Ragnvald Lindblom,Johan de Faire,Karl-Erik Arfors. Владелец: Phairson Medical Inc. Дата публикации: 1995-06-13.

ROTHIA SUBTILISINS, S8A FAMILY PROTEASES, AS THERAPEUTIC ENZYMES FOR APPLICATION IN GLUTEN-INTOLERANCE DISORDERS

Номер патента: US20190040375A1. Автор: Helmerhorst Eva J.,Schuppan Detlef,Tian Na,WEI Guoxian. Владелец: TRUSTEES OF BOSTON UNIVERSITY. Дата публикации: 2019-02-07.

APPLICATION OF SYK SERVING AS THERAPEUTIC TARGET FOR HEPATIC FIBROSIS/HEPATIC CIRRHOSIS

Номер патента: US20180044685A1. Автор: Hong Jian. Владелец: . Дата публикации: 2018-02-15.

Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease

Номер патента: US20180100156A1. Автор: Gordon J. Lutz,Melanie K. Tallent,Nicole Michele Lykens. Владелец: DREXEL UNIVERSITY. Дата публикации: 2018-04-12.

METHODS OF USING GAP JUNCTIONS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF DEGENERATIVE DISORDERS OF THE RETINA

Номер патента: US20170106047A1. Автор: Bloomfield Stewart. Владелец: The Research Foundation for The State University of New York. Дата публикации: 2017-04-20.

High-Throughput Identification of Patient-Specific Neoepitopes as Therapeutic Targets for Cancer Immunotherapies

Номер патента: US20220270709A1. Автор: NGUYEN ANDREW,Soon-Shiong Patrick,Benz Stephen Charles,Sanborn John Zachary,NIAZI Kayvan,RABIZADEH Shahrooz,VASKE Charles Joseph. Владелец: . Дата публикации: 2022-08-25.

ANTI-miR-27b AND ANTI-miR-148a OLIGONUCLEOTIDES AS THERAPEUTIC TOOLS FOR TREATING DYSLIPIDEMIAS AND CARDIOVASCULAR DISEASES

Номер патента: US20160138018A1. Автор: Carlos Fernandez-Hernando,Leigh GOEDEKE. Владелец: New York University NYU. Дата публикации: 2016-05-19.

MIRNAS AS THERAPEUTIC TARGETS IN CANCER

Номер патента: US20150152422A1. Автор: Wang Yuan,SONG BO,Ju Jingfang. Владелец: . Дата публикации: 2015-06-04.

GRAPHENE QUANTUM DOT AS THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH ABNORMAL FIBRILLATION OR AGGREGATION OF NEUROPROTEIN

Номер патента: US20210252051A1. Автор: HONG Byung Hee,YOO Je Min. Владелец: . Дата публикации: 2021-08-19.

PKC Delta Inhibitors for use as Therapeutics

Номер патента: US20160250183A1. Автор: Faller Douglas V.,Williams Robert M.. Владелец: . Дата публикации: 2016-09-01.

Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases

Номер патента: US20200338173A1. Автор: Chuanhai Cao,Xiaoyang Lin,Yuzhu Hong. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2020-10-29.

METHODS OF USING GAP JUNCTIONS AS THERAPEUTIC TARGETS FOR THE TREATMENT OF DEGENERATIVE DISORDERS OF THE RETINA

Номер патента: US20170354710A1. Автор: Bloomfield Stewart. Владелец: The Research Foundation for The State University of New York. Дата публикации: 2017-12-14.

MODULATION OF PRE-MRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE

Номер патента: US20180355361A1. Автор: Lutz Gordon J.,Tallent Melanie K.,Lykens Nicole Michele. Владелец: . Дата публикации: 2018-12-13.

Epha4 as therapeutic target of prc and pdaca

Номер патента: WO2005083086A2. Автор: Yusuke Nakamura,Hidewaki Nakagawa,Shuichi Nakatsuru. Владелец: Oncotherapy Science, Inc.. Дата публикации: 2005-09-09.

Protein biomarkers for diagnosing soft tissue diseases and as therapeutic targets for oral hygiene intervention

Номер патента: RU2523383C2. Автор: Ин ЯН,Харш М. ТРИВЕДИ,Тао СЮЙ. Владелец: КОЛГЕЙТ-ПАЛМОЛИВ КОМПАНИ. Дата публикации: 2014-07-20.

Cd44 Variants As Therapeutic Targets

Номер патента: US20080171042A1. Автор: Kenneth A. Iczkowski,Archangel Levi Omara-Opyene. Владелец: University of Florida Research Foundation Inc. Дата публикации: 2008-07-17.

MICRORNAS AS THERAPEUTIC TARGETS FOR ISCHEMIC STROKE

Номер патента: US20210238593A1. Автор: Reddy P. Hemachandra,VIJAYAN Murali. Владелец: Texas Tech University System. Дата публикации: 2021-08-05.

Cholesterol 24-hydroxylase (cyp46) as therapeutic target for the treatment of alzheimer's disease

Номер патента: WO2004055201A2. Автор: Stefan Golz,Gerhard Konig,Yan-Hong Liu,Martin GÜLDENAGEL. Владелец: Bayer Healthcare AG. Дата публикации: 2004-07-01.

Using Cdc6 as therapeutic, prognostic and diagnostic targets for cell growth/proliferation

Номер патента: US20020192696A1. Автор: Ambrose JONG. Владелец: Individual. Дата публикации: 2002-12-19.

Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same

Номер патента: WO2014031881A3. Автор: Jeffrey A. Loeb,Leonard Lipovich. Владелец: Loeb Jeffrey A. Дата публикации: 2014-05-08.

Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same

Номер патента: US20170356043A1. Автор: Jeffrey A. Loeb,Leonard A. Lipovich. Владелец: WAYNE STATE UNIVERSITY. Дата публикации: 2017-12-14.

Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same

Номер патента: US20200263250A1. Автор: Jeffrey A. Loeb,Leonard Lipovich. Владелец: WAYNE STATE UNIVERSITY. Дата публикации: 2020-08-20.

Method and apparatus for production and refinement of microbial consortia and method of use of microbial consortia as therapeutic agent

Номер патента: US20060172406A1. Автор: Mark Newman,Roy Cullimore,Lori Johnston,Charles Pellegrino. Владелец: Individual. Дата публикации: 2006-08-03.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils

Номер патента: AU2019245787B2. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2024-09-19.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils

Номер патента: EP3774996A1. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2021-02-17.

Novel hyperbranched polyesters and their use as wax inhibitor, as pour point depressant, as lubricant or in lubricating oils

Номер патента: CA3092527A1. Автор: Edward Bohres,XIAO Fu,Radoslaw Kierat,Stefan Frenzel,Anna Maria MUELLER-CRISTADORO,Felix Alexander WESTERHAUS,Tina NOACK. Владелец: BASF SE. Дата публикации: 2019-10-03.

Soybean transformation using hppd inhibitors as selection agents

Номер патента: EP2531601A1. Автор: Bernard Pelissier,Yannick Favre,Flavie Coulombier,Hélène ECKERT. Владелец: Bayer CropScience AG. Дата публикации: 2012-12-12.

Composition for inducing dedifferentiation into cancer stem cells comprising ribosome-activating inhibitor as active ingredient, cancer organoid culture method and anticancer drug screening platform based thereon

Номер патента: US20180355323A1. Автор: Seung Joon Lee,Yuseok MOON. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2018-12-13.

Composition for inducing dedifferentiation into cancer stem cells comprising ribosome-activating inhibitor as active ingredient, cancer organoid culture method and anticancer drug screening platform based thereon

Номер патента: US11091740B2. Автор: Seung Joon Lee,Yuseok MOON. Владелец: University Industry Cooperation Foundation of Pusan National University. Дата публикации: 2021-08-17.

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20170000808A1. Автор: Van Zandt Michael,Jagdmann Gunnar E.. Владелец: . Дата публикации: 2017-01-05.

ARGINASE INHIBITOR COMBINATION THERAPIES

Номер патента: US20180161349A1. Автор: PARLATI Francesco,Gross Matthew I.,MAKKOUK Amani. Владелец: . Дата публикации: 2018-06-14.

USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS

Номер патента: US20150164930A1. Автор: Meurs Hermanus,Zaagsma Johan,Maarsingh Harm,Van Duin Michel. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2015-06-18.

Use of arginase inhibitors in the treatment of asthma and allergic rhinitis

Номер патента: EP2083812B1. Автор: Hermanus Meurs,Johan Zaagsma,Harm Maarsingh,Michel Van Duin. Владелец: Rijksuniversiteit Groningen. Дата публикации: 2017-04-05.

Processes for the preparation of arginase inhibitors and their synthetic intermediates

Номер патента: TW202216662A. Автор: 喬瑟夫 斯卡拉芬妮,安東尼 Ｊ 湯曼尼,羅伯特 Ｊ 維森,丹尼爾 卡博,韋恩 韓,施國強,孫飛強,陸國彪,杰克 梁. Владелец: 美商英塞特公司. Дата публикации: 2022-05-01.

PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES

Номер патента: US20220041630A1. Автор: Liang Jack,Han Wayne,Wilson Robert J.,SCLAFANI Joseph,Tomaine Anthony J.,Carper Daniel,Shi George,Sun Feiquiang,Lu Guobiao. Владелец: INCYTE CORPORATION. Дата публикации: 2022-02-10.

Use of arginase inhibitors in the treatment of asthma and allergic rhinitis

Номер патента: CA2669300A1. Автор: Hermanus Meurs,Johan Zaagsma,Harm Maarsingh,Michel Van Duin. Владелец: Michel Van Duin. Дата публикации: 2008-05-29.

Human helicase ddx3 inhibitors as therapeutic agents

Номер патента: ITRM20150070A1. Автор: . Владелец: Azienda Ospedaliera Univ Senese. Дата публикации: 2016-08-13.

MACROCYCLIC PRODRUG COMPOUNDS USEFUL AS THERAPEUTICS

Номер патента: US20140135290A1. Автор: Chabala John C.,CHEN Ruihong,Yu Jin-Chen,WINSSINGER Nicolas,BARLUENGA Sofia,HECK James,Rubenstein Allan. Владелец: . Дата публикации: 2014-05-15.

ORGANOMETALLIC COMPLEXES AS THERAPEUTIC AGENTS

Номер патента: US20140371193A1. Автор: KALKUNTE Satyan,BRARD Laurent,Strongin Robert,Singh Rakesh,Alpturk Onur. Владелец: . Дата публикации: 2014-12-18.

Use of p1p derivatives as therapeutic agent for sepsis

Номер патента: US20220079960A1. Автор: Young Jun Park,Su Jin Kim,Jeong Min Lee,Myeong Jun Choi,Won Kyo HAN. Владелец: Axceso Biopharmaco ltd. Дата публикации: 2022-03-17.

Use of p1p derivatives as therapeutic agent for sepsis

Номер патента: CA3126907A1. Автор: Young Jun Park,Su Jin Kim,Jeong Min Lee,Myeong Jun Choi,Won Kyo HAN. Владелец: Axceso Biopharma Co Ltd. Дата публикации: 2020-08-06.

Use of p1p derivatives as therapeutic agent for sepsis

Номер патента: CA3126907C. Автор: Young Jun Park,Su Jin Kim,Jeong Min Lee,Myeong Jun Choi,Won Kyo HAN. Владелец: Axceso Biopharma Co Ltd. Дата публикации: 2023-08-22.

Use of p1p derivative as therapeutic agent for sepsis

Номер патента: EP3919061A4. Автор: Young Jun Park,Su Jin Kim,Jeong Min Lee,Myeong Jun Choi,Won Kyo HAN. Владелец: Axceso Biopharma Co Ltd. Дата публикации: 2022-10-05.

USE OF P1P DERIVATIVES AS THERAPEUTIC AGENT FOR SEPSIS

Номер патента: US20220079960A1. Автор: Kim Su Jin,Park Young Jun,LEE Jeong Min,HAN Won Kyo,CHOI Myeong Jun. Владелец: AXCESO BIOPHARMACO.,LTD.. Дата публикации: 2022-03-17.

Destabilized are 3'utrs as therapeutics for cancer

Номер патента: WO2024182760A2. Автор: Olorunseun O. Ogunwobi,Kevin Struhl,Chidiebere U. Awah. Владелец: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK. Дата публикации: 2024-09-06.

Substituted arylcyclopentenes as therapeutic agents

Номер патента: US09796696B2. Автор: Yariv Donde,Jeremiah H. Nguyen. Владелец: Allergan Inc. Дата публикации: 2017-10-24.

Substituted arylcyclopentenes as therapeutic agents

Номер патента: US20140323510A1. Автор: Yariv Donde,Jeremiah H. Nguyen. Владелец: Allergan Inc. Дата публикации: 2014-10-30.

Substituted arylcyclopentenes as therapeutic agents

Номер патента: US20170057941A1. Автор: Yariv Donde,Jeremiah H. Nguyen. Владелец: Allergan Inc. Дата публикации: 2017-03-02.

DESTABILIZED ARE 3'UTRs AS THERAPEUTICS FOR CANCER

Номер патента: US20230331818A1. Автор: Olorunseun O. Ogunwobi,Kevin Struhl,Chidiebere U. Awah. Владелец: Harvard College. Дата публикации: 2023-10-19.

New amides of lysergic acid and methods of their production as well as therapeutical means containing these compounds

Номер патента: CS260497B1. Автор: Reni Bartsch,Angelika Rostock,Joachim Schmidt,Wolfgang Hoffmann,Erika Glusa,Werner Grawert,Christoph Dauth,Roland Hempel,Evelyn Morgenstern,Karlheinz Heidenbluth. Владелец: Karlheinz Heidenbluth. Дата публикации: 1988-12-15.

New fusion gene as therapeutic target in proliferative diseases

Номер патента: WO2015110538A1. Автор: Barbara KLINK,Khalil ABOUELARADAT,Evelin SCHROECK. Владелец: TECHNISCHE UNIVERSITAT DRESDEN. Дата публикации: 2015-07-30.

Azabicyclic spiroether derivatives and their use as therapeutic agents

Номер патента: US20020147207A1. Автор: Piotr Raubo,Janusz Kulagowski,Ian Huscroft. Владелец: Individual. Дата публикации: 2002-10-10.

Formamide compounds as therapeutic agents

Номер патента: WO2000012466A1. Автор: Robert Carl Andrews,David John Cowan,Darryl Lynn Mcdougald,David Lee Musso,Jennifer Badiang Stanford,Michael David Gaul,Marc Werner Andersen,Michael Howard Rabinowitz,Joseph Howing Chan,Robert William Wiethe,Dulce Garrido Babacz. Владелец: Glaxo Group Limited. Дата публикации: 2000-03-09.

PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20130079354A1. Автор: CHAKKA Nagasree,Sun Shaoyi,Kamboj Rajender,Kodumuru Vishnumurthy,Liu Shifeng,Sviridov Serguei,Abreo Melwyn,LI Wenbao,HARVEY Daniel F.,KONDRATENKO Mikhail A.,WINTHER Michael D.,GSCHWEND Heinz W.. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2013-03-28.

SYNTHESIS OF BICYCLIC COMPOUNDS AND METHOD FOR THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20130210904A1. Автор: BRANT Michael G.,BOULANGER Martin J.,Wulff Jeremy E.,Mason Jeremy W.,Bromba Caleb M.. Владелец: . Дата публикации: 2013-08-15.

SUBSTITUTED HETEROCYCLES AS THERAPEUTIC AGENTS FOR TREATING CANCER

Номер патента: US20130211079A1. Автор: DOEMLING Alexander. Владелец: . Дата публикации: 2013-08-15.

PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20130237572A1. Автор: Zhang Zaihui,Yan Jun,Du Xinyao,CHEN Jianxin,DAYNARD Timothy S.,Wang Shisen,Chopiuk Gregory B.,Sviridov Serguei V.. Владелец: Dermira (Canada), Inc.. Дата публикации: 2013-09-12.

SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20130252962A1. Автор: Wood Mark,CHAKKA Nagasree,Fu Jianmin,Jia Qi,Sun Shaoyi,Chafeev Mikhail,Chowdhury Sultan,Hsieh Tom,Liu Shifeng,Sun Jianyu,Sviridov Serguei,ZENOVA Alla Yurevna,Cadieux Jean-Jacques Alexandre,FRASER Lauren,LANGILLE Jonathan,GAUTHIER Simon J.,DOUGLAS Amy Frances,CIKOJEVIC Zoran. Владелец: . Дата публикации: 2013-09-26.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20130253024A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: N30 PHARMACEUTICALS, INC.. Дата публикации: 2013-09-26.

ASYMMETRIC SYNTHESES FOR SPIRO-OXINDOLE COMPOUNDS USEFUL AS THERAPEUTIC AGENTS

Номер патента: US20130274483A1. Автор: Fu Jianmin,Sun Shaoyi,MANSOUR Tarek Suhayl,Chowdhury Sultan,GRIMWOOD Michael Edward,HEMEON Ivan William. Владелец: . Дата публикации: 2013-10-17.

GLUCOCORTICOID INDUCED LEUCINE ZIPPER MIMETICS AS THERAPEUTIC AGENTS IN MULTIPLE SCLEROSIS

Номер патента: US20130338077A1. Автор: SRINIVASAN Mythily. Владелец: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION. Дата публикации: 2013-12-19.

Hepatocyte Growth Factor Mimics as Therapeutic Agents

Номер патента: US20140051633A1. Автор: Harding Joseph W.,Wright John W.,Benoist Caroline C.,Kawas Leen H.,Wayman Gary A.. Владелец: WASHINGTON STATE UNIVERSITY. Дата публикации: 2014-02-20.

NOVEL SMALL-MOLECULES AS THERAPEUTICS

Номер патента: US20140088104A1. Автор: FLYNN BERNARD LUKE,Baell Jonathan Bayldon,Sleebs Brad,Street Ian Phillip,Paul Dharam,"OConnor Sue",Harvey Andrew John,Wojciech Damian. Владелец: BIONOMICS LIMITED. Дата публикации: 2014-03-27.

HEPATOCYTE GROWTH FACTOR (HGF) MIMICS AS THERAPEUTIC AGENTS

Номер патента: US20140094413A1. Автор: Harding Joseph W.,Wright John W.,Benoist Caroline C.,Kawas Leen H.,Wayman Gary A.. Владелец: WASHINGTON STATE UNIVERSITY. Дата публикации: 2014-04-03.

INHIBITORS OF GLI1 AS THERAPEUTIC AGENTS

Номер патента: US20220009935A1. Автор: Greenlee William J.,VAN DRIE John,HUANG Xinyan,SALZER James,SHOHDY Nadim. Владелец: . Дата публикации: 2022-01-13.

FUSION POLYNUCLEOTIDES AND FUSION POLYPEPTIDES ASSOCIATED WITH CANCER AND PARTICULARLY MELANOMA AND THEIR USES AS THERAPEUTIC AND DIAGNOSTIC TARGETS

Номер патента: US20160010068A1. Автор: He Jie,LIPSON Doron,Bastian Boris C.,Wieser Thomas,CRONIN Maureen,STEPHENS James Philip,YALENSKY Roman. Владелец: . Дата публикации: 2016-01-14.

HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS

Номер патента: US20140107125A1. Автор: Zhang Zaihui,DAYNARD Timothy S.,Wang Shisen,Chopiuk Gregory B.,Sviridov Serguei V.,Chafeev Mikhail A.. Владелец: Dermira (Canada), Inc.. Дата публикации: 2014-04-17.

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

Номер патента: US20210024464A1. Автор: Rennie Paul,TCHERKASSOV Artem,YOUNG Robert N.,ANDRE Christophe M.. Владелец: . Дата публикации: 2021-01-28.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity

Номер патента: US20140113945A1. Автор: Rosenthal Gary J.,Scoggin Charles H.,Colagiovanni Dorothy. Владелец: N30 PHARMACEUTICALS, INC.. Дата публикации: 2014-04-24.

MAO INHIBITORS AND THEIR CONJUGATES AS THERAPEUTICS FOR THE TREATMENT OF BRAIN CANCER

Номер патента: US20170029371A1. Автор: Chen Thomas C.,SHIH Jean C.,Hoffman Florence M.. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2017-02-02.

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

Номер патента: US20170029372A1. Автор: Rennie Paul,TCHERKASSOV Artem,YOUNG Robert N.,ANDRE Christophe M.. Владелец: . Дата публикации: 2017-02-02.

INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS

Номер патента: US20220073532A1. Автор: Maloney David,Lowery Robert G.,Kumar Meera,Boxer Matthew,Boyd Susan. Владелец: . Дата публикации: 2022-03-10.

Substituted arylcyclopentenes as therapeutic agents

Номер патента: US20170057941A1. Автор: Yariv Donde,Jeremiah H. Nguyen. Владелец: Allergan Inc. Дата публикации: 2017-03-02.

HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS

Номер патента: US20170066742A1. Автор: Kim Jin Kwan,Park Seong Jin,Kim Myeong-Seop,KIM Sumin,KIM Hadong,RYU Ki Moon,PARK Taesun,SHEEN Joon-Ho,YOON Taeyoung,JANG Mi Yeon. Владелец: . Дата публикации: 2017-03-09.

5-(PYRIMIDIN-4-YL)THIAZOL-2-YL UREA DERIVATIVES AS THERAPEUTIC AGENTS

Номер патента: US20210070746A1. Автор: Wang Shudong,PHILIP Stephen,YU Mingfeng. Владелец: . Дата публикации: 2021-03-11.

ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20170073351A1. Автор: Fu Jianmin,Chafeev Mikhail,Cadieux Jean-Jacques Alexandre. Владелец: . Дата публикации: 2017-03-16.

Anti-PD1 Antibodies and their Use as Therapeutics and Diagnostics

Номер патента: US20150079109A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: Beigene, Ltd.. Дата публикации: 2015-03-19.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20140155447A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: N30 PHARMACEUTICALS, INC.. Дата публикации: 2014-06-05.

F11 RECEPTOR (F11R) ANTAGONISTS AS THERAPEUTIC AGENTS

Номер патента: US20140155576A1. Автор: Kornecki Elizabeth,Babinska Anna,Ehrlich Yigal H.. Владелец: . Дата публикации: 2014-06-05.

Trapped Chemokine Variants as Therapeutic Agents for Inflammation-Related Diseases Including Infections, Diabetes, and Cancer

Номер патента: US20190092827A1. Автор: Rajarathnam Krishna,Chopra Ashok. Владелец: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM. Дата публикации: 2019-03-28.

CTRP6 WHICH CAN BE USED AS THERAPEUTIC AND PROPHYLACTIC AGENT FOR AUTOIMMUNE DISEASES

Номер патента: US20140194343A1. Автор: Iwakura Yoichiro,MURAYAMA Masanori,Ishigame Harumichi,Kakuta Shigeru. Владелец: THE UNIVERSITY OF TOKYO. Дата публикации: 2014-07-10.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20140194425A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: N30 PHARMACEUTICALS, INC.. Дата публикации: 2014-07-10.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20140194481A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: N30 PHARMACEUTICALS, INC.. Дата публикации: 2014-07-10.

SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20170114075A1. Автор: Wood Mark,CHAKKA Nagasree,Fu Jianmin,Jia Qi,Sun Shaoyi,Chafeev Mikhail,Chowdhury Sultan,Hsieh Tom,Liu Shifeng,Sun Jianyu,Sviridov Serguei,ZENOVA Alla Yurevna,Cadieux Jean-Jacques Alexandre,FRASER Lauren,LANGILLE Jonathan,GAUTHIER Simon J.,DOUGLAS Amy Frances,CIKOJEVIC Zoran. Владелец: . Дата публикации: 2017-04-27.

HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS

Номер патента: US20190119252A1. Автор: Kim Jin Kwan,Park Seong Jin,Kim Myeong-Seop,KIM Sumin,KIM Hadong,RYU Ki Moon,PARK Taesun,SHEEN Joon-Ho,YOON Taeyoung,JANG Mi Yeon. Владелец: . Дата публикации: 2019-04-25.

MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS

Номер патента: US20140205593A1. Автор: Yansura Daniel G.,Schwall Ralph H.,Huang Arthur Jyh-Yen. Владелец: Genentech, Inc.. Дата публикации: 2014-07-24.

COMPOUNDS FOR USE AS THERAPEUTIC AGENTS AFFECTING P53 EXPRESSION AND/OR ACTIVITY

Номер патента: US20140206690A1. Автор: Roux Pierre,Tazi Jamal,Mahuteau Florence,Najman Romain,Scherrer Didier. Владелец: . Дата публикации: 2014-07-24.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20180162868A1. Автор: Johnson,Jia Qi,DEHNHARDT Christoph Martin,Chowdhury Sultan,DECKER Shannon Marie,FOCKEN Thilo,GRIMWOOD Michael Edward,WILSON Michael Scott,ZENOVA Alla Yurevna,JR. James Philip,ANDREZ Jean-Christophe,Burford Kristen Nicole,Bogucki David Earl,Cohen Charles Jay,Devita Robert Joseph,Empfield James Roy,Hasan Syed Abid. Владелец: . Дата публикации: 2018-06-14.

HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20200157089A1. Автор: Jia Qi,Sun Shaoyi,DEHNHARDT Christoph Martin,FOCKEN Thilo,GRIMWOOD Michael Edward,WILSON Michael Scott,ZENOVA Alla Yurevna,ANDREZ Jean-Christophe,Burford Kristen Nicole,Lofstrand Verner Alexander,Wesolowski Steven Sigmund. Владелец: . Дата публикации: 2020-05-21.

SECONDARY AMINES AS THERAPEUTIC AGENTS

Номер патента: US20150175567A1. Автор: Old David W.,Ngo Vinh X.. Владелец: . Дата публикации: 2015-06-25.

BIARYL ETHER SULFONAMIDES AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20140256736A1. Автор: Zhang Zaihui,Fonarev Julia,Liu Shifeng,FOCKEN Thilo,Chahal Navjot,OBALLA Renata Marcella. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2014-09-11.

NOVEL EP4 AGONISTS AS THERAPEUTIC COMPOUNDS

Номер патента: US20180170858A1. Автор: Old David W.,Hein Christopher D.. Владелец: . Дата публикации: 2018-06-21.

HUMAN ANDROGEN RECEPTOR DNA-BINDING DOMAN (DBD) COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

Номер патента: US20170183319A1. Автор: Rennie Paul,TCHERKASSOV Artem,BAN Fuqiang,DALAL Kush,LI Huifang,LeBlanc Eric Joseph Jean,Tverdokhlebov Anton V.,Babiy Sergiy,Bogomol Evgeniia,Dunayenko Kateryna. Владелец: The University of British Columbia. Дата публикации: 2017-06-29.

SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS

Номер патента: US20150210717A1. Автор: Günes Cagatay,Hoffman Elena Marita,Rudolph Karl Lenhard. Владелец: . Дата публикации: 2015-07-30.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20190194184A1. Автор: Johnson,DEHNHARDT Christoph Martin,Chowdhury Sultan,FOCKEN Thilo,GRIMWOOD Michael Edward,ZENOVA Alla Yurevna,JR. James Philip,ANDREZ Jean-Christophe,Burford Kristen Nicole,Cohen Charles Jay,Devita Robert Joseph,Empfield James Roy,Hasan Syed Abid. Владелец: . Дата публикации: 2019-06-27.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20140296245A1. Автор: Jia Qi,Sun Shaoyi,Zhang Zaihui,Chafeev Mikhail,ZENOVA Alla Yurevna,OBALLA Renata Marcella. Владелец: . Дата публикации: 2014-10-02.

SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS

Номер патента: US20140323510A1. Автор: Donde Yariv,Nguyen Jeremiah H.. Владелец: ALLERGAN, INC.. Дата публикации: 2014-10-30.

PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20140350009A1. Автор: Zhang Zaihui,Yan Jun,Du Xinyao,CHEN Jianxin,DAYNARD Timothy S.,Wang Shisen,Chopiuk Gregory B.,Sviridov Serguei V.. Владелец: Dermira (Canada), Inc.. Дата публикации: 2014-11-27.

SUBSTITUTED CYCLOPENTENES AS THERAPEUTIC AGENTS

Номер патента: US20140357705A1. Автор: Donde Yariv,Nguyen Jeremiah H.. Владелец: ALLERGAN, INC.. Дата публикации: 2014-12-04.

BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20170283837A1. Автор: Malcolm J. Kavarana,Richard C. PEET. Владелец: Full Spectrum Laboratories Ltd. Дата публикации: 2017-10-05.

BIOSYNTHESIS OF CANNABINOID PRODRUGS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20170298399A1. Автор: Peet Richard C.,Kavarana Malcolm J.. Владелец: . Дата публикации: 2017-10-19.

Anti-PD1 Antibodies and their Use as Therapeutics and Diagnostics

Номер патента: US20150315274A1. Автор: Peng Hao,Song Jing,Li Kang,Liu Qi,Zhang Tong,XU Lanlan. Владелец: . Дата публикации: 2015-11-05.

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

Номер патента: US20190300480A1. Автор: Rennie Paul,TCHERKASSOV Artem,YOUNG Robert N.,ANDRE Christophe M.. Владелец: . Дата публикации: 2019-10-03.

NEW FUSION GENE AS THERAPEUTIC TARGET IN PROLIFERATIVE DISEASES

Номер патента: US20160340738A1. Автор: KLINK Barbara,ABOUELARADAT Khalil,SCHROECK Evelin. Владелец: . Дата публикации: 2016-11-24.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20170334902A1. Автор: Johnson,DEHNHARDT Christoph Martin,Chowdhury Sultan,FOCKEN Thilo,GRIMWOOD Michael Edward,ZENOVA Alla Yurevna,JR. James Philip,ANDREZ Jean-Christophe,Burford Kristen Nicole,Cohen Charles Jay,Devita Robert Joseph,Empfield James Roy,Hasan Syed Abid. Владелец: . Дата публикации: 2017-11-23.

5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20200331915A1. Автор: Blass Benjamin E.,Canney Daniel J.,Blattner Kevin M.. Владелец: . Дата публикации: 2020-10-22.

DIPEPTIDE-REPEAT PROTEINS AS THERAPEUTIC TARGET IN NEURODEGENERATIVE DISEASES WITH HEXANUCLEOTIDE REPEAT EXPANSION

Номер патента: US20150361166A1. Автор: Mori Kohji,HAASS Christian,EDBAUER DIETER,WENG SHIH-MING,ARZTBERGER THOMAS,KREMMER ELISABETH. Владелец: . Дата публикации: 2015-12-17.

HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS

Номер патента: US20170355690A9. Автор: Kim Jin Kwan,Park Seong Jin,Kim Myeong-Seop,KIM Sumin,KIM Hadong,RYU Ki Moon,PARK Taesun,SHEEN Joon-Ho,YOON Taeyoung,JANG Mi Yeon. Владелец: . Дата публикации: 2017-12-14.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20200354354A1. Автор: Johnson,DEHNHARDT Christoph Martin,Chowdhury Sultan,FOCKEN Thilo,GRIMWOOD Michael Edward,ZENOVA Alla Yurevna,JR. James Philip,ANDREZ Jean-Christophe,Burford Kristen Nicole,Cohen Charles Jay,Devita Robert Joseph,Empfield James Roy,Hasan Syed Abid. Владелец: . Дата публикации: 2020-11-12.

BIOSYNTHESIS OF CANNABINOID PRODRUGS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20190382814A1. Автор: Peet Richard C.,Kavarana Malcolm J.. Владелец: . Дата публикации: 2019-12-19.

METHODS OF DESIGNING NOVEL ANTIBODY MIMETICS FOR USE IN DETECTING ANTIGENS AND AS THERAPEUTIC AGENTS

Номер патента: US20190385705A1. Автор: Daunert Sylvia,Deo Sapna K.,Dikici Emre,Mascini Marcello. Владелец: . Дата публикации: 2019-12-19.

HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20220348570A1. Автор: Jia Qi,Sun Shaoyi,DEHNHARDT Christoph Martin,FOCKEN Thilo,GRIMWOOD Michael Edward,WILSON Michael Scott,ZENOVA Alla Yurevna,ANDREZ Jean-Christophe,Burford Kristen Nicole,Lofstrand Verner Alexander,Wesolowski Steven Sigmund. Владелец: . Дата публикации: 2022-11-03.

5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20220348581A1. Автор: Blass Benjamin E.,Canney Daniel J.,Blattner Kevin M.. Владелец: . Дата публикации: 2022-11-03.

Deazapurine nucleoside analogs and their use as therapeutic agents

Номер патента: WO2003061576A2. Автор: Zhi Hong,Haoyun An,Varaprasad Chamakura,Yili Ding. Владелец: Ribapharm Inc.. Дата публикации: 2003-07-31.

Deazapurine nucleoside analogs and their use as therapeutic agents

Номер патента: WO2003061576A3. Автор: Zhi Hong,Haoyun An,Varaprasad Chamakura,Yili Ding. Владелец: Yili Ding. Дата публикации: 2004-04-01.

Deazapurine nucleoside analogs and their use as therapeutic agents

Номер патента: WO2003062257A1. Автор: Zhi Hong,Haoyun An,Varaprasad Chamakura,Kanda Ramasamy. Владелец: Ribapharm Inc.. Дата публикации: 2003-07-31.

Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics

Номер патента: KR100639844B1. Автор: 미첼 이. 레프,윌리암 에스. 클로에저,타케히코 나카무라. Владелец: 바이오겐 아이덱 엠에이 인코포레이티드. Дата публикации: 2006-10-27.

Salts of pyridoxine monoesters prepn. - from 4-3-O-isopropylidene pyridoxine via the acid chloride, useful as therapeutics

Номер патента: FR2313366A2. Автор: . Владелец: Ugine Kuhlmann SA. Дата публикации: 1976-12-31.

Imidazopyridine derivatives, their preparation and their application as therapeutics

Номер патента: FR2612927A1. Автор: John Allen,Pascal George,Guy Jaurand. Владелец: Synthelabo SA. Дата публикации: 1988-09-30.

Process for the preparation of water-soluble saccharide conjugates and saccharide mimetics by the Diels-Alder reaction and their use as therapeutics or diagnostics

Номер патента: DE10041221A1. Автор: Hans-Christian Kliem,Bernd Sauerbrei,Manfred Wiesler. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2002-03-14.

Steroids containing a 3, 4 or 6 membered spiranic cycle in 17 position, process and intermediates for preparing the same, use thereof as therapeutic agents and pharmaceutical compositions containing them

Номер патента: CA1340344C. Автор: Lucien Nedelec,Andre Claussner,Daniel Philibert,Martine Moquilewsky. Владелец: Roussel Uclaf SA. Дата публикации: 1999-01-26.

Fused Bicyclic Heterocycles as Therapeutic Agents

Номер патента: US20210395222A1. Автор: John K. Dickson,Andrew S. Chi,Xinyan HUANG,Nadim SHOHDY. Владелец: New York University NYU. Дата публикации: 2021-12-23.

Hla-h, hla-j, hla-l, hla-v and hla-y as therapeutic and diagnostic targets

Номер патента: CA3154939A1. Автор: Ralph Markus Wirtz,Wolfgang Wurfel,Christoph Winterhalter,Franziska Wurfel. Владелец: Individual. Дата публикации: 2021-04-29.

(2-alkoxy) phenylpiperazinic derivatives; process for preparing the same and their use as therapeutic agents

Номер патента: CA1252465A. Автор: Marie-Helene Creuzet,Claude Feniou,Francoise Guichard,Gisele Prat,Henri Pontagnier. Владелец: Cortial SA. Дата публикации: 1989-04-11.

Azabicyclic ether derivatives and their use as therapeutic agents

Номер патента: US6727249B2. Автор: Piotr Antoni Raubo,Neil Roy Curtis,Janusz Jozef Kulagowski,Ian Thomas Huscroft. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2004-04-27.

Use of arginase inhibitor as an agent for slowing down hair loss, eyebrows or eyelashes, and for preventing and treating hair loss of natural origin

Номер патента: FR2973234A1. Автор: Albert Duranton. Владелец: LOreal SA. Дата публикации: 2012-10-05.

The purposes of suramin and arginase inhibitor in malignant tumour

Номер патента: CN107405404A. Автор: 塞米·欧尤·奥皮约. Владелец: Individual. Дата публикации: 2017-11-28.

Use of suramin and arginase inhibitors for malignant neoplasms

Номер патента: KR20170129896A. Автор: 새미 오유 오피요. Владелец: 새미 오유 오피요. Дата публикации: 2017-11-27.

Arginase Inhibitors for the Treatment of Depression

Номер патента: US20110318271A1. Автор: Eero Vasar,Vallo Volke,Maarja Krass,Annika Volke. Владелец: Tartu Ülikool (University Of Tartu). Дата публикации: 2011-12-29.

ARGINASE INHIBITORS FOR THE TREATMENT OF DEPRESSION

Номер патента: RU2011129717A. Автор: Валло ВОЛКЕ,Мааря КРАСС,Анника ВОЛКЕ,Ээро ВАЗАР. Владелец: Тартуский Университет. Дата публикации: 2013-02-10.

USE OF SURAMIN AND ARGINASE INHIBITORS IN MALIGNANT NEOPLASIA

Номер патента: US20180078515A1. Автор: OPIYO Sammy Oyoo. Владелец: . Дата публикации: 2018-03-22.

Histone deacetylase inhibitors as therapeutic agents for Niemann-Pick type C disease

Номер патента: US9333222B2. Автор: Olaf Wiest,Frederick R. Maxfield,Paul Helquist. Владелец: University of Notre Dame . Дата публикации: 2016-05-10.

Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents

Номер патента: US5486540A. Автор: Steven W. Andrews. Владелец: Allergan Inc. Дата публикации: 1996-01-23.

Glycosylation inhibitors as therapeutics for stroke

Номер патента: WO2023205124A2. Автор: Napoleone Ferrara,Pin LI. Владелец: The Regents of the University of California. Дата публикации: 2023-10-26.

Neurotrophic tyrosine receptor kinase inhibitors as therapeutics for liver disease

Номер патента: WO2023230454A1. Автор: SHUANG Wang,Scott Friedman. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-11-30.

Glycosylation inhibitors as therapeutics for stroke

Номер патента: WO2023205124A3. Автор: Napoleone Ferrara,Pin LI. Владелец: The Regents of the University of California. Дата публикации: 2023-11-23.

Kcnq channels as therapeutic targets

Номер патента: US20140303226A1. Автор: Ira S. Cohen,Jianmin Cui,Xiaoqin Zou. Владелец: University of Missouri System. Дата публикации: 2014-10-09.

Kcnq channels as therapeutic targets

Номер патента: US20160228411A1. Автор: Ira S. Cohen,Jianmin Cui,Xiaoqin Zou. Владелец: University of Missouri System. Дата публикации: 2016-08-11.

Cis-gnetin h and trans-gnetin h as therapeutic agents

Номер патента: US20190290611A1. Автор: Ying Gao,Elliot Altman,Anthony FARONE,Hyo Park. Владелец: Middle Tennessee State University. Дата публикации: 2019-09-26.

KCNQ channels as therapeutic targets

Номер патента: US9345688B2. Автор: Ira S. Cohen,Jianmin Cui,Xiaoqin Zou. Владелец: University of Missouri System. Дата публикации: 2016-05-24.

Cis-gnetin h and trans-gnetin h as therapeutic agents

Номер патента: EP3197470A1. Автор: Ying Gao,Elliot Altman,Anthony FARONE,Hyo Park. Владелец: Middle Tennessee State University. Дата публикации: 2017-08-02.

Alkane diol derivatives as therapeutic agents for the treatment of bone conditions

Номер патента: EP1441716A1. Автор: Kenneth John Armour,Stuart Hamilton Inst. of Medical Sciences RALSTON,Iain Robert Institute of Medical Sciences GREIG,Robert Jurgen Inst. of Medical Sciences VAN'T HOF. Владелец: University of Aberdeen. Дата публикации: 2004-08-04.

Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (als) and other neurodegenerative conditions

Номер патента: US20210121425A1. Автор: Luis Barbeito,Carlos BATTHYANY,Gloria Virginia LOPEZ,Carlos ESCANDE,Williams Arturo Porcal Quinta,Mariana INGOLD,Lucia COLELLA,Emiliano Trías,Sofía Ibarburu. Владелец: Universidad De La Republica. Дата публикации: 2021-04-29.

Analogues of cysteamine as therapeutic agents for cystic fibrosis

Номер патента: US20200179312A1. Автор: Fabio Borella,Luigi Maiuri,Giorgio Cozza,Valeria Villella,Andrea Venerando. Владелец: Ierfc European Institute For Cystic Fibrosis Research. Дата публикации: 2020-06-11.

Gsno reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

Номер патента: US20220062264A1. Автор: Farid Ahmed,Syed Kashif Zaidi,Md. Nasrul Hoda,Muhammad Hussain Al-Qahtani,Heba Al Khatabi. Владелец: KING ABDULAZIZ UNIVERSITY. Дата публикации: 2022-03-03.

Gsno reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

Номер патента: US20220062262A1. Автор: Syed Kashif Zaidi,Md. Nasrul Hoda,Muhammad Hussain Al-Qahtani. Владелец: KING ABDULAZIZ UNIVERSITY. Дата публикации: 2022-03-03.

Uroporphyrin i as therapeutic compound against prion diseases

Номер патента: WO2024133215A1. Автор: Oscar Millet Aguilar-Galindo,Joaquín CASTILLA CASTRILLÓN,Ganeko BERNARDO-SEISDEDOS,Jorge MORENO CHARCO,Hasier ERAÑA LASAGABASTER,Sandra GARCÍA MARTÍNEZ. Владелец: Atlas Molecular Pharma, S.L.. Дата публикации: 2024-06-27.

Repurposed compound as therapeutic for hpv-associated cancers

Номер патента: US20240009182A1. Автор: Paul CHAN Kay Sheung,Siaw Shi BOON,Chichao XIA. Владелец: Chinese University of Hong Kong CUHK. Дата публикации: 2024-01-11.

Ibogaine analogs as therapeutics for neurological and psychiatric disorders

Номер патента: US20230102206A1. Автор: Dalibor Sames,Václav HAVEL. Владелец: Columbia University in the City of New York. Дата публикации: 2023-03-30.

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma

Номер патента: US11738036B2. Автор: Ruby JOHN ANTO,Lekshmi REGHU NATH. Владелец: Rajiv Gandhi Centre For Biotechnology An Autonomous Institute Under Department Of Biotechnology Government Of India. Дата публикации: 2023-08-29.

Phosphaplatin compounds as therapeutic agents selectively targeting highly glycolytic tumor cells and methods thereof

Номер патента: EP4232044A1. Автор: Tyler D. Ames,Alberto Anel. Владелец: Promontory Therapeutics Inc. Дата публикации: 2023-08-30.

Methods for solubilization of arsenic sulfide minerals and their use as therapeutics

Номер патента: WO2021035226A2. Автор: Andrea Savarino,Lishomwa Ndhlovu,Iart Luca SHYTAJ,Marina Lusic,Bojana LUCIC,Mahmoud ELHEFNAWI. Владелец: Elhefnawi Mahmoud. Дата публикации: 2021-02-25.

Use of apomorphine as therapeutic agent for necroptosis-related diseases

Номер патента: EP4427749A1. Автор: Man Sup Kwak,In Ho Park,Jeon-Soo Shin,Myeonggil HAN. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2024-09-11.

Methods for solubilization of arsenic sulfide minerals and their use as therapeutics

Номер патента: WO2021035226A3. Автор: Andrea Savarino,Lishomwa Ndhlovu,Iart Luca SHYTAJ,Marina Lusic,Bojana LUCIC,Mahmoud ELHEFNAWI. Владелец: Elhefnawi Mahmoud. Дата публикации: 2021-05-20.

Insulin-mimetics as therapeutic adjuncts for bone regeneration

Номер патента: US09999636B2. Автор: James P. O'connor,Joseph Benevenia,Sheldon S. Lin,Aaron WEY,Sangeeta SUBRAMANIAN,Paul CHIRICHELLA,Michael J. VIVES,John Koerner,David N. Paglia. Владелец: Rutgers State University of New Jersey. Дата публикации: 2018-06-19.

Neuronal nicotinic acetylcholine receptor partial agonists as therapeutics for chronic tinnitus

Номер патента: US20220088028A1. Автор: Brandon Cox,Donald Caspary,Thomas Brozoski. Владелец: Southern Illinois University System. Дата публикации: 2022-03-24.

The use of aryl-, heteroaryl- and alkyltartronic acids as therapeutical agents

Номер патента: AU5371294A. Автор: Gaetano Clavenna,Carmelo A. Gandolfi,Gianfranco Caselli,Marco Mantovanini,Claudio Omini,Lorella Cotini. Владелец: Dompe Farmaceutici SpA. Дата публикации: 1994-05-24.

Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions

Номер патента: AU2020370013A1. Автор: Luis Barbeito,Carlos BATTHYANY,Gloria Virginia LOPEZ,Carlos ESCANDE,Mariana INGOLD,Lucia COLELLA,Emiliano Trías,Sofía Ibarburu,Arturo Williams PORCAL QUINTA. Владелец: Univerisdad de la Republica. Дата публикации: 2022-05-26.

Methods for solubilization of arsenic sulfide minerals and their use as therapeutics

Номер патента: WO2021035226A9. Автор: Andrea Savarino,Lishomwa Ndhlovu,Iart Luca SHYTAJ,Marina Lusic,Bojana LUCIC,Mahmoud ELHEFNAWI. Владелец: Elhefnawi Mahmoud. Дата публикации: 2021-03-25.

Cdki pathway inhibitors as selective inhibitors of tumor cell growth

Номер патента: WO2007133772A3. Автор: Donald Porter,Bey-Dih Chang,Igor B Roninson. Владелец: Igor B Roninson. Дата публикации: 2008-11-20.

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

Номер патента: US09468598B2. Автор: Rango Dietrich,Hartmut Ney,Klaus Eistetter. Владелец: AstraZeneca AB. Дата публикации: 2016-10-18.

PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20130143941A1. Автор: Chen Haigang,Yang Meidong,Winters Conrad Stewart. Владелец: . Дата публикации: 2013-06-06.

SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS

Номер патента: US20130178536A1. Автор: Vander Jagt David L.,Deck Lorraine M.,Royer Robert E.,Heidrich John E.,Sillerud Laurel O.. Владелец: STC.UNM. Дата публикации: 2013-07-11.

Vanadium Compounds as Therapeutic Adjuncts for Cartilage Injury and Repair

Номер патента: US20150030653A1. Автор: Virak Tan,James P. O'connor,Joseph Benevenia,Sheldon S. Lin,Aaron WEY,David N. Paglia. Владелец: Rutgers State University of New Jersey. Дата публикации: 2015-01-29.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20160045477A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: . Дата публикации: 2016-02-18.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20170049750A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: . Дата публикации: 2017-02-23.

2H-INDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS FOR BRAIN CANCERS AND BRAIN METASTASES

Номер патента: US20220079944A1. Автор: Zhang Don,Greco Michael Nicholas,Costanzo Michael John,Peng Jirong. Владелец: . Дата публикации: 2022-03-17.

NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS

Номер патента: US20220088028A1. Автор: Caspary Donald,Brozoski Thomas,Cox Brandon. Владелец: . Дата публикации: 2022-03-24.

PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND THEIR USE AS THERAPEUTIC AGENTS

Номер патента: US20170095449A1. Автор: Chen Haigang,Yang Meidong,Winters Conrad Stewart. Владелец: . Дата публикации: 2017-04-06.

ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS

Номер патента: US20210121425A1. Автор: Barbeito Luis,Batthyány Carlos,López Gloria Virginia,Escande Carlos,Porcal Quinta Williams Arturo,Ingold Mariana,Colella Lucia,Trías Emiliano,Ibarburu Sofía. Владелец: . Дата публикации: 2021-04-29.

Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents

Номер патента: US20150126570A1. Автор: Strong Sarah,Sun Xicheng,Qiu Jian,Wasley Jan,Rosenthal Gary J.. Владелец: . Дата публикации: 2015-05-07.

Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma

Номер патента: US20210154220A1. Автор: Anto Ruby John,Nath Lekshmi Reghu. Владелец: . Дата публикации: 2021-05-27.

USE OF MILOXACIN IN PREPARATION OF MEDICINES FOR TREATING AND/OR PREVENTING DISEASES WITH T-TYPE CALCIUM CHANNELS AS THERAPEUTIC TARGET

Номер патента: US20220305002A1. Автор: Zhang Yuan,Sun Yufang,Tao Jin,JIANG Xinghong. Владелец: . Дата публикации: 2022-09-29.

Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma

Номер патента: US20190160088A1. Автор: Anto Ruby John,Nath Lekshmi Reghu. Владелец: . Дата публикации: 2019-05-30.

Adamantyl Derivatives as Therapeutic Agents

Номер патента: US20140256816A1. Автор: SINGH Rakesh K.,Moore Richard G.. Владелец: Women & Infants' Hospital of Rhode Island. Дата публикации: 2014-09-11.

PRION PROTEIN LIGANDS AS THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISORDERS

Номер патента: US20150196508A1. Автор: Harris David A.,IRACI Nunzio,Biasini Emiliano,Beeler Aaron,Fluharty Brian R.,Barreca Maria Letizia,Ingham Oscar. Владелец: . Дата публикации: 2015-07-16.

ANALOGUES OF CYSTEAMINE AS THERAPEUTIC AGENTS FOR CYSTIC FIBROSIS

Номер патента: US20200179312A1. Автор: Maiuri Luigi,Borella Fabio,Villella Valeria,Cozza Giorgio,Venerando Andrea. Владелец: I.E.R.F.C. EUROPEAN INSTITUTE FOR CYSTIC FIBROSIS RESEARCH. Дата публикации: 2020-06-11.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20150202194A1. Автор: WEINER David M.,DAVIS Robert E.,BRANN Mark R.,ANDERSSON Carl-Magnus A.,Uldam Allan K.. Владелец: . Дата публикации: 2015-07-23.

A COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION

Номер патента: US20170209401A1. Автор: GHAHARY Aziz,JALILI Reza B.,KILANI Runhangiz T.,LI Yunyuan. Владелец: . Дата публикации: 2017-07-27.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20170209424A1. Автор: WEINER David M.,DAVIS Robert E.,BRANN Mark R.,ANDERSSON Carl-Magnus A.,Uldam Allan K.. Владелец: . Дата публикации: 2017-07-27.

KCNQ CHANNELS AS THERAPEUTIC TARGETS

Номер патента: US20140303226A1. Автор: Cohen Ira S.,Cui Jianmin,Zou Xiaoqin. Владелец: . Дата публикации: 2014-10-09.

KCNQ CHANNELS AS THERAPEUTIC TARGETS

Номер патента: US20160228411A1. Автор: Cohen Ira S.,Cui Jianmin,Zou Xiaoqin. Владелец: . Дата публикации: 2016-08-11.

CIS- AND TRANS-SUFFRUTICOSOL D AS THERAPEUTIC AGENTS

Номер патента: US20180221329A1. Автор: Gao Ying,Altman Elliot. Владелец: Middle Tennessee State University. Дата публикации: 2018-08-09.

Histatins as therapeutic agents for ocular surface disease

Номер патента: US20170224771A1. Автор: Uma Mahesh Babu,Robert P. Sambursky,Robert W. VanDine. Владелец: Rapid Pathogen Screening Inc. Дата публикации: 2017-08-10.

INSULIN-MIMETICS AS THERAPEUTIC ADJUNCTS FOR BONE REGENERATION

Номер патента: US20140322292A1. Автор: Lin Sheldon S.,Benevenia Joseph,"OCONNOR James P.",Paglia David N.,Wey Aaron,Subramanian Sangeeta,Koerner John D.. Владелец: Rutgers, The State University of New Jersey. Дата публикации: 2014-10-30.

TYROSINE ISOMERS AS THERAPEUTIC AGENTS

Номер патента: US20140323575A1. Автор: Ruggiero Raul A.,Bruzzo Iraola Juan,Bustuoabad Oscar,Chiarella Paula,Meiss Roberto. Владелец: . Дата публикации: 2014-10-30.

Bis-Benzyl-Tetrahydroisoquinoline Derivatives As Therapeutics For Filovirus

Номер патента: US20190275027A1. Автор: TIDWELL Michael W.,Bauta William E.,Malakhov Andrey D.,JR. Alejandro,BOHMANN Jonathan A.,SANTILLAN. Владелец: . Дата публикации: 2019-09-12.

ISOXAZOLINES AS THERAPEUTIC AGENTS

Номер патента: US20150297596A1. Автор: Breinlinger Eric C.,Calderwood David J.,Swann Steven L.,Chitty Venkata Srikanth,Mukherjee Subhendu,Thunuguntla Siva Sanjeeva Rao,Hosahalli Subramanya Seetharama Shastry. Владелец: AbbVie Inc.. Дата публикации: 2015-10-22.

CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS

Номер патента: US20190290611A1. Автор: Gao Ying,Altman Elliot,Park Hyo,FARONE Anthony. Владелец: Middle Tennessee State University. Дата публикации: 2019-09-26.

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

Номер патента: US20150320718A1. Автор: ROBINSON JAMES,Verner Erik J.,Buggy Joseph J.,Sendzik Martin,Baskaran Chitra. Владелец: . Дата публикации: 2015-11-12.

CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS

Номер патента: US20170326098A1. Автор: Gao Ying,Altman Elliot,Park Hyo,FARONE Anthony. Владелец: Middle Tennessee State University. Дата публикации: 2017-11-16.

PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE OR BLOOD CANCERS

Номер патента: US20190328748A1. Автор: PRICE Matthew,Ames Tyler. Владелец: . Дата публикации: 2019-10-31.

COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS

Номер патента: US20160374992A1. Автор: Paik David Choohyun,Trokel Stephen Lewis. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2016-12-29.

2-ANILINOPYRIMIDINE DERIVATIVES AS THERAPEUTIC AGENTS FOR TREATMENT OF BRAIN CANCERS

Номер патента: US20190365755A1. Автор: GREEN Michael Alan,Zhang Don,Greco Michael Nicholas,Costanzo Michael John,Peng Jirong,Wilde Victoria Lynn. Владелец: Beta Pharma, Inc.. Дата публикации: 2019-12-05.

Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders

Номер патента: WO2004078261A1. Автор: Stuart Hamilton Ralston,Iain Robert Greig,Ruth Alexandra Ross,Aymen Ibrahim Idris Mohamed,Robert Jurgen Van't Hof. Владелец: THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN. Дата публикации: 2004-09-16.

Use of spiro-oxindole compounds as therapeutic agents

Номер патента: US8466188B2. Автор: Jianyu Sun,Serguei Sviridov,Sultan Chowdhury,Jianmin Fu,Rajender Kamboj,Tom Hsieh,Shifeng Liu,Robert Fraser,Mikhail Chafeev,Duanjie Hou,Shaoyi Sun,Mehran Seid Bagherzadeh,Nagasree Chakka,Vandna Raina. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2013-06-18.

Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents

Номер патента: US9504671B2. Автор: Haigang Chen,Conrad Stewart Winters,Meidong Yang. Владелец: Xenon Pharmaceuticals Inc. Дата публикации: 2016-11-29.

Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease

Номер патента: AU609932B2. Автор: Takahiro Ogawa,Yoshikazu Kuribayashi,Kazumichi Ushio,Akira Ohtori. Владелец: Senju Pharmaceutical Co Ltd. Дата публикации: 1991-05-09.

Combination of kynurenine and antigen-presenting cells (APCs) as therapeutic agents in immunomodulation and methods for their use in immunomodulation

Номер патента: JP6898228B2. Автор: アジズ・ガハリー,レザ・ビー・ジャリリ,ルハンジズ・ティー・キラニ,ユンユアン・リ. Владелец: ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア. Дата публикации: 2021-07-07.

Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents

Номер патента: CN1133434C. Автор: Rm,R·M·布尔克. Владелец: Allergan Sales LLC. Дата публикации: 2004-01-07.

Application of miloxacin in preparation of drug for treating and/or preventing disease taking t-type calcium channel as therapeutic target

Номер патента: WO2022077823A1. Автор: 张园,陶金,孙玉芳,蒋星红. Владелец: 苏州大学. Дата публикации: 2022-04-21.

Heterocyclic-substituted alkanamides as therapeutic compounds

Номер патента: EP1958666A1. Автор: Stefan Stutz,Peter Herold,Robert Mah,Vincenzo Tschinke,Dirk Behnke,Aleksandar Stojanovic,Stjepan Jelakovic,Christiane Marti. Владелец: Speedel Experimenta AG. Дата публикации: 2008-08-20.

Treatment of IBD and IBS using probiotic bacteria and fermented cereal as therapeutic effectors

Номер патента: JP5363811B2. Автор: ハンス イスラエルセン. Владелец: ノルディスク リバランス アクティーゼルスカブ. Дата публикации: 2013-12-11.

Enterostatin as therapeutic agent for hypoglycemia

Номер патента: WO2007101179A2. Автор: David A. York,Miejung Park. Владелец: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2007-09-07.

A combination of kynurenine and antigen presenting cells (apc) as therapeutics and methods for their use in immune modulation

Номер патента: CA2962655C. Автор: Aziz Ghahary,Reza B. JALILI,Ruhangiz T. Kilani,Yunyuan LI. Владелец: University of British Columbia. Дата публикации: 2022-08-09.

Mercaptoacylcysteine derivatives as therapeutic agents for osteoarthritis

Номер патента: CA2377686A1. Автор: Miwa Takai,Hiroyuki Aono. Владелец: Individual. Дата публикации: 2000-12-28.

Fractions of snake blood, their preparation and use as therapeutic agents

Номер патента: EP1349557A2. Автор: Fiorenzo Refosco,Marina Ziche,Mario Pazzagli,Angelo Michele Palmieri,Mario Leonardo Granito,Francesco Stanisci,Concetta Antonia Montemurno,Maria Squeo,Vincenzo De Filippis. Владелец: Individual. Дата публикации: 2003-10-08.

Fractions of snake blood, their preparation and use as therapeutic agents

Номер патента: WO2002047697A2. Автор: Fiorenzo Refosco,Marina Ziche,Mario Pazzagli,Angelo Michele Palmieri,Mario Leonardo Granito,Francesco Stanisci,Concetta Antonia Montemurno,Maria Squeo,Vincenzo De Filippis. Владелец: Vincenzo De Filippis. Дата публикации: 2002-06-20.

Fractions of snake blood, their preparation and use as therapeutic agents

Номер патента: WO2002047697A3. Автор: Fiorenzo Refosco,Marina Ziche,Mario Pazzagli,Angelo Michele Palmieri,Mario Leonardo Granito,Francesco Stanisci,Concetta Antonia Montemurno,Maria Squeo,Filippis Vincenzo De. Владелец: Filippis Vincenzo De. Дата публикации: 2002-11-07.

Use of inclusion bodies as therapeutic agents

Номер патента: EP2429562A1. Автор: Jose Luis CORCHERO NIETO,Antonio Pedro Villaverde Corrales,Esther Vázquez Gómez,Elena Garcia-Fruitos. Владелец: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN. Дата публикации: 2012-03-21.

Use of Inclusion Bodies as Therapeutic Agents

Номер патента: US20140308237A1. Автор: Jose Luis CORCHERO NIETO,Antonio Pedro Villaverde Corrales,Esther Vázquez Gómez,Elena Garcia-Fruitos. Владелец: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN. Дата публикации: 2014-10-16.

Use of Inclusion Bodies as Therapeutic Agents

Номер патента: US20120148529A1. Автор: Esther Vázquez Gómez,Elena Garcia-Fruitos,Jose Luis Corchero,Antonio Pedro Villa Verde Corrales. Владелец: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN. Дата публикации: 2012-06-14.

Microparticles dried by spraying as therapeutic carriers

Номер патента: RU2147226C1. Автор: Дерек Саттон Эндрю,Алан Джонсон Ричард. Владелец: Квадрант Хэлткэа (Ю Кей) Лимитед. Дата публикации: 2000-04-10.

Use of relaxin as therapeutic or preventing agent

Номер патента: WO1995003822A3. Автор: Mario Bigazzi. Владелец: Mario Bigazzi. Дата публикации: 1995-03-30.

Cortistatin 17 and neuropeptide 1 for use as therapeutic agent

Номер патента: WO2009043523A3. Автор: Gerald Bacher,Fabio Cavalli,Dorian Bevec,Vera Cavalli. Владелец: Mondobiotech Lab Ag. Дата публикации: 2009-07-23.

Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary and para-alimentary (food-supplements) products; their methods of preparation; their uses as preventive and/or as therapeutic agents

Номер патента: WO2002013838A1. Автор: Manuel De Mello Pinto-Ribeiro. Владелец: Fundaçao Essprit-Icarus (Fundaçao Europeia De Investigaçao Medica), Ngo; Ipss.. Дата публикации: 2002-02-21.

Use of a peptide as therapeutic agent

Номер патента: WO2009043524A3. Автор: Gerald Bacher,Fabio Cavalli,Dorian Bevec,Vera Cavalli. Владелец: Mondobiotech Lab Ag. Дата публикации: 2009-07-09.

Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary and para-alimentary (food-supplements) products; their methods of preparation; their uses as preventive and/or as therapeutic agents

Номер патента: EP1399172A1. Автор: Manuel De Mello Pinto-Ribeiro. Владелец: Fundacao Esspritt-Icarus (fundacao Europeia De Investigacao Medica) Ngo Ipss. Дата публикации: 2004-03-24.

Use of L. undulata extract as therapeutics for allergic diseases

Номер патента: US7993653B2. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: lndustry University Cooperation Foundation of Pukyong National University. Дата публикации: 2011-08-09.

Use of L. undulata extract as therapeutics for allergic diseases

Номер патента: US8486415B2. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: Pukyong National University. Дата публикации: 2013-07-16.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: US20060008483A1. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Biotech Tools SA. Дата публикации: 2006-01-12.

Novel use of l. undulata extract as therapeutics for allergic diseases

Номер патента: US20100129393A1. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: lndustry University Cooperation Foundation of Pukyong National University. Дата публикации: 2010-05-27.

Novel use of l. undulata extract as therapeutics for allergic diseases

Номер патента: US20120237541A1. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: Individual. Дата публикации: 2012-09-20.

Novel use of l. undulata extract as therapeutics for allergic diseases

Номер патента: US20110256171A1. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: Individual. Дата публикации: 2011-10-20.

Use of L. undulata extract as therapeutics for allergic diseases

Номер патента: US8211441B2. Автор: Inhak Choi,Se-Kwon Kim,Won-kyo Jung,Yung Hyun Choi,Il-Whan Choi,Sung Su Yea. Владелец: lndustry University Cooperation Foundation of Pukyong National University. Дата публикации: 2012-07-03.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: WO2003094827A3. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Sebastien Baudart. Дата публикации: 2004-01-29.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: EP1501481A2. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Biotech Tools SA. Дата публикации: 2005-02-02.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: WO2003094827A2. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Biotech Tools SA. Дата публикации: 2003-11-20.

Fractions of snake blood, their preparation and use as therapeutic agents

Номер патента: WO2002047697A8. Автор: Fiorenzo Refosco,Marina Ziche,Mario Pazzagli,Angelo Michele Palmieri,Mario Leonardo Granito,Francesco Stanisci,Concetta Antonia Montemurno,Maria Squeo,Filippis Vincenzo De. Владелец: Filippis Vincenzo De. Дата публикации: 2003-03-20.

Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease

Номер патента: CA2723270C. Автор: Ezio Ghigo,Maria Felice Brizzi,Giampiero Muccioli. Владелец: ALIZÉ PHARMA SAS. Дата публикации: 2018-03-13.

Fractions of snake blood, their preparation and use as therapeutic agents

Номер патента: AU2002217110A1. Автор: Fiorenzo Refosco,Marina Ziche,Mario Pazzagli,Angelo Michele Palmieri,Mario Leonardo Granito,Francesco Stanisci,Concetta Antonia Montemurno,Maria Squeo,Vincenzo De Filippis. Владелец: Individual. Дата публикации: 2002-06-24.

Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Номер патента: AU715512B2. Автор: Richard Alan Johnson,Andrew Derek Sutton,Jill Elizabeth Ogden. Владелец: Quadrant Healthcare UK Ltd. Дата публикации: 2000-02-03.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: AU2003229409A8. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Biotech Tools SA. Дата публикации: 2003-11-11.

Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Номер патента: AU2302097A. Автор: Richard Alan Johnson,Andrew Derek Sutton,Jill Elizabeth Ogden. Владелец: Quadrant Healthcare UK Ltd. Дата публикации: 1997-10-22.

Spray-dried microparticles as therapeutic vehicles for use in gene therapy.

Номер патента: ZA972837B. Автор: Richard Alan Johnson,Andrew Derek Sutton,Jill Elizabeth Ogden. Владелец: Andaris Ltd. Дата публикации: 1998-04-03.

Natural ingredients formulations use as therapeutics

Номер патента: AU2020100352A4. Автор: Gang Peng,Sa Xiao,Zhiyong He. Владелец: Apex Glory Int Trading Pty Ltd. Дата публикации: 2020-04-16.

Porous microcapsules and their use as therapeutic and diagnostic vehicles

Номер патента: AU4713397A. Автор: Nicholas David Osborne,Graham John Turnbull. Владелец: Andaris Ltd. Дата публикации: 1998-05-15.

Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles

Номер патента: AU2003229409A1. Автор: Thierry Legon,Frederic Henot,Roland Frebillot,Sebastien Baudart. Владелец: Biotech Tools SA. Дата публикации: 2003-11-11.

Txa2 inhibitor as stimulator or inducer of mhc class i cross-presentation

Номер патента: WO2016102352A1. Автор: Jost Enninga,Alexandre Bobard. Владелец: INSTITUT PASTEUR. Дата публикации: 2016-06-30.

Use of Inclusion Bodies as Therapeutic Agents

Номер патента: US20120148529A1. Автор: Esther Vázquez Gómez,Elena Garcia-Fruitos,Jose Luis Corchero,Antonio Pedro Villa Verde Corrales. Владелец: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina CIBERBBN. Дата публикации: 2012-06-14.

INSULIN-MIMETICS AS THERAPEUTIC ADJUNCTS FOR BONE REGENERATION

Номер патента: US20150010499A1. Автор: Lin Sheldon S.,Benevenia Joseph,"OCONNOR James P.",Paglia David N.,Wey Aaron,Subramanian Sangeeta,Koerner John D.. Владелец: . Дата публикации: 2015-01-08.

High-Throughput Identification of Patient-Specific Neoepitopes As Therapeutic Targets For Cancer Immunotherapies

Номер патента: US20190034582A1. Автор: NGUYEN ANDREW,Soon-Shiong Patrick,Sanborn John Zachary,NIAZI Kayvan,RABIZADEH Shahrooz,VASKE Charles Joseph,Benz Steven Charles. Владелец: . Дата публикации: 2019-01-31.

Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents

Номер патента: US20140154257A1. Автор: DeChristopher Luanne Robalo. Владелец: . Дата публикации: 2014-06-05.

Polymerizable quantum dot nanoparticles and their use as therapeutic, ablation and tattooing agents

Номер патента: US20180092815A1. Автор: Imad Naasani,Mark Saunders. Владелец: Nanoco Technologies Ltd. Дата публикации: 2018-04-05.

ACETYLATED CRYSTALLIN POLYPEPTIDES AND MIMETICS THEREOF AS THERAPEUTIC AGENTS

Номер патента: US20150133388A1. Автор: NAGARAJ Ram,Nahomi Rooban B.. Владелец: . Дата публикации: 2015-05-14.

INSULIN-MIMETICS AS THERAPEUTIC ADJUNCTS FOR BONE REGENERATION

Номер патента: US20160151416A1. Автор: Lin Sheldon S.,Koerner John,Vives Michael J.,Benevenia Joseph,"OCONNOR James P.",Paglia David N.,Wey Aaron,Subramanian Sangeeta,Chirichella Paul. Владелец: . Дата публикации: 2016-06-02.

USES OF BT LIPOPEPTIDES AS THERAPEUTICS FOR OBESITY AND RELATED DISEASES

Номер патента: US20160193287A1. Автор: Jiang Yiwei. Владелец: . Дата публикации: 2016-07-07.

Use of Inclusion Bodies as Therapeutic Agents

Номер патента: US20140308237A1. Автор: Villaverde Corrales Antonio Pedro,Vázquez Gómez Esther,GARCIA-FRUITOS Elena,CORCHERO NIETO Jose Luis. Владелец: . Дата публикации: 2014-10-16.

PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS

Номер патента: US20200261560A1. Автор: SHIAO Tze Chieh,ROY Rene. Владелец: . Дата публикации: 2020-08-20.

LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER

Номер патента: US20140377263A1. Автор: Lieberman Judy,SONG Erwei,YU Fengyan,HU Xiaoqu. Владелец: THE CHILDREN'S HOSPITAL CORPORATION. Дата публикации: 2014-12-25.

NUCLEAR PARASPECKLE ASSEMBLY TRANSCRIPT 1 AS THERAPEUTIC TARGETING IN NEURODEGENERATION

Номер патента: US20190282605A1. Автор: Kuo Hung-Chih,Wu Yi-Ying. Владелец: . Дата публикации: 2019-09-19.

CARDIOSPHERE-DERIVED CELLS (CDCS) AS THERAPEUTIC AGENTS FOR PULMONARY HYPERTENSION

Номер патента: US20170296591A1. Автор: Lewis Michael I.,Marbán Eduardo. Владелец: CEDARS-SINAI MEDICAL CENTER. Дата публикации: 2017-10-19.

PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS

Номер патента: US20190290746A1. Автор: SHIAO Tze Chieh,ROY Rene. Владелец: . Дата публикации: 2019-09-26.

Metallic Gold Cluster Molecules As Therapeutic Agents for Arthritic Animals

Номер патента: US20170304408A1. Автор: Gao Xueyun. Владелец: . Дата публикации: 2017-10-26.

ZINC OR MANGANESE COMPOUNDS AS THERAPEUTIC ADJUNCTS FOR CARTILAGE REGENERATION AND REPAIR

Номер патента: US20180318344A1. Автор: Lin Sheldon S.,Benevenia Joseph,"OCONNOR James P.",Tan Virak,Paglia David N.,Wey Aaron. Владелец: . Дата публикации: 2018-11-08.

Polyamine analogs as therapeutic agents for skin diseases

Номер патента: WO2007111993A2. Автор: Lawrence J. Marton,Randolph M. Johnson. Владелец: Cellgate, Inc.. Дата публикации: 2007-10-04.

Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)

Номер патента: EP2197477A2. Автор: Gerald Bacher,Fabio Cavalli,Dorian Bevec,Vera Cavalli. Владелец: Mondobiotech Laboratories Ag. Дата публикации: 2010-06-23.

Ratite extracts as therapeutic agents

Номер патента: CA2297984A1. Автор: Donna L. Cardinale Fezler. Владелец: Donna L. Cardinale Fezler. Дата публикации: 1999-02-18.

Astressin and beta- endorphin for use as therapeutic agents

Номер патента: US20100204111A1. Автор: Dorian Bevec. Владелец: Mondobiotech Laboratories Ag. Дата публикации: 2010-08-12.

Uses of BT lipopeptides as therapeutics for obesity and related diseases

Номер патента: US9744211B2. Автор: Yiwei Jiang. Владелец: MYGALAXY Ltd Co. Дата публикации: 2017-08-29.

Insulin-mimetics as therapeutic adjuncts for bone regeneration

Номер патента: EP2785358B1. Автор: Joseph Benevenia,Sheldon Suton Lin,David Naisby Paglia,James Patrick O'connor,Aaron WEY,Sangeeta SUBRAMANIAN,Paul CHIRICHELLA,Michael J. VIVES,John D. Koerner. Владелец: Rutgers State University of New Jersey. Дата публикации: 2022-06-01.

Lipid constructs as therapeutic and imaging agents

Номер патента: CA2455598A1. Автор: Neal Edward Dechene,Charles Aaron Wartchow,John S. Pease. Владелец: Individual. Дата публикации: 2003-02-13.

Screening method of substances effective as therapeutic agents for prostate cancer

Номер патента: JPWO2010087319A1. Автор: 智之 鈴木,貞夫 黒光,崇 古谷,鈴木　智之,健太郎 遠城,綾 菊地,行孝 出山,良子 栗原. Владелец: Astellas Pharma Inc. Дата публикации: 2012-08-02.

Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets

Номер патента: WO2003025128A9. Автор: Timothy A Haystead. Владелец: Univ Duke. Дата публикации: 2004-04-29.

Psa and klk2 as therapeutic targets and molecules inhibiting psa and klk2

Номер патента: US20110177059A1. Автор: Chawnshang Chang. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2011-07-21.

Psa and klk2 as therapeutic targets and molecules inhibiting psa and klk2

Номер патента: WO2010017257A2. Автор: Chawnshang Chang. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2010-02-11.

miRNAs AS THERAPEUTIC TARGETS IN CANCER

Номер патента: US20160024597A1. Автор: Wang Yuan,SONG BO,Ju Jingfang. Владелец: . Дата публикации: 2016-01-28.

USE OF miR-23a-3p AND/OR miR-27a-3p MIMICS AS THERAPEUTIC AGENTS FOR INHIBITION OF NEURONAL APOPTOSIS FOLLOWING BRAIN INJURY

Номер патента: US20150037403A1. Автор: FADEN ALAN,SABIRZHANOV BORIS,STOICA BOGDAN. Владелец: . Дата публикации: 2015-02-05.

MODULATION OF PRE-MRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE

Номер патента: US20170037411A1. Автор: Lutz Gordon J.,Tallent Melanie K.,Lykens Nicole Michele. Владелец: . Дата публикации: 2017-02-09.

MODULATION OF PRE-MRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE

Номер патента: US20140249210A1. Автор: Lutz Gordon J.,Tallent Melanie K.,Lykens Nicole Michele. Владелец: Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine. Дата публикации: 2014-09-04.

Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same

Номер патента: US20200263250A1. Автор: Jeffrey A. Loeb,Leonard Lipovich. Владелец: WAYNE STATE UNIVERSITY. Дата публикации: 2020-08-20.

INHIBITORS OF MICRORNAs miR-155, miR-103, miR-105 and miR-107 THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF

Номер патента: US20180291374A1. Автор: Kenneth D. Bloch,Pankaj Arora,Connie Wu,Christopher Newton-Cheh,Thomas J. Wang. Владелец: General Hospital Corp. Дата публикации: 2018-10-11.

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

Номер патента: US20150307937A1. Автор: Lipovich Leonard,Loeb Jeffrey A. Владелец: WAYNE STATE UNIVERSITY. Дата публикации: 2015-10-29.

DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS

Номер патента: US20150329864A1. Автор: Iyer Radhakrishnan P.,Coughlin John Edward. Владелец: Spring Bank Pharmaceuticals, Inc.. Дата публикации: 2015-11-19.

Activity-dependent gene pairs as therapeutic targets and methods and devices to identify the same

Номер патента: US20170356043A1. Автор: Jeffrey A. Loeb,Leonard A. Lipovich. Владелец: WAYNE STATE UNIVERSITY. Дата публикации: 2017-12-14.

Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof

Номер патента: WO2006003488A2. Автор: Chris Reutelingsperger. Владелец: I.P. Randwijck B.V.. Дата публикации: 2006-01-12.

Application of fullerene c60 aqueous solution as therapeutic agent at atopic dermatitis disease

Номер патента: RU2641091C1. Автор: Муса Рахимович Хаитов,Сергей Михайлович Андреев,Надежда Николаевна Шершакова,Елена Николаевна Барабошкина,Артем Андреевич Шатилов,Дарья Дмитриевна Шабанова. Владелец: Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России). Дата публикации: 2018-01-15.

Pyridazine derivatives and their use as therapeutic agents

Номер патента: SG145720A1. Автор: . Владелец: Zhang Zaihui Agent S Ella Cheo. Дата публикации: 2008-09-29.

Substituted phthalazines and their use as therapeutic agents

Номер патента: JO971B1. Автор: ويليام بريستو نورمان,ادوارد ماسي بيتر,جون نيكول كينيث,فريمان سيم مالكولم. Владелец: ذي بوتس كومباني ليمتد. Дата публикации: 1979-12-01.

Anti-pd1 antibodies and their use as therapeutics and diagnostics

Номер патента: SG10201810284VA. Автор: Hao Peng,Kang Li,QI Liu,Jing Song,Tong Zhang,Lanlan Xu. Владелец: Beigene Ltd. Дата публикации: 2018-12-28.

3-acylaminopyridin derivatives, applicable as serine-threonine proteinkinase gsk3b inhibitors, as medications for type ii diabetes treatment

Номер патента: RU2570907C2. Автор: Алексей Сергеевич Морозов,Николай Серафимович Зефиров,Валерий Николаевич Даниленко,Владимир Александрович Палюлин,Мария Георгиевна Алексеева,Дилара Анваровна Мавлетова,Дмитрий Иванович Осолодкин. Владелец: Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан". Дата публикации: 2015-12-20.

ARGINASE INHIBITORS AS THERAPEUTICS

Номер патента: US20120129806A1. Автор: . Владелец: . Дата публикации: 2012-05-24.

Arginase inhibitors and methods of use

Номер патента: AU2010206535B2. Автор: Gary Lee Olson,David W. Christianson,Bruce Edward Tomczuk,Richard Scott Pottorf,Andrew Vargha Colasanti. Владелец: Corridor Pharmaceuticals Inc. Дата публикации: 2015-08-27.

Potassium channel inhibitors as therapeutic agents in lymphoma and leukaemia

Номер патента: RU2533288C2. Автор: Евгений Александрович Никитин,Анна Вячеславовна Баранова,Андрей Борисович Судариков,Андрей Владимирович Марахонов,Михаил Юрьевич Скоблов,Белла Вениаминовна Бидерман. Владелец: Федеральное государственное бюджетное учреждение "Медико-генетический научный центр" Российской академии медицинских наук. Дата публикации: 2014-11-20.

Use of thymohexin as therapeutic agent

Номер патента: TN2011000576A1. Автор: V Lebedev V,Boujbel L,B Bonicek B,Matha V. Владелец: Les Laboratoires Medis S A. Дата публикации: 2013-05-24.

Pyridazine derivatives and their use as therapeutic agents

Номер патента: RU2326118C2. Автор: Сергей СВИРИДОВ,Хайнц У. ГШВЕНД,Шифэн ЛЮ,Райэндер КАМБОЙ,Зайсюй ЧЖАН,Яньминь ФУ,Шаои СУНЬ,Михаил ЧАФЕЕВ,Мелвин АБРЕО,Майкл Д. УИНТЕР,Марк У. ХОЛЛАДЕЙ,Веньбао ЛИ,Чи ТУ,Вандна РАЙНА,Нагасри ЧАККА,Султан ЧОВДХУРУ,Дуаньце ХОУ,Вишнумурту КОДУМУРУ,Сеньгень СУНЬ. Владелец: Зинон Фармасьютиклз Инк.. Дата публикации: 2008-06-10.

Antibodies for use as therapeutics against bacterial infections

Номер патента: GB202117107D0. Автор: . Владелец: Kymab Ltd. Дата публикации: 2022-01-12.

Antibodies for use as therapeutics against bacterial infections

Номер патента: GB202117106D0. Автор: . Владелец: Kymab Ltd. Дата публикации: 2022-01-12.

Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents

Номер патента: HUP9903036A3. Автор: . Владелец: Indena SpA. Дата публикации: 2001-08-28.

Oncolytic Viruses as Therapeutic Agents for Treating Cancer

Номер патента: AU2020904486A0. Автор: Darren Shafren. Владелец: Immvirx Pty Ltd. Дата публикации: 2021-01-07.

Oncolytic Viruses as Therapeutic Agents for Treating Cancer

Номер патента: AU2020904485A0. Автор: Darren Shafren. Владелец: Immvirx Pty Ltd. Дата публикации: 2021-01-07.

Oncolytic viruses as therapeutic agents for treating cancer

Номер патента: AU2023900305A0. Автор: Darren Shafren. Владелец: Immvirx Pty Ltd. Дата публикации: 2023-02-23.

Alkane diol derivatives as therapeutic agents for the treatment of bone conditions

Номер патента: AU2002339076A1. Автор: Stuart Hamilton Ralston,Iain Robert Greig,Robert Jurgen Van't Hof,Kenneth John Armour. Владелец: University of Aberdeen. Дата публикации: 2003-05-12.

Antibodies for use as therapeutics against bacterial infections

Номер патента: GB202117101D0. Автор: . Владелец: Kymab Ltd. Дата публикации: 2022-01-12.

Oncolytic viruses as therapeutic agents for treating cancer

Номер патента: AU2023900306A0. Автор: Darren Shafren. Владелец: Immvirx Pty Ltd. Дата публикации: 2023-02-23.

ไอโซซาโซลีน (Isoxazolines) ในฐานะเป็นตัวกระทำทางการรักษา ISOXAZOLINES AS THERAPEUTIC AGENTS

Номер патента: TH155598A. Автор: เจ. คาลเดอร์วูด นายเดวิด,ซี. เบรนลิงเจอร์ นายอีริค,แอล. สวานน์ นายสตีเวน,มุกเคอร์จี นายสุเพนดุ,จิตตี นายเวนกะตา-ศรีกานต์,ศานจีวา ราว ทุนุกันตลา นายศิวา,สีทารามา แชสทรี โฮซาฮาลลี นายสุบราแมนยา. Владелец: นางสาวสนธยา สังขพงศ์. Дата публикации: 2016-09-06.

Porous microcapsules and their use as therapeutic and diagnostic vehicles

Номер патента: MXPA99003630A. Автор: John Turnbull Graham,David Osborne Nicholas. Владелец: Quadrant Healthcare (Uk) Limited. Дата публикации: 2000-09-04.

Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma

Номер патента: US20120021047A1. Автор: Campisi Judith,Desprez Pierre-Yves. Владелец: . Дата публикации: 2012-01-26.

PROTEIN BIOMARKERS FOR SOFT TISSUE DISEASE DIAGNOSIS AND AS THERAPEUTIC TARGETS FOR ORAL CARE INTERVENTION

Номер патента: US20120028261A1. Автор: Trivedi Harsh M.,Xu Tao,Yang Ying. Владелец: Colgate-Palmolive Company. Дата публикации: 2012-02-02.

F11 RECEPTOR (F11R) ANTAGONISTS AS THERAPEUTIC AGENTS

Номер патента: US20120035094A1. Автор: . Владелец: . Дата публикации: 2012-02-09.

SPIROHETEROCYCLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20120035199A9. Автор: Fu Jianmin,Kamboj Rajender,Chafeev Mikhail,Chowdhury Sultan,Fraser Robert,Liu Shifeng,Bagherzadeh Mehran Seid,Sun Jianyu,Sviridov Serguei. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2012-02-09.

DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS

Номер патента: US20120053226A1. Автор: Iyer Radhakrishnan P.,Coughlin John E.. Владелец: Spring Bank Pharmaceuticals, Inc.. Дата публикации: 2012-03-01.

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

Номер патента: US20120064032A1. Автор: ROBINSON JAMES,Verner Erik J.,Buggy Joseph J.,Sendzik Martin,Baskaran Chitra. Владелец: Pharmacyclics, Inc.. Дата публикации: 2012-03-15.

1, 4-Benzoxazine Compounds and Derivatives Thereof as Therapeutic Drugs for the Treatment of Neurodegenerative Conditions

Номер патента: US20120094991A1. Автор: . Владелец: . Дата публикации: 2012-04-19.

BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS

Номер патента: US20120122811A1. Автор: Bond Silas,Duan Jianmin,Francom Paula,Frey Barbara,Bethell Richard,Kukolj George. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2012-05-17.

SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20120122909A9. Автор: CHAKKA Nagasree,Fu Jianmin,Sun Shaoyi,Hou Duanjie,Kamboj Rajender,Chafeev Mikhail,Chowdhury Sultan,Fraser Robert,Hsieh Tom,Liu Shifeng,Ralna Vandna,Bagherzadeh Mehran Seid,Sun Jianyu,Sviridov Serguei. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2012-05-17.

Caveolin peptides and their use as therapeutics

Номер патента: US20120149651A1. Автор: Sessa William C.. Владелец: YALE UNIVERSITY. Дата публикации: 2012-06-14.

Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning

Номер патента: US20120157462A1. Автор: Johnson Alan T.,JIAO Guan-Sheng. Владелец: . Дата публикации: 2012-06-21.

Crosslinked Polymers with the Crosslinker as Therapeutic For Sustained Release

Номер патента: US20120197028A1. Автор: . Владелец: Confluent Surgical, Inc. Дата публикации: 2012-08-02.

Vanilloid Fatty Hydroxamates as Therapeutic Anti-inflammatory Pharmaceuticals

Номер патента: US20120252891A1. Автор: Laskin Jeffrey D.,Heindel Ned D.,Lacey Carl Jeffrey,Pillai Abhilash N.,Gordon Marion,Heck Diane E.. Владелец: . Дата публикации: 2012-10-04.

NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20120258993A1. Автор: Giannini Giuseppe,Cabri Walter,Hanessian Stephan,Auzzas Luciana,Larsson Andreas. Владелец: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.. Дата публикации: 2012-10-11.

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

Номер патента: US20120277221A1. Автор: . Владелец: . Дата публикации: 2012-11-01.

SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

Номер патента: US20120295897A1. Автор: Wood Mark,CHAKKA Nagasree,Fu Jianmin,Jia Qi,Sun Shaoyi,Chafeev Mikhail,Chowdhury Sultan,Hsieh Tom,Liu Shifeng,Sun Jianyu,Sviridov Serguei,ZENOVA Alla Yurevna,FRASER Lauren,LANGILLE Jonathan,GAUTHIER Simon J.,DOUGLAS Amy Frances,CIKOJEVIC Zoran,Cadieux Jean-Jacques. Владелец: Xenon Pharmaceuticals Inc.. Дата публикации: 2012-11-22.

MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE

Номер патента: US20120316223A1. Автор: . Владелец: Philadelphia Health and Education Corp. d/b/a Drexel University College of Medicine. Дата публикации: 2012-12-13.

SOLUBLE PROTEINS FOR USE AS THERAPEUTICS

Номер патента: US20130011401A1. Автор: Huber Thomas,Kolbinger Frank,Sarfati Marie,Welzenbach Karl. Владелец: NOVARTIS AG. Дата публикации: 2013-01-10.

BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS

Номер патента: US20130018013A1. Автор: Draffan Alistair George,Harding Michael,Bond Silas,Duan Jianmin,Francom Paula,Frey Barbara,Hufton Richard,Jahangiri Saba,Lilly Michael John,Tyndall Edward,Bethell Richard,Kukolj George. Владелец: BIOTA SCIENTIFIC MANAGEMENT PTY LTD. Дата публикации: 2013-01-17.

ORGANOMETALLIC COMPLEXES AS THERAPEUTIC AGENTS

Номер патента: US20130023511A1. Автор: KALKUNTE Satyan,BRARD Laurent,Strongin Robert,Singh Rakesh,Alpturk Onur. Владелец: . Дата публикации: 2013-01-24.

Isoxazolines as Therapeutic Agents

Номер патента: US20130023526A1. Автор: Breinlinger Eric C.,Calderwood David J.,Swann Steven L.,Chitty Venkata Srikanth,Shastry Hosahalli Subramanyah Seetharama,Mukherjee Subhendu,Thunuguntla Siva Sanjeeva Rao. Владелец: ABBOTT LABORATORIES. Дата публикации: 2013-01-24.

SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES

Номер патента: US20130040934A1. Автор: Cmiljanovic Vladimir,Cmiljanovic Natasa,Giese Bernd,Wymann Matthias. Владелец: . Дата публикации: 2013-02-14.

EXTRACELLULAR IFI16 AS THERAPEUTIC AGENTS

Номер патента: US20130058956A1. Автор: Mondini Michele,Costa Silvia,Gariglio Marisa,Landolfo Santo. Владелец: Universita degli Studi del Piemonte Orientale "A Avogedro" (University of Piemonte Orientale). Дата публикации: 2013-03-07.

Novel spiroheterocyclic compound and application of same serving as therapeutic agent

Номер патента: CN102268000A. Автор: 王怡,梁广,李校堃,吴建章,赵承光,蔡跃飘. Владелец: Wenzhou Medical College. Дата публикации: 2011-12-07.

Modified peptides as therapeutic agents

Номер патента: AU2004231208A1. Автор: Chuan-Fa Liu,Ulrich Feige,Thomas Charles Boone,Jean Marie Gudas,Janet C. Cheetham. Владелец: AMGEN INC. Дата публикации: 2004-12-09.

Substituted fused and bridged bicyclic compounds as therapeutic agents

Номер патента: CA2189567C. Автор: HONG Hu,Gunnar Erik Jagdmann, Jr.,Jose Serafin Mendoza. Владелец: Eli Lilly and Co. Дата публикации: 2006-02-14.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.